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The large-scale production of monoclonal antibodies (MAb) by mammalian cells in batch 
and fed-batch culture systems is limited by the unwanted decline in cell viability and 
reduced productivity that may result from changes in culture conditions. Therefore, it 
becomes imperative to gain an in-depth knowledge of the factors affecting cell growth 
and cell viability that in turn determine the antibody production. An attempt has been 
made to obtain an overall model that predicts the behaviour of both batch and fed-batch 
systems as a function of the extra-cellular nutrient/metabolite concentrations. Such model 
formulation will aid in identifying and eventually controlling the dominant factors in play 
to optimize monoclonal antibody (MAb) production in the future. 
 
Murine hybridoma 130-8F producing anti-F-glycoprotein monoclonal antibody was 
grown in D-MEM medium (Gibco 12100) with 2% FBS. A systematic approach based on 
Metabolic Flux Analysis (MFA) was applied for the calculation of intracellular fluxes for 
metabolites from available extracellular concentration values. Based on the set of 
identified significant fluxes (from MFA), the original metabolic network was reduced to 
a set of significant reactions. The reactions in the reduced metabolic network were then 
combined to yield a set of macro-reactions obeying Monod kinetics. Half saturation 
constants were fixed empirically to avoid computational difficulties that parameter 
estimation for an over-parameterized system of equations would cause. Using Quadratic 
Programming, the proposed Dynamic Model was calibrated and model prediction was 
carried out individually for batch and fed-batch runs. Flux distribution for batch and fed-
batch modes were compared to determine whether the same model structure could be 
applied to both the feeding profiles.  Correlation analysis was performed to formulate a 
Biomass Model for predicting cell concentration and viability as a function of the 
extracellular metabolite concentrations in batch and fed-batch experiments. Quadratic 
Programming was applied once again for estimation of growth and death coefficients in 
the equations for viable and dead cell predictions. The prediction accuracy of these model 
equations was tested by using experimental data from additional runs. Further, the 
 
 iv 
Dynamic Model was integrated with the Biomass Model to get an Integrated Model 
capable of predicting concentration values for substrates, extracellular metabolites, and 
viable and dead cell concentration by utilizing only starting concentrations as input. 
 
It was found that even though the set of significant fluxes was the same for batch and fed-
batch operations, the order of these fluxes was different between the two systems. There 
was a gradual metabolic shift in the fed-batch system with time indicating that under 
conditions of nutrient limitation, the available energy is channeled towards maintenance 
rather than growth. Also, available literature with regard to cell kinetics during fed-batch 
operation suggests that under nutrient limited conditions, the cells move from a viable, 
non-apoptotic state to a viable apoptotic state. This is believed to lead to variations in 
antibody production rates and might explain inaccurate predictions for MAb obtained 
from the model proposed in the current work. As a result more detailed analysis of the 
system and in particular, the switch from non-apoptotic to apoptotic state is required. 
 
As a continuation of efforts to study the system in-depth, fluorescence imaging is 
currently being applied as a tool to capture the changes in cell morphology along the 
course of experimental batch and fed-batch runs. These experiments maybe able to 
elucidate the transition from non-apoptotic to apoptotic cells and this information maybe 
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1.1 Need for Large Scale Production of Monoclonal Antibodies (MAb)  
The last decade has seen an unprecedented increase in the demand for biopharmaceuticals produced 
from animal cell culture processes, primarily due to their application in diagnostics and therapeutic 
treatments. Mammalian cells are widely used to produce recombinant proteins such as hormones, 
enzymes, cytokines and antibodies for therapeutic purposes. Despite increasing demand, the 
manufacturers are faced with the challenge of meeting lower cost expectations of the health system 
and competition from other manufacturers. All these factors make it crucial that a more efficient 
production strategies than the ones currently in practice are devised for the large-scale manufacture of 
these drugs.  
1.2 Fermentation Strategies for Large Scale Production 
There are three possible fermentation strategies commonly utilized for antibody production 
on an industrial scale: 
• Batch Operation 
• Continuous Operation 
• Fed-batch Operation 
These operations are discussed in more detail below. 
1.2.1 Batch Operation 
Suspension cultures were initially propagated in batch operated bioreactors in which cells 
grow in a finite volume of liquid nutrient medium and follow a sigmoid pattern of growth. 
All cells are harvested at the same time. However, batch processes suffer from problems of 
nutrient limitation, low cell densities, low productivity and high toxin accumulation that 




1.2.2 Continuous Operation 
In continuous fermentations fresh nutrient medium is added continuously to the fermentation 
vessel, accompanied by a corresponding continuous withdrawal of a portion of the medium 
for recovery of cells or fermentation products. Operating with continuous cultures makes it 
possible to achieve high cell density and high productivity without any nutrient limitation or 
growth inhibition due to toxin build-up in the system. But the drawback of continuous culture 
is that it requires a higher level of technical skill to operate and loss of productivity due to 
genetic changes may also occur. Additionally, continuous fermentations often waste nutrient 
substrate. 
1.2.3 Fed-batch Operation 
Fedbatch operations combine the advantages of batch and continuous modes and minimize 
the disadvantages that either of the two possesses. Just like batch operations, they are 
relatively easy to perform and simple to scale-up and unlike continuous culture systems, no 
additional special pieces of equipment are required to switch from batch to fed-batch 
operation. At the same time, they ensure prolonged cell growth (high cell densities) and 
product formation due to extension of working time that is particularly important in the 
production of growth-associated products. 
1.3 Challenges in MAb Production 
The large-scale production of MAb by mammalian cells in batch and fed-batch culture 
systems is limited by the unwanted decline in cell viability and reduced productivity that may 
result from changes in culture conditions. Therefore, it becomes imperative to gain an in-
depth knowledge of the factors affecting cell viability and subsequently antibody production. 
By understanding these effects it will become possible to impose the necessary conditions 




1.4 Past Efforts and Scope of the Research 
Some limited research work has been conducted on hybridoma cells (Ljunggren and 
Haggstrom, 1994) that illustrates that a dual substrate (glucose and glutamine) limited 
feeding profile reduces overflow metabolism of the two major growth inhibitors- lactate and 
ammonia without a decline in growth rate. Such reports have led to the exploration of fed-
batch culture mode in the current work to explore the possibility of developing an optimum 
feeding profile. In further studies, the kinetics of apoptosis onset and the correlation with 
exhaustion of nutrients in hybridoma cultures has been revealed (Franek and Dolnikova, 
1991; Mercille and Massie, 1994). Since the overall cell population in a bioreactor culture is 
comprised of individual cells going through the various transitions of the cell cycle, a better 
understanding of the system response necessitates a better understanding of cells on an 
individual level. The existing models lack in the level of detail required to explicitly model 
and predict system properties affecting MAb production and quite often use experimental 
values along the duration of the run as inputs. Overcoming these shortcomings of existing 
models may lead to substantial improvements in process efficiency and MAb production. 
Additional details on relevant research are presented in Chapter 2. 
1.5 Identification of Apoptosis and Necrosis 
There have been accounts in literature of an increase in the rate of MAb production 
associated with the onset of cell death in hybridoma cultures (Simpson et al., 1997). It has 
been documented that cell morphology is a clear indicator of the state of a cell. Each stage of 
the cell-life cycle exhibits characteristic morphology. Fluorescence imaging provides the 
means of identifying the different stages of cell growth and death by capturing the changes in 
cell morphology as the cell progresses through the various stages of its life-cycle (Mercille 
and Massie, 1994; Renvoize et al., 1997; Ziegler et al., 2004). 
1.6 Summary 
The focus of the thesis is the identification of an accurate mathematical model that accounts 
for the heterogeneity in the cell population and predicts the optimum feeding profile for a 
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fed-batch culture to enhance MAb productivity. A fluorescence imaging protocol/technique 
has been developed as a tool to capture the changes in cell morphology along the course of 
experimental batch runs to build on the model proposed in the current work. Identification of 
an active death process like apoptosis and the factors controlling it (as opposed to a passive 
one, i.e., necrosis) may lead to new strategies for the minimization of cell death during 
commercial animal cell culture. Ultimately, this may lead to substantial improvements in 
process efficiency. A switch from hybridoma to CHO cell cultures has been done as the CHO 
cell line has been reported to have better specific MAb productivity and it might lead to an 
























This chapter provides an overview of past literature with regards to the work presented in 
later chapters and has been sub-divided into three sections. The three sections discuss-  
(i) Biological Background 
(ii) Measurement Techniques 
(iii) Model Development 
 
The first section of this chapter discusses the common fermentation strategies for large-scale 
MAb production and the cell growth in a fermentation process. The second section provides 
an overview of the imaging techniques available for the quantification of cell sub-populations 
and similar measurements. The third section focuses on the various classical mathematical 
models utilized for modelling animal cell cultures. 
2.1 Biological Background 
2.1.1 Common Fermentation Strategies 
2.1.1.1 Batch Fermentation 
Suspension cultures were initially grown in  batch operated bioreactors in which cells grow 
in a finite volume of liquid nutrient medium and follow a sigmoid pattern of growth. All cells 
are harvested at the same time. For years, batch fermenters were prepared, inoculated, and 
run to completion with nothing added except air and some agent to control foaming. 
According to the reports that address animal cell culture in stirred bioreactors, production in 
stirred batch bioreactors is easy to perform and simple to scale-up with cell density varying 
between 106 and 107 cells/ml (Chisti, 1993; Shuler, 1999; Griffiths, 1988; Glacken et al., 
1983). However, batch processes suffer from problems of nutrient limitation, low cell 
densities, low productivity and potential high toxin accumulation that may lead to product 
degradation. Also, the down-time between batches may be too long and amounts to a wastage 
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of operation time. It seems obvious that the batch process changes should affect formation of 
the product and that these changes can be controlled by nutrient addition or process 
modification. However, it took a long while for this concept to gain momentum.  
2.1.1.2 Continuous Fermentation 
On the other hand, in continuous fermentations nutrient medium is added continuously to the 
fermentation vessel, accompanied by a corresponding continuous withdrawal of a portion of 
the medium for recovery of cells or fermentation products. Operating with continuous 
cultures makes it possible to achieve high cell densities and high antibody productivity 
without any nutrient limitation or growth inhibition due to toxin build-up in the system. But 
on the other side, it requires a higher level of technical skill to operate a continuous culture. 
Another drawback is that there may be loss of productivity due to genetic changes in the 
culture. Product quality control is often a serious problem. Additionally, continuous 
fermentations often waste nutrient substrate. The fermentation broth as it is continuously 
withdrawn for product recovery contains a certain amount of residual unused nutrients of the 
medium as well as a portion of the fresh nutrient constituents being continuously added to the 
fermentation (http://www.raifoundation.org). 
2.1.1.3 Fed-batch Fermentation 
Fed-batch operations combine the advantages of batch and continuous modes and minimize 
the disadvantages that either of the two possesses. In fed-batch culture, nutrients are 
continuously or semi-continuously added to the bioreactor, while effluent is removed 
discontinuously.  
 
Just like batch operations, they are relatively easy to perform and simple to scale-up 
(http://fachschaft.bci.unidortmund.de). Furthermore, unlike continuous culture systems, no 
additional special piece of equipment is required to convert from batch to fed-batch operation 
(Longobardi, 1994). At the same time, they ensure prolonged cell growth (high cell densities) 
and cell maintenance due to extension of working time, which is particularly important in the 
production of non-growth-associated products such as antibodies (Agrawal et al., 1989). It is 
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possible to exercise control over the production of by-products, or catabolite repression 
effects, due to limited provision of only those substrates solely required for product 
formation. In addition, fedbatch operation allows for the replacement of water lost by 
evaporation (McNiel, and Harvey, 1990). However, in a cyclic fed-batch culture, due care 
must be taken in the design of the process to ensure that toxic metabolites do not accumulate 
to inhibitory levels, and that nutrients other than those incorporated into the feed medium do 
not become limiting. Also, if many cycles are run, the accumulation of nonproducing or low-
producing mutants may result. 
2.1.2 Phases of Culture Growth during Fermentation 
When operating a mammalian cell culture, one encounters various different phases of growth 
and/or death starting from the point of inoculation of the medium with cell culture right until 
shut-down. The cell population in a batch culture, that happens to be the simplest mode of 
operation, typically has the following phases of development: (1)lag phase, (2)logarithmic or 
exponential growth phase, (3)deceleration phase, (4)stationary phase, (5)death phase (Shuler 
and Kargi, 1992). Figure 2-1 on the next page describes a batch growth cycle. 
2.1.2.1 Lag Phase 
Upon inoculation of cells into fresh medium, the cells take some time to acclimatize to the 
new nutrient/growth environment by means of reorganizing their molecular constituents. 
Depending on the composition of the new medium, new enzymes are synthesized, the 
synthesis of some other enzymes is repressed, and the internal machinery of cells is adapted 
to the new environmental conditions. These changes reflect the intracellular mechanisms for 
regulation of the metabolic processes. During this phase, the cell mass increases a little while 
the cell number remains essentially constant. However, at times when the seed density for the 
culture is too low or the cell viability of the seeding culture is not high enough, there may be 
encountered a pseudo-lag phase. It must be understood that this phase of arrested growth is 
not because of adaptation of cells to new culture environment but due to small inoculum size 





Figure 2-1 Typical Growth Curve for a Mammalian Batch Culture 
 
2.1.2.2 Exponential Growth Phase 
The lag phase is followed by the exponential growth phase, also known as the logarithmic 
growth phase. In this phase, the cells have adjusted to their new environment and are able to 
multiply rapidly which is indicated by a steady exponential increase in cell number density 
with time. The exponential phase is often regarded as a period of balanced growth in which 
all components of a cell grow at the same rate. This means that the average composition of a 
single cell remains approximately constant during this phase of growth. Thus, during 
balanced growth, the specific growth rate determined from either cell number or cell mass 
will be the same. The exponential growth rate follows first order kinetics (Shuler and Kargi, 
1992):  
μXdt






















where X and X0 are the instantaneous and initial viable cell concentrations, respectively; t 
represents the culture time from the instant of inoculation and μ signifies the growth rate 
constant. 
2.1.2.3 Deceleration Phase 
Since in a batch process there is no subsequent addition of nutrients to the system during the 
course of its operation, there is an eventual depletion of one or more essential nutrients. As 
there is no product recovery during the course of the batch either, there may be a gradual 
build-up of toxic or inhibitory by-products. The rapidly changing culture environment results 
in unbalanced growth. This state corresponds to the deceleration phase of growth. While in 
the exponential growth phase the cellular metabolic control system is directed to achieve 
maximum rates of reproduction, the deceleration phase witnesses the restructuring of the cell 
to increase the prospects of cell survival in response to the rapidly changing conditions. This 
phase is rather short-spanned and is often considered as a continuum between the exponential 
and stationary phase rather than as a separate phase by itself (Shuler and Kargi, 1992). 
2.1.2.4 Stationary Phase 
The deceleration phase is succeeded by the stationary phase, when cell division ceases. In 
other words, the growth rate is equal to the death rate. Even though the net growth rate is 
zero during the stationary phase, cells are still metabolically active and produce secondary 
metabolites (non-growth related products). In fact, the production of some metabolites is 
enhanced during the stationary phase (antibodies, hormones, etc.) due to metabolite 
deregulation (Suzuki and Ollis, 1990). During the course of the stationary phase, one or more 
of the following phenomena may take place: 
1. Total cell concentration stays constant but the number of viable cells decreases. 
2. Cell lysis is observed and there is a decline in viable cell concentration. A second 
growth phase may occur as cells may grow on products of lysed cells (cryptic 
growth). 
3. Cells do not grow but are metabolically active and produce secondary metabolites 




Reasons attributed to termination of growth may be either exhaustion of an essential nutrient 
or accumulation of toxic products. If there is production of an inhibitory product during the 
course of the batch operation, the growth rate will slow down with accumulation of that 
inhibitory substance and above a certain concentration of this inhibitor the growth will cease 
completely (Shuler and Kargi, 1992). In some studies, the kinetics of apoptosis onset and the 
correlation with exhaustion of nutrients in hybridoma cultures has been revealed (Franek and 
Dolnikova, 1994; Mercille and Massie, 1994). Incidence of cell death in A. fumigates, a 
pathogen has been reported by Mousavi and Geoffrey (2003) during the stationary phase, that 
appears to share similarities to apoptotic cell death in higher eukaryotes and seems to be 
dependent on a caspase-like activity. This was proved by the association of the pattern of 
death observed with markers for apoptotic death. Although, a connection between cell cycle 
and apoptosis has been suggested in mammalian cells, its nature is not clear yet (Frame and 
Balmain, 2000; Shapiro, 2001; Sears and Nevins, 2002). It has been hypothesized in the 
current work that an exit from stationary phase might be a prerequisite for apoptosis. 
2.1.2.5 Death Phase 
The death phase or decline phase follows the stationary phase. However, there is an overlap 
between these two stages of growth as some cell death may have already started in the 
stationary phase. The rate of death follows first order kinetics (Shuler and Kargi, 1992): 
Xkddt
dX ′−=    (2.2) 
where X is the instantaneous cell concentration at time t; and kd׳ is the death rate constant. 
2.1.2.6 Fedbatch culture mode: Extension of Stationary Phase 
The fed-batch culture is initiated in the same way as a batch culture starting with inoculation 
of nutrient volume with seed culture. The Lag and Exponential phase progress in the same 
way as in batch culture mode.  In a batch culture, stationary phase occurs when the cells run 
out of their carbon and energy source or a particular nutrient. Many products are produced 
when cell growth slows down; i.e., during the stationary phase of a batch culture. A batch 
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culture, however, will produce relatively small amounts of these products as without 
sufficient nutrients, cells will not be able to maintain homeostasis and thus lyse or become 
biochemically inactive.  
 
However, in a fedbatch culture small nutrient volumes are gradually added to the culture in 
such a way that the nutrient(s) do not get exhausted and there is little or no toxin build-up 
over time. This intermittent feeding serves in replenishing the exhausted nutrients and/or 
dilution of toxified medium which promotes further growth and alleviates the adverse effects 
of toxin on cell growth. In this way, cells can have sufficient nutrients to either grow slowly 
or to maintain their internal integrity. Thus, the cells are maintained in an apparent stationary 
phase mode longer than in batch cultures (i.e., slow or no growth), but at the same time 
continue to produce products. Thus, a fed-batch reactor is expected to extend the stationary 
phase in fermentation (http://www.np.edu.sg/home/sitemap.html). 
2.1.3 Cell Cycle 
Since a cell culture comprises of individual cells, it is not possible to develop an 
understanding of the overall system without an understanding of the processes taking place 
within a single cell itself. Typically, the life-cycle of an individual cell progresses through the 
following 4 stages  
(http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/C/CellCycle.html):  
• G1 - Gap1 
• S - Synthesis 
• G2 - Gap2 
• M - Mitosis 
 
During the initial phase of a fermentation run, a cell feeds on nutrients available in the 
system, producing RNA and synthesizing protein. This stage is called the G1 phase where the 
cell grows in size and prepares itself for cell-division. Increase in cell size is followed by 
DNA replication; this is the S phase. After DNA replication is complete, the cell enters the 
 
 12 
G2 phase, where it grows further and produces new proteins. Finally, it enters the mitosis 
stage where the cell divides into two daughter cells. This process of cell growth can continue 




Figure 2-2 Illustration of a Cell-cycle 
modified from (http://users.rcn.com) 
 
At times there may be errors in functions performed during the cell cycle. To remedy the 
errors that may be introduced during cell development, there are in-built checkpoints in the 
cell cycle that interrupt/abort the cell cycle if such an event occurs 
(http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/C/CellCycle.html). 
 
• G1 checkpoint- Before the cell enters the S-phase, the checkpoint mechanism in 








cycle until the damage can be repaired. If the damage is irreparable, the cell enters 
the death phase and self-destructs by apoptosis. 
• G2 checkpoint: A check is made on the successful replication of DNA that takes 
place during S phase. If replication stops at any point on the DNA, progress 
through the cell cycle is halted until the problem can be fixed. If not, cell death by 
apoptosis is triggered.  
(http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/A/Apoptosis.html).  
2.1.4 Association of Cell Cycle with the Progress of Culture 
In a bioreactor that contains a large cell population, there are cells going through the various 
developmental stages of the cell-cycle all at the same time. Thus, there exist a number of sub-
populations that are in different stages of the cell-cycle and make up an average overall cell 
population. In other words, the lag phase represents the state of the system where the 
population/culture is dominated by cells in the G1 stage that are feeding and growing in order 
to multiply, although there will be cells that are in any of the other three cell-cycle stages. 
Over time, majority of the cells progress from G1 to the mitosis stage where they divide and 
it is classified as the exponential stage of culture growth. With the subsequent exhaustion of 
nutrients, the cell growth slows down which is broadly regarded as the stationary phase. Due 
to lack of substrate, the cells go into growth arrest as they are unable to clear the checkpoints 
set in place by the cell machinery 
(http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/A/Apoptosis.html). 
 
The progression of cell culture from stationary phase to decline phase marks the onset of 
death. 
2.1.5 Cell Death in Bioreactors- Apoptosis and Necrosis 
Cell death can be broadly classified into two categories (Wyllie, 2004; Renvoize et al., 
1997): 




Apoptosis, also called programmed cell death, is a physiological process that occurs under 
normal conditions by which unwanted or useless cells are eliminated during development or 
other biological process. Apoptosis is an energy requiring process. 
 
Necrosis also known as accidental cell death is a passive, catabolic pathological process that 
occurs when cells are exposed to as serious physical or chemical insult like heat stress or 
toxic agents. 
2.1.5.1 Causes of Apoptosis 
There has been evidence in literature (Mercille and Massie, 1994; Singh et al., 1994) 
supporting the incidence of apoptosis due to the following factors: 
• Nutrient limitation (namely, glucose and glutamine) 
• Oxygen deprivation 
• Cystine deprivation 
• Serum limitation 
• Hypoxia 
2.1.5.2 Causes of Necrosis 
• Ammonia accumulation (lowest concentration reported = 2mM) 
• Lactate accumulation (lowest concentration reported = 20mM) 
• Osmotic pressure 
• pH 
The lowest concentration of ammonia and lactic acid reported to cause necrosis in culture is 
2mM and 20 mM, respectively (Newland et al., 1990). It must be mentioned however, that 
when both are present in the culture, lactate and ammonia have a negative cumulative effect 
on cell growth and viability at concentrations lower than what have been reported for each of 
them individually. (Newland et al., 1990) reported lactate concentrations greater than 12mM 
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and ammonia in the range (1-4mM) to be growth inhibitory. Osmotic pressure may cause cell 
death via necrosis by cell implosion from hypertonic solutions, or cell explosion from 
hypotonic solutions (http://www.extravasation.org.uk). Some substances have been reported 
to cause tissue damage by having an osmolality greater than that of serum (281-289 
mOsmol/L) (Upton et al., 1979).  
2.1.5.3 Identification of Apoptosis and Necrosis 
It has been documented that cell morphology is a clear indicator of the state of a cell. Each 
stage of the cell-life cycle exhibits characteristic morphology. Fluorescence imaging provides 
the means of identifying the different stages of cell growth and death by capturing the 
changes in cell morphology as the cell progresses through the various stages of its life-cycle 
(Mercille and Massie, 1994; Renvoize et al., 1997; Ziegler et al., 2004). 
2.2 Cell Culture Related Measurement Techniques 
2.2.1 Estimation of Cell Viability 
The most widely practiced method for estimation of cell viability is the Dye Exclusion test 
which is based on the principle that live cells possess intact cell membranes that exclude 
certain dyes, such as Trypan Blue, Eosin, or propidium iodide, whereas dead cells do not. In 
this test, a cell suspension is mixed with a pre-determined volume ration of the dye. The 
mixture is transferred to a hemacytometer and visually examined under a microscope to 
determine whether cells take up or exclude dye. A viable cell will have a clear cytoplasm 
whereas a nonviable cell will have a blue cytoplasm (http://www.invitrogen.com).  
2.2.2 Amino-acid Analysis 
Amino acid analysis was pioneered by Moore et al. (1958). Over time the method was 




A pre-column derivatization method for the analysis of primary and secondary amino-acids 
developed by Bidlingmeyer (1984) based upon the formation of a phenylthiocarbamyl 
derivative of the amino acids. 
2.2.2.2 Ion Chromatography (IC) - An Alternative  
Ion Chromatography that uses amperometry as the principle for amino acid detection is an 
improvement over HPLC as it does not require derivatization and is therefore a much faster 
method of analysis. This method is designed specifically for analytes that can be oxidized at 
a selected potential, leaving all the other compounds undetected. The Integrated Pulsed 
Amperometric Detection (IPAD) as it is formally called is a powerful method that provides a 
broad linear range of detection with very low detection limits (Hanko et al., 2004). 
2.2.3 Assays for Apoptosis Detection 
A series of morphological changes distinct to the incidence of death by apoptosis in 
comparison to necrosis still remain the standard method its identification (Kerr et al., 1972; 
Renvoize et al., 1997). The different techniques that apply morphology of apoptotic cells for 
their identification have been mentioned as follows (Renvoize et al., 1997). 
2.2.3.1 Electron and Light Microscopy 
This method utilizes the detailed structural aspects of apoptosis, such as the loss of microvilli 
and pseudopodia and dilation of the endoplasmic reticulum. However, centrifugation and 
spreading of apoptotic cells on a glass slide can be damaging to the cells and lead to biased 
results. 
2.2.3.2 DNA Electrophoresis 
Apoptosis identification by means of agarose gel electrophoresis of DNA remains a 
significant method for identifying the oligonucleosomal digestion of chromatin. However, 
the application of this technique is limited to a qualitative analysis only. 
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2.2.3.3 Flow Cytometry 
This method of analysis is based on the principle that apoptotic cells, among other typical 
features, exhibit DNA fragmentation and loss of nuclear DNA content. Use of a 
fluorochrome, such as propidium iodide, that is capable of binding and labeling DNA which 
makes it possible to obtain a rapid (within about 2 hours) and precise quantitative evaluation 
of cellular DNA content by flow cytometric analysis (Riccardi and Nicoletti, 2006). The only 
drawback of this method is that nuclear fragments of clumps of chromosomes could be 
counted as apoptotic cells (Darynkiewicz et al., 1997). 
2.2.3.4 Fluorescence Light Microscopy 
This technique utilizes the DNA-binding properties of fluorescent dyes for the purpose of 
characterization of apoptosis and necrosis. Apoptotic index and membrane integrity can be 
simultaneously determined and there is no cell-fixation step involved unlike flow cytometry. 
This protocol has been described in greater detail in Chapter 3 that discusses various 
experimental methods adopted. Due to the reasons states before, fluorescence light 
microscopy presents a simplistic way of quantitative determination of the apoptotic index. 
2.2.3.5 Caspase Measurement- FRET 
Most forms of apoptosis involve activation of caspases (Xiang et al., 1998). FRET is an 
experimental method that allows the continuous monitoring of caspase activity in individual 
mammalian cells. Caspases are proteases, which play essential roles in apoptosis and cleave 
(cut) other proteins. They are called cysteine proteases, because they use a cysteine residue to 
cleave other substrate proteins at the aspartic acid residue (http://www.wikipedia.org). More 
than a dozen caspases have been identified in mammalian systems using fluorescence 
resonance energy transfer (FRET) - a method, based on covalent linkage of a green 
fluorescent protein (GFP) with a and blue fluorescent protein (BFP) by a short peptide. FRET 
allows caspase activity in individual cells to be measured over time. Using this method, the 
kinetic differences in caspase activity between cells in a population can be correlated with 
whether the cells live or die within a particular time frame. These differences in caspase 
activity can be detected several hours before death actually occurs (Xiang et al., 1998). 
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2.3 Mathematical Modelling  
The performance of cells, in large, cell cultures can be controlled and enhanced provided that 
the system properties can be maintained at the required state. Mathematical models are 
especially useful for simulation, optimization and control purposes. A realistic cell model 
will not only aid in optimizing productivity but once such a model is formulated, prediction 
results can be obtained for metabolite concentrations that may otherwise be difficult to 
measure.  
2.3.1 Principles behind Model Formulation 
In general, the quantitative description of a bioprocess in terms of a mathematical model 
involves formulation of three fundamental types of equations (Tziampazis and Sambanis, 
1994)  
• Mass Balance equations 
• Yield equations 
• Rate equations 
 
The mass balance equations that are developed based on the reactor configuration and are 
essentially same for all cell systems if intrinsic kinetics of the culture is not taken into 
account. The yield and rate equations that describe cellular metabolism are independent of 
the reactor configuration. The yield equations are based on material and energy balances and 
relate the amounts/rates of the metabolite consumption and production. Although they may 
involve several underlying assumptions about metabolism, they have a theoretical basis and 
hence are reliable. The rate equations describe the kinetics of various processes, generally as 
functions of intracellular parameters and the composition of the extracellular medium. Being 
empirical in nature, rate equations are the most unreliable segment constituting a model 
(Tziampazis and Sambanis, 1994). The process mass balances and the yield equations are not 
sufficient to fully describe the system. To remove the remaining degrees of freedom, 
formulation of rate equations or measurements of the rates on-line is required (Andrews, 
1993; Hu and Himes, 1986). However, it is not always feasible to make on-line rate 
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measurements but for a few compounds. Consequently, certain rate equations need to be 
specified. In the absence of sufficient knowledge, experimental results are utilized to obtain 
information about cellular processes and hypothesize kinetic expressions (Glacken et al., 
1988). 
2.3.2 Classical Mathematical Models for Animal Cell Cultures- A Classification 
In cell process technology, models for animal cell cultures can be classified into the 
following categories (Tziampazis and Sambanis, 1994): 
• Segregated/ Unsegregated,  
• Structured/ Unstructured, and  
• Deterministic/ Stochastic.  
 
Figure 2-3 offers a schematic view of the above categorization. 
 
Figure 2-3 Model Classification for Cell Culture Systems  




Structured models attempt to elucidate intracellular processes in that they possess structure 
either in the physical sense, namely the organelles, cell shape or size, or in the biochemical 
sense where biomass is subdivided into its intracellular biochemical components. Structured 
models can provide a measure of the quality of the cell population and are based on more 
fundamental processes (Sidoli et al., 2004). On the other hand, unstructured models do not 
account for the intracellular processes and acknowledge only implicitly the change of cellular 
physiological state with the environment (Fredrickson, 1976). Such models treat the cell as a 
single homogeneous unit, hence their biological basis is limited, and the mathematical 
equations involved are only phenomenological descriptions of the actual system. 
Unstructured models are of limited applicability in situations where the cellular environment 
is highly dynamic in nature. Being highly empirical in nature, they are primarily used in 
cases where only parameter estimation is required for developing the full model in light of 
lacking physical knowledge of the system. Although their extrapolating ability is limited, 
these models are relatively easy to build, and are generally suitable for simulating steady-
state or slowly-changing systems. Structured models are superior to unstructured models as 
they attempt to imitate the biological system by separating/lumping the biomaterial into 
compartments that are chemically and/or physically distinct. The compartments' interactions 
with each other and with the environment are described by stoichiometric equations that 
account for various metabolic pathways and/or kinetic rate expressions. The evolution of 
concentrations with respect to time is mainly based on mass and energy balances and 
transport and reaction rate terms (Tziampazis and Sambanis, 1994). Structured models have 
wider applicability and have better extrapolating capability than unstructured models. 
Unstructured models, on the other hand, can provide a simplistic but quick alternative for the 
development of process systems applications (Tziampazis and Sambanis, 1994). 
 
Not all cells in a mammalian cell culture are alike; they are heterogeneous in composition.  
By classifying a model as being segregated or unsegregated, it is possible to account for the 
heterogeneity of the cell culture with regards to cell age, size, growth rate and metabolic 
state. Referring to a cell culture as segregated implies that it is composed of cells in different 
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stages of development and it is therefore heterogeneous. Conversely, an unsegregated model 
views the population as consisting of identical "average cells" and uses a lumped variable 
such as total biomass per unit volume, to describe the entire population. Segregated models 
build on the heterogeneous composition of a culture and offer the advantage of relating cell 
properties and biochemical activities within distinct parts of the population. Segregated 
models based on cell cycle relate the kinetics of growth, metabolic processes and product 
formation to the distribution of the population among the phases. Considering the differences 
between cells in the population is more representative of the true physical state. However, 
segregated models are also more computationally difficult to handle (Bailey and Ollis, 1986).  
 
Variability within a cell culture can be accounted for by means of stochastic models that 
describe random processes. For systems in which the cellular processes are not subject to 
variability, a deterministic model is applied. Stochastic models use probability distribution 
functions to describe process dynamics at the cell and population levels. Since they account 
for randomness in the culture, they are more accurate than deterministic models but that is 
the case only as long as the systems contains a small numbers of cells (Tziampazis and 
Sambanis, 1994). A more detailed description of the various categories discussed above 
follows. 
2.3.2.1 Unstructured Non-segregated Models 
The simplest way to model cell culture systems will be to consider an unstructured, 
unsegregated model. As these models do not require system details for their generation, they 
are essentially based on experimental data to derive information on cellular processes and 
postulate kinetic expressions. Generally, in the starting phase of model development for 
animal cell culture systems researchers and bioengineers focused on empirical models. 
 
For such a model, the growth rate expression can be written as (Shuler and Kargi, 1992): 
rx = dX/dt = µX   (2.3) 
 
where, rx is the rate of cell generation, X is the cell concentration and  




Many cell culture processes exhibit saturation type kinetics, i.e., the rate of the process µ is 
limited by a certain factor when its concentration c is low, but the limiting effect disappears 
and the process rate reaches a maximum value µmax, as the concentration increases. This 
behavior can be described by a Monod-type equation which is the most commonly used 
expression that relates the specific growth rate of the cell to the substrate concentration. 





=    (2.4)  
where, µ = specific growth rate  
µ max = maximum specific growth  
S = substrate concentration  





Figure 2-4 Monod’s Growth Curve 
 
Figure 2-4 depicts the dependence of µ on S according to Monod’s equation. One should 
note that Monod's equation is empirical and does not have any mechanistic basis. This 
equation is only valid for an exponentially growing or steady state culture under condition of 
balanced growth. The equation does not fair well during transient conditions. Despite its 
simplicity and no fundamental basis, it works surprisingly well in a large number of steady 
state and dynamic situations. This characteristic has important implications in control of 
bioreactors.  
 
In contrast to behavior described by Monod kinetics, the effect of an inhibitor on the rate 
becomes pronounced when its concentration reaches a minimum threshold value; in other 
words, an inhibitor reduces the rate of a process as its level i increases. Such effects can be 







Ollis, 1986). Of those inhibition models, the simpler and easier to use is that of purely non-







=    (2.5) 
In the above equations, µ and µmax have the same implication as mentioned before. i is the 
inhibitor concentration while Ki is the inhibition constant. 
 
It is plausible that instead of one metabolite being the controlling factor, there may be a 
group of metabolites that control the metabolic processes within the culture. In that case, the 
expressions given above can be modified to incorporate additional terms (thus increasing the 
number of model parameters). Multiplicative models with concentration terms raised to 
various powers, introducing dependency of the parameters to other factors through empirical 
functions have been illustrated (Barford et al., 1992; Glacken et al., 1989). Factorial 
experiments may be considered to study and model the individual and interactive effect of 
many variables, individually and interactively, on the process considered (Sidoli et al., 2004). 
These models are rudimentary but offer insight into which of the variables are important and 
need to be studied further. 
2.3.2.2 Structured Non-segregated Models / Single cell models 
Although unstructured models may provide information on how the system properties affect 
the growth kinetics, they lack the level of detail necessary to understand change in cell 
kinetics and/or physiology in response to change(s) in culture conditions as such an approach 
does not consider intracellular processes. On the other hand, structured unsegregated models 
collectively known as single-cell models (SCMs) offer the advantage of explicitly accounting 
for intracellular phenomenon such as cell cycle changes, alterations in cell size and shape; 
this feature is particularly important during transient or unbalanced growth conditions. In 
addition, cases where the rate of transport between organelles is potentially rate-limiting, 
SCMs explicitly consider intracellular spatial organization within the cell. Under the SCM 
approach, a cell is divided into compartments on the basis of difference in 
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composition/concentration. However, it is assumed that each compartment is a lumped phase 
i.e., concentrations are constant throughout the compartment (Tziampazis and Sambanis, 
1994).  
  
In order to describe these biochemical processes, the same basic engineering formulations are 
utilized, as discussed previously under unstructured non-segregated models, namely mass 
balance, yield and rate equations. Cellular metabolism can be incorporated into an SCM 
model by defining terms like (i) transport, (ii) primary metabolism, (iii) product synthesis, 
and (iv) cell growth and death with respect to the system (Tziampazis and Sambanis, 1994). 
Transport processes include transport kinetics of biochemical species across membranes and 
between the various compartments that the cell has been divided into. In addition to 
transport, primary metabolism and product synthesis relates conceptually to two or more 
linked compartments within which either particular metabolic pathways and/or entire 
metabolic cycles operate. Conservation equations written for each compartment and for each 
biochemical species, result in a set of ordinary differential equations. Equation (2.6) 
illustrates the generic form of these conservation equations (Tziampazis and Sambanis, 
1994). The accumulation of any given component i depends on its flow into or out of the 
compartment j as a result of transport across the compartment barrier (first and second terms 
on the RHS of equation (2.6)), intra-compartmental reactions generating and consuming the 
component (third and fourth terms on the RHS) and its dilution due to growth of the cell and 










































  (2.6) 
where Cij is the concentration of the ith component in the jth compartment, Rijk represents the 
transport rate of species i into or out of compartment j from the kth source or sink 
compartment; Nin is number of source compartments; Nout  is number of sink compartments; 
rijl – reaction rate of component i in compartment j in the lth i-generating or i-consuming 
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reaction; Ngen – number of reactions generating component i; Ncon – number of reactions 
consuming component i; 
 
Figure 2-5 Single Cell Compartmentalization 
adapted from (Sidoli et al., 2004) 
 
Figure 2-5 represents compartmentalization of the cell in the physiological context with 
cellular structures, such as organelles, pooled biochemical components or the cell 
environment being treated as compartments. However a problem with multi-compartment 
models is that the ODEs in equation (2.6) that represent distinct pooled concentrations do not 
give any idea of spatial distribution of concentration gradients along the surface of the 
compartment but rather at a single point and do not represent physical dimensions or cell 
geometry. To overcome this drawback, instead of assuming constant concentration 
throughout a compartment as per the lumped phase assumption, a concession is made 
allowing concentration gradients to exist in some compartments. Hence, the resulting 
conservation equations will then include partial derivatives and additional diffusion equations 
that are required to compute the diffusive fluxes within the spatial geometry of each 
compartment. However, the addition of these terms and equations makes the model 
mathematically and computationally more complex (Tziampazis and Sambanis, 1994). There 





(i)  Kinetic Approach 
There are numerous reactions occurring within the cell at any time, and further within the 
compartments themselves. Kinetic models follow a deterministic approach where one can 
account for intracellular dynamics by rate and transport mechanisms that give rise to a set of 
differential algebraic equations (DAEs), which are then integrated over the domain of 
interest, generally the culture time and results in well-defined time trajectories for all model 
variables (Gombert and Nielson, 2000). The most commonly used form of expression to 
describe the reaction rates is the Michaelis–Menten equation. However, one must keep in 
mind that incorporating a greater level of detail into the system means that the more complex 
the reaction kinetics will be and the greater the number of parameters required in the SCM. It 
is important not to over-parameterize the model as this will result in parameter estimation 
problems due to measurement noise and make the model very time consuming to solve. An 
additional drawback in incorporating greater detail in terms of complex dynamic expressions 
is that it normally results in non-linearity in both parameters and variables which makes the 
models really difficult to solve. In addition, kinetic models are unable to incorporate 
regulation and control of cellular activity, which requires dynamic simulation (Tziampazis 
and Sambanis, 1994). 
 
(ii) Stoichiometric Approach 
Stoichiometric modelling represents an alternative to the kinetic approach. Such a model 
yields a static instance of metabolic activity and is represented by a system of flux balance 
equations based on reaction stoichiometry of a metabolic network with accompanying 
constraints on flux values. The resulting equations are solved as a constrained optimization 
problem using some assumed objective; there exists a mathematical and therefore 
physiological feasible region in which a range of possible mathematical solutions or 
phenotypes are acceptable though not optimal (Gombert and Nielson, 2000).  
 
The key advantage of stoichiometric models is that they can account for competing reactions, 
which enables us to study the relative activity of certain pathways under various culture 
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conditions. For example, the existence of more than one physiological steady state, known as 
steady-state multiplicity, has been observed by a number of investigators using 
stoichiometric models and metabolic flux analysis (Follstad et al., 1999; Europa et al., 2000; 
Cruz et al., 1999; Zhou et al., 1997; Linz et al., 1997; Paredes et al., 1999).  
 
Generally, most existing SCMs are only partially mechanistic and contain empirical 
mathematical functions that best seem to describe the observed phenomenon. This is due to 
the fact that many cellular processes that these models seek to describe have not yet been 
accurately described. The development of SCMs requires the incorporation and integration of 
either parts or the entirety of other smaller models each of which describe specific sub-
processes. Utilizing the most accurate sub-models that correspond to the components of 
cellular metabolism is, therefore, of key importance to the construction of a good SCM. On 
the whole, the SCM approach is a very effective tool to relate hypotheses about molecular 
level mechanisms to the whole cell and population response to changes in the local 
environment (Tziampazis and Sambanis, 1994).  
2.3.2.3 Segregated Models- Population Balance Models 
All segregated (or corpuscular) models can be collectively grouped under the category of 
population balance models (PBMs). PBMs have been available since the 1960s and are the 
most mathematically concise way of elucidating the property variation of cells within a 
population and recognize the individuality of cells within a population. 
PBMs are further classified into (Mantzaris et al., 2001): 
(i) Single- or Multi-variable,  
(ii)  Single- or Multi-staged, and  
(iii) Mass or Age-structured  
 
A single-variable model differentiates on the basis of one cell property which is generally 
cell mass. Whereas a multi-variable model uses more than one cellular characteristic to 
distinguish between cells and can be used to account for any number of biochemical 
constituents within the cell. Using a multi-stage model, it is possible to describe multiple 
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developmental phases in the population with each stage of growth added representing each 
additional phase considered.  
 
Finally, if population differentiation is done on the basis of mass conservation laws, then the 
model is mass structured, whereas if cell age/maturity is used, the model is said to be age 
structured (Tziampazis and Sambanis, 1994).  
 
Three parameters are required in a generalized PBM, each having physiological significance. 
They are: (i) the single cell growth rates, (ii) the transition rates between each of the cell 
cycle phases, and (iii) the partition function. Together, these three process parameters define 
the collective state of the cell population (Sidoli et al., 2004; Tziampazis and Sambanis, 
1994).  
 
In essence, PBMs are a number balance on a cell population. Unfortunately, they are also 
particularly difficult to solve, being partial-integro-differential equations and the accurate 
determination of model parameters imposes a more limiting restriction. Hence, in general, 
numerical methods must be used for their solution (Villadsen, 1999).  
 
(i) A Single-stage Single-variable PBM  
Single stage PBMs consider cell growth as a single stage in that there is no subdivision of the 
cell cycle. The cell mass (m) is used to distinguish the physiological states of cells- parent or 
daughter cells. The key variable of interest is the total number of cells or cell number 












































In equation (2.7) above, LHS of the equation changes as a result of specific cell lifecycle 
events represented by RHS of the equation. The first derivative term on the LHS accounts for 
accumulation of cells over time while the second term on the LHS accounts for loss of cells 
of a given mass due to their transition into larger cells – single cell growth. The RHS of the 
equation represents the two fundamental life-cycle processes, namely cell division, which 
results in the loss of dividing cells of mass m with a division rate Γ(m, S) and cell birth, 
which gives rise to two daughter cells from the division of a single parent cell of mass m'. 
Thus, the product ΓN represents the total number of parent cells in the culture at any time t. 
The partition function, p(m, m', S) expresses the probability of a parent cell of mass m' 
giving birth to a daughter cell of mass m so that 2pΓN quantifies the number of newborn 
cells originating from parent cells of a single mass. As parent cells take on a range of masses 
m0 along the mass continuum, to include all parent cell divisions, integration is required for 
calculating all possible parent cell masses ranging from the minimum, τ, to the theoretical 
maximum, i.e., infinity. To completely define the model, the physiological functions r, Γ and 
p expressed in equation (2.7) and the substrate variation S must be specified along with initial 
and boundary conditions (Sidoli et al., 2004).  
 
Initial Condition: 
At the start of the culture process (t =0), the number distribution of cells (N0) is known and 
can be expressed as: 
N(m,0)=N0(m)  (2.8) 
Boundary Conditions:  
The boundary condition is derived from knowledge of the fact that cells can’t have zero 
mass.  
N(0,t)=0  (2.9) 
The most widely used representation for substrate, S is by relating it to biomass production 
rate via a yield coefficient, Y (Mantzaris et al., 1999). 
 










dS    (2.10) 
where, the initial substrate concentration (at t=0) S0 is known. 
 
The partition function, p, which is mathematically a distribution function and specifies 
distribution of cellular material of a parent cell amongst its two daughter cells, is expressed 


























=′   (2.11) 
 
Other distributions of cell partition function that have been used in previous studies are a 
Gaussian-type distribution implemented by Eakman et al. (1966) where the underlying 
assumption made is that the partition function variance is very small which translates to equal 
partitioning always occurring.  
 
The division rate, Γ is proportionally related to growth r by the expression as most commonly 








  (2.12) 
where, f(m) is the division probability density function assumed to be a LHS truncated 
normal distribution with a mean of µf and standard deviation σf. 
 
The normal distribution is truncated to exclude cells of mass less than zero. The denominator 
of the density function represents the proportion of all cells that have reached a mass m and 
remain undivided. It is used to re-normalize f (m) in order to yield the fraction of cells of 
mass m that will divide, given that no division of cells with mass less than m has yet taken 




Various forms have been used to describe the growth rate, including constant, linear and 
quadratic growth forms. 
 
(ii) Single-stage Multi-variable PBM.  
It is possible to distinguish cells on the basis of more than one physiological state. 
Mathematically, this translates to the use of a ‘physiological state’ vector (x) in place of the 
cell-mass (m) only as done in the previous section. Otherwise, the form of this PBM is 








         (2.13) 
Here, the variables used have the same meaning as mentioned before. D is the dilution rate 
and r(x,s) is the single cell growth rate. 
 
Once again, the corresponding initial and boundary conditions may be specified as follows 
(Sidoli et al., 2004).  
 
Initial Condition: 
 N(x,0)=N0(x)   (2.14) 
Boundary Conditions: 
r(x,S)N(x,t)=0  ∀x∈B  (2.15) 
where, B represents the physiological state space boundary and at least one element of x is at 
its maximum or minimum value. The cell environment is considered as multi-component 
represented by a vector form s. The physiological state vector x has maximum (xmax) and 
minimum (xmin) states of daughter cells, and parent cells cannot divide unless in a minimum 




The equation for the substrate utilization- equation (2.16) has been taken from Liou and 
Fredrickson (1997) that applies PBMs to a CSTR setup. An extra term has been included to 








f    (2.16) 
where, q is a nutrient consumption vector. 
 
The equation (2.16) is subject to the following initial conditions:  
S(0)=S0  (2.17) 
 
(iii) A Multi-stage Multi-variable PBM 
Unlike single stage PBMs that are based on the premise that cell life cycle is represented by 
one stage from birth to death, multistage PBMs divide the overall culture population into 
subpopulations based on a distinct classification of cell cycle phases. Thus each 
subpopulation is treated to be in a distinct phase of growth. Hatzis et al. (1995) illustrated the 
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Each equation in (2.18)-(2.20) provides a population balance for each cycle phase population 
Ni for 3 phase cycle, i.e., i=1…3. Since a ‘constant environment’ has been assumed, substrate 
concentration s does not feature in the model equations. Consequently, an equation for 
expressing the substrate utilization is not required in this case. The distribution of the cellular 
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properties at the phase transitions can either be measured directly and used to generate a 
histogram that can be used directly to describe the transition rate, or be approximated by a 
parametric distribution.  
 
Irrespective of which approach is used the shape of the distribution will determine the 
transition rate. Also, the physiological functions r, Γ, and p are related to experimentally 
obtainable cell properties and can thus be determined from known experimental population 
data. This eliminates the need for simulating the behavior of a population based on assumed 
functions for single cell parameters (Tziampazis and Sambanis, 1994). 
2.3.2.4 Combined Single Cell and Population Balance Models  
Single cell models describe detailed intracellular structure but introduce no population 
heterogeneity. On the other hand, population Balance models emphasize characterization of 
overall cell population into subpopulations based on differences in growth phases of the cell 
cycle but fail to take into account intracellular detail.  Thus combining the two models may 
help to address inaccuracies associated with either of the two approaches. 
 
The single cell-population balance model developed by Sidoli et al. (2006) uses SCMs to 
describe growth and death mechanisms that appear as part of the bigger PBM. 
2.3.3 Common Models Proposed for Antibody Production 
Ultimately, the key motivation to improve cell culture Modelling is the need to optimize the 
system for achieving increased productivity. Since protein production is the ultimate goal of 
many cell culture operations, accurate quantitative descriptions of this process are important 
for simulation and optimization of product formation. For this, it is necessary to have 
predictive models relating the growth and death rates, and the specific rates of substrate 





Cell growth and death depend on the chemical composition of the medium and the age of the 
culture. As is evident from the vast amount of literature available, a lot of work has been 
done in this respect till date. This section focuses on the gradual development and 
improvement of models in cell process technology over the years. 
 
An unsegregated, unstructured model for explaining growth and antibody production in 
hybridoma cultures was developed by Barford et al. (1992). Their work laid the foundation 
for more detailed and extensive models capturing cellular kinetics to a greater detail than had 
been done previously.  
 
The model was unique in the sense that 
(i)  A detailed stoichiometry (for catabolic, anabolic reactions and their interactive 
effects) was included and was capable of explaining both continuous and fedbatch 
behavior. 
(ii)  A large number of nutrients were simulated through the model. The nutrients were 
clubbed into 6 groups that were then solved for. The reader is referred to Barford et 
al. (1992) for details. 
(iii) The model was more extensive than previous models as it could simulate both 
fedbatch and continuous behavior. 
 
Nutrient consumption rates were explained by Monod expressions and simple linear kinetics 
was used for internal metabolism. 
 
A number of unstructured models for cell-specific antibody production have been compared 
by Portner and Schafer (1996) for hybridomas in chemostat cultures. Specific growth rate, 
substrate concentration, serum and death rate have all been proposed as being the variables 
on which productivity depends, although which of these should be used and to what extent 




Table 2-1 that follows illustrates the common factors considered to model animal cell 
cultures. Most of the correlations for the specific growth rate are Monod type but differ in 
their choice of glucose or glutamine as the growth limiting substrate. Some models consider 
both of them as growth limiting species. Some models include additional terms to account for 
growth inhibition. Metabolites such as lactate and ammonia were found to be inhibitory or 
toxic for the system. Some models allow for the absence of cell growth at non-zero substrate 
concentrations by incorporating a ‘threshold term’. In one particular case, serum has been 
included as a variable affecting specific growth rate. However, serum is subject to batch to 
batch variability and some of the components in serum cannot be accounted for. 
Consequently, there is a general tendency to work with serum-free media, which may 
eliminate the need to consider serum effects in any future models. Antibody production 
seems to follow non-growth associated kinetics, negatively growth-associated kinetics 
increased specific productivity (at reduced growth rates) or a combination of the two. 
Exceptions, however, exist. 
 
Table 2-1: Correlations for the Specific Growth Rate and the Specific Death Rate 
adapted from (Portner and Schafer, 1996) 
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Non-segregated structured models have also been developed to describe product formation. 
Compartmental models describe the system as a set of distinct pools which may be defined 
either by location or by kinetic behavior. Interactions between compartments occur via 
unidirectional substance transfer, usually following first order kinetics with or without time 
delays (Noe and Delenick, 1989). Other types of kinetic equations, such as Michaelis-
Menten, can be incorporated, notwithstanding increasing mathematical complexity. 
(Sambanis et al., 1991) developed a model incorporating chemical and physical structure to 
describe intracellular protein trafficking and secretion in a pituitary cell line. Sanderson 
(1997) has been reported to have developed a structured, unsegregated, deterministic SCM 
for mammalian cells that may be applicable to any type of suspension culture. The model 
incorporates glycolysis, glutaminolysis, the TCA cycle, the pentose-phosphate pathway, and 
fatty and amino acid metabolism in addition to cell growth and death and antibody 
production into a compartmental form. There are three cell-related compartments: the 
medium, cytoplasm and mitochondria. The concentrations of some 49 biochemical 
components are modeled using Monod-type kinetics. The model accounts for the effects of 
feedback inhibition in certain reactions and competitive reactions by modifying the 
Michaelis–Menten expression. Transport equations account for membrane transport and link 
the various intracellular and extracellular concentrations. A simplified concentration driving 
force has been used to quantify flux. The model’s practical accuracy is accessed by using 
certain experimental data set for model calibration and then performing a second experiment 
under different conditions and comparing the data with the model’s simulation. The ratio of 
the difference (error) between measured and predicted concentration values of the reaction 
species provides an indication of the model’s accuracy. The error lies in the range of 10% to 
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15%. Simulations for glutamine and antibody concentration, however, are significantly 
inaccurate.  
 
Segregated models for mammalian cell cycle have been developed with population 
characterization based on differences in cellular activities, morphology, and even mechanical 
properties (Mitchison, 1971; Needham et al., 1990; Ramirez and Mutharasan, 1990; 
Henderson et al., 1992).  
 
Segregated models can be enhanced by incorporating additional biological information to 
create models of higher structure. For example, the cell cycle theory can be combined with 
intracellular processes like the translation of messenger RNA (mRNA) to protein product 
(Suzuki and Ollis, 1990). There also exist cell cycle models that take into account the 
reportedly different antibody synthesis rates in each of the cell cycle phases (Garatun et al., 
1976; Liberti and Baglioni, 1973; Mitchison, 1971; Abraham et al., 1976; Ramirez and 
Mutharasan, 1990). The advantage offered by these models is that no particular productivity 
function is needed. Instead, the productivity is described as a function of the population 
fractions in each cycle phase that are in turn dependent on the growth rate and can be 
described either with the aid of deterministic (Suzuki and Ollis, 1990) or stochastic models 
(Linardos et al., 1992; Cazzador and Mariani, 1993). An underlying assumption made here is 
that the synthesis rate is constant in each cycle phase; the culture conditions affect only the 
viable cell number and the distribution of cells among the phases. The validity of this 
assumption probably depends on the particular system under consideration and the range of 
conditions employed. 
2.4 Summary 
From the above description it is evident that a structured, segregated, stochastic model is the 
ideal form of cell model. A major challenge presented by these models, however, is that they 
easily get so intensive computationally with increasing detail in the model that they cannot be 
easily handled by computers. Parameter and process lumping and timescale separation 
methods can be used as tool for providing the necessary simplifications. In the future, such 
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models could be further improved by incorporating new biological knowledge, which rapidly 
accumulates with the advent of new techniques, and by simplifying the final expressions so 
that the resulting descriptions remain computationally manageable. 
 
Since currently available experimental data is limited, a compromise needs to be made on the 
level of detail incorporated into the proposed model to avoid over-parameterization and non-
linearity in the model. Hence, an unstructured, segregated, deterministic model has been 
proposed. A systematic approach has been adopted for model development based on Metabolic 
Flux Analysis (MFA) proposed by Provost and Bastin (2004) that has been applied by Gao et 
al. (2006) with some modifications for batch production of MAb. However, in the mentioned 
works, in the development of the MFA and the resulting dynamic model of metabolites, the 
viable and dead cell concentrations and their corresponding rates of change have not been 
explicitly modeled. Instead, their experimental values have been used as an input for the 
metabolites model.  
 
The current work addresses these issues as follows:  
1. MFA is applied to a fed batch situation in order to obtain a dynamic model for this 
mode of operation. In this context, this study compares the flux values obtained in 
batch and fed batch operations and investigates whether the same structure of the 
dynamic model is applicable to both.  
2. The viable and dead cell concentrations are explicitly modeled. Correlation analysis is 
used to investigate the dependencies of growth and death rates on nutrient and 
product concentrations. Then, the cell concentrations model is coupled to the 
metabolites dynamic model that utilizes experimental starting values to come up with 
an integrated model that predicts for all significant system variables, including viable 
and dead cell concentrations, independent of subsequent experimental values.  
 
The dynamic metabolic model proposed is based on a combination of stoichiometric and 
dynamic mass balances and has been explained in detail in further sections. First, 
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stoichiometric flux balances based on a comprehensive metabolic network were constructed. 
Second, the metabolic network was simplified by systematic elimination of fluxes that were 
deemed insignificant. 
 
The objective of the experimental and modelling efforts presented in the thesis is the 
identification of an accurate mathematical model that accounts for the heterogeneity in the 
cell population and predicts the optimum feeding profile for a fed-batch mode culture to 
enhance MAb productivity. Fluorescence imaging has been applied as a tool to capture the 
changes in cell morphology along the course of experimental batch runs to build on the 
model proposed in the current work. Identification of an active death process like apoptosis 
and the factors controlling it (as opposed to a passive one, i.e., necrosis) may lead to new 
strategies for the minimization of cell death during commercial animal cell culture. 
Ultimately, this may lead to substantial improvements in process efficiency. A switch from 
hybridoma to CHO cell cultures might lead to an appreciation of the differences in kinetics of 




Materials & Methods 
A set of batch and fed-batch experiments were conducted using a hybridoma 130-8F cell line 
and a Chinese Hamster Ovary IgG1-9B8 cell line. The details of the experimental 
infrastructure and the experimental settings have been summarized in this chapter. The 
experimental techniques applied for analysis of the experimental samples have been covered 
as well. 
3.1 Sources of Materials 
Bellco, N.J., U.S.A.: 250 mL Bellco Spinners; 1000 mL Bellco Spinners 
Corning (from various locations): 75 cm2 T-Flask  
Invitrogen Canada Inc., Burlington, Ontario: Gibco D-MEM containing glutamine and 
glucose (12100), Gibco D-MEM w/o glutamine and glucose (23800), DMSO (Gibco 11101-
011), D-MEM high Glucose (10566), Ham’s F-12 Nutrient Mix (11765), L-Glutamine 
(25030), D-Glucose (15023)  
JRH Biosciences - A Division of Sigma-Aldrich Corp. (from various locations): Fetal 
Bovine Serum (FBS, JRH 12107-78P) 
Nalgene (from various locations): 1.8 ml cryovials  
Sigma, Burlington or Oakville, ON: sodium hydrogen carbonate (S-5761), pluronic F68 (P-
1300), insulin (I-6634), transferrin (T-1283), FeSO4* (F-8633), ZnSO4* (Z-0251), sodium 
pyruvate (P-5280), lipoic acid* (T-1395), biotin* (B-4639), putrescine* (P-5780), CuS04* 
(C-8027), cholesterol (C-8503), linoleic acid (L-1012), β-cyclodextrin (C-4805), proline 
(Sigma P-8449), 66 mg/L l-asparagine (Sigma A-4159), and 33.5 mg/L l-aspartic acid 
(Sigma A-4534), glutamine (Sigma G-8540) and glucose (Sigma G-6152), histidine (Sigma 
H-5659), threonine (Sigma T-8625), arginine (Sigma A-3784), tyrosine (Sigma T-3754), 
valine (Sigma V-0500), methionine (Sigma M-2893), tryptophan (Sigma T-0271), 
phenalanine (Aldrich 16,261-2), isoleucine (Sigma I-2952), leucine (Sigma L-1512), and  
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lysine (Sigma L-5626); Sigma Ammonia Kit (Sigma 171-B), Acridine Orange (Aldrich 
A6014), Ethidium Bromide (Aldrich E8751), Amino Acid Standard (AA-S-18) 
VWR (from various locations) - SFX-CHO-GLN-GHT (CA16777) , Glass Slides and cover-
slips: 3in.x1in.; 1mm thickness glass-slides and 25mm2 cover-slips. 
Caution: Acridine Orange and Ethidium Bromide have been found by the Ames test to be 
highly mutagenic and must be handled carefully. 
3.2 Cell Line 
The cell line, hybridoma 130-8F, used in this study was obtained from Sanofi Pasteur Ltd. 
Toronto, Ontario. The cell strain was produced by the fusion of Sp 2/0 myeloma cells with 
spleen cells from 12 to 20 week old immunized BALB/c mice (De Alwis Seneviratne, 2004).  
 
The CHO cell line, IgG1-9B8, used for the second set of experiments involving fluorescence 
imaging was obtained from Cangene Corporation, Mississauga, Ontario. The cell line was 
produced as a result of modifications performed on another CHO cell line originally 
produced by ATCC. 
 
In addition, seed-bank for two other cell lines was created. The first cell line was a 
hybridoma CRL-10463 obtained from ATCC. The other cell line was a CHO CRL-9606 also 
obtained from ATCC. CRL-9606 is a producer of human tissue plasminogen activator (t-pA). 
However, they were not utilized for experimental work because the focus was attached to the 
first two cell lines mentioned. 
3.3 Media Formulation 
3.3.1 Hybridoma 130-8F 
The hybridoma cells were cultured in basal medium consisting of D-MEM containing 25 
mmol/L glucose and 4 mmol/L L-glutamine. The medium was further supplemented with 
additional reagents that have been specified in Table 3-1 along with their final concentration 
in the medium (De Alwis Seneviratne, 2004). 
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Table 3-1: Supplements added to Basal Medium 
Component Concentration 
Sodium hydrogen carbonate, NaHCO3  2.2 g/L 
PluronicF68  0.7 g/L 
Insulin  9mg/L 
Transferrin  5 mg/L 
Zinc Sulphate, ZnSO4*  0.86 mg/L 
Sodium pyruvate  0.11 mg/L 
Lipoic acid*  0.1 mg/L 
Biotin*  0.1 mg/L 
Putrescine*  0.161 mg/L 
Copper Sulphate anhydrous, CuS04*  0.0025 mg/L 
Cholesterol  0.5 mg/L 
Linoleic acid  0.08 mg/L 
ß-cyclodextrin  0.1 g/L 
Proline  29 mg/L 
L-asparagine  66 mg/L 
L-aspartic acid  33.5 mg/L 
 
Solutions marked with an asterix (*) were added from pre-made concentrate solutions. 
 
It must be noted that amino acids originally present in the medium were taken into 
consideration when creating supplemented medium based feed solutions for fed-batch runs. 
For feed solutions, glutamine and glucose were added to “glutamine and glucose free basal 
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media” as required. Additional amino acids added to fed-batch feed medium have been 
specified in Table 3-2 that follows. 








Basal medium from powdered DMEM was prepared by dissolving it in 18.0 mOhm-cm 
Milli-Q water. The resulting concentrate was diluted to the desired volume, pH equilibrated 
to 7.2 and, filtered through a 0.2 μm filter. Basal medium was stored at 4°C for a maximum 
of 3 weeks prior to use. Insulin was dissolved in 10 mL of Milli-Q water with the aid of a 
few drops of 2.0M HCl. Fetal Bovine Serum (FBS, JRH 12107-78P) was added prior to use 
on a per liter basis. 
3.3.2 CHO IgG1-9B8 
For CHO cells grown in serum free conditions, the basal medium used was HyQ-SFX CHO 
containing 17.5 mmol/L glucose but no glutamine; it was supplemented with glutamine upon 
use to be brought to a final concentration of 3 mmol/L glutamine. For CHO cells grown in 
serum supplemented conditions, the basal medium used was D-MEM containing 4mmol/L 
glutamine, 4500mg/L glucose, 1mmol/L sodium pyruvate and 1500 mg/L sodium 
bicarbonate. For both serum-supplemented and serum-free cultures, no amino-acid 
supplementation was done.  
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3.3.3 Hybridoma CRL-10463 
The basal medium was D-MEM containing 4mmol/L glutamine, 4500mg/L glucose, 
1mmol/L sodium pyruvate and 1500 mg/L sodium bicarbonate. For passaging cells, the basal 
medium was supplemented 10% v/v fetal bovine serum (FBS) but no amino-acid 
supplementation was done. 
3.3.4 CHO CRL-9606 
Ham’s F-12 Nutrient Mix was utilized as the basal medium. It contained 4mmol/L glutamine, 
4.5 g/L glucose. The culture medium contained 90% v/v basal media and 10% v/v fetal 
bovine serum (FBS). No amino-acid supplementation was done. 
3.4 Pre-Experiment Protocols 
All cultures were grown in a CO2 incubator (Sanyo IR Sensor, 37 °C) at 8.0% CO2 for 
hybridoma 130-8F and 5.0 % CO2 for the other cell lines mentioned in section 3.3. In case of 
the hybridoma 130-8F, the culture pH was maintained in the range 7.1-7.4  by adding a 
solution of 7.5% NaHSO4 as per requirements (De Alwis Seneviratne, 2004). 
3.4.1 Developing a Cell Bank 
3.4.1.1 Cell Bank for 130-8F 
Cells for 130-8F were adapted to growth in 2% serum conditions over a period of two 
months prior to performing the actual experiments. It was observed that the reduction in 
serum did not result in a reduction of overall productivity or robustness of the cell-line. The 
cell bank was established using these adapted cells. 
 
Cells in the late exponential growth phase (>90% viability) were centrifuged, re-suspended at 
a concentration of 30 x 106 cells/mL, and aliquoted into 100x1-1.8 mL cryovials. The vials 
were initially frozen at -80°C and half of the cell bank was transferred to liquid nitrogen 
storage. The cells used in subsequent experiments were obtained from the vials stored at        
-80°C (De Alwis Seneviratne, 2004). 
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3.4.1.2 Cell Bank for IgG1-9B8 
One of the frozen vials received from Cangene was thawed upon arrival and transferred to a 
T-flask. The cells were passaged a number of times to ensure that they had adapted to the 
new culture environment. Cells in late exponential growth phase (>90% viability) were 
centrifuged, re-suspended at a concentration of 1.0 x 106 cells/mL, and aliquoted into 40x1-
1.8 mL cryovials. The vials were initially frozen at -80°C for 24 hours and then transferred to 
liquid nitrogen storage. Two vials from the freeze-down were stored in the -80°C freezer as 
backup. 
 
A supplementary cell bank of serum adapted cells for this cell line was also created. Cells in 
late exponential growth phase (>90% viability) were centrifuged, re-suspended at a 
concentration of 0.5 x 106 cells/mL, and aliquoted into 40x1-1.8 mL cryovials. The vials 
were initially frozen at -80°C for 24 hours and then transferred to liquid nitrogen storage.  
3.4.1.3 Cell Bank for CRL-10463 and CRL-9606 
For hybridoma CRL-10463, the frozen vial was thawed and the contents of the vial were 
transferred to a T-flask. The vial for CHO CRL-9606 cell was received from ATCC and was 
thawed upon arrival and its contents transferred to a flask.  
 
Thereafter, the procedure for the two cell lines was the same. The cells were passaged a 
number of times to ensure that they had adapted to the culture environment. Cells in late 
exponential growth phase (>90% viability) were centrifuged, re-suspended at a concentration 
of 107cells/mL for CRL-10463 and 4x106 cells/ml for CRL-9606, and aliquoted into 40x1-
1.2 mL cryovials. The vials were initially frozen at -80°C for 24 hours and then transferred to 
liquid nitrogen storage. Two vials from the freeze-down for each of the cell lines were stored 
in the -80°C freezer as backup but were lost due to a freezer malfunction. 
 
For freezing down a cell bank, the composition of the freezing medium is as described in 
Table 3-3.  
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Table 3-3: Freezing Medium 









i.e., the basal 
medium 




0 45 0 0 
DMSO 10 10 10 10 
Serum 10 0 10 10 
 
3.4.2 Initiation of Cell Culture from Thawed Vials 
Cell culture was initiated by thawing a cryovial in a 37°C water bath for under 2 minutes.  
3.4.2.1 Hybridoma 130-8F 
The contents of the thawed vial were suspended in 10mL of fresh media, centrifuged for 4 
minutes at 1000 rpm. The supernatant was removed in order to eliminate DMSO that may 
inhibit cell growth to some extent. The cell pellet was resuspended in a 75 cm2 T-Flask 
containing 21mL fresh media with 15% (or 10%) serum. The T-flasks were incubated for 
two to three days (depending on the rate of cell growth) before passaging (De Alwis 
Seneviratne, 2004).  
3.4.2.1.1 Serum Reduction 
The hybridoma cells were grown in serum containing medium. Cells were passaged every 
two days during the week and every three days if it was a weekend, i.e., a Monday, 
Wednesday, and Friday. At high serum concentrations some cell attachment was observed on 
the bottom of the flask. Cells were detached by sharp tapping. The T-flasks were repeatedly 
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monitored under a microscope to ensure that almost all the cells had detached from the 
surface of the flask. If the attachment of cells to the surface still persisted, the flask was 
tapped a few more times. Cell concentration and viability were determined and cells were 
further passaged using an inoculation density of 0.1 x 106 cells/ml. The serum concentration 
was gradually decreased as outlined in Table 3-4. Once the cells reached 2% serum 
conditions, it was observed that cell attachment was considerably less. At least two weeks 
were required from initial thaw to the commencement of experiments the details of which 
have been covered in later sections. The cells were grown in suspension using spinners for 
two or three consecutive passages prior to the start of the batch and fed-batch experiments. 
Table 3-4: Procedure for Serum Reduction  
(De Alwis Seneviratne, 2004) 
Passage Percentage Serum 
1 15 (10) 
2 10 (7.5) 
3 7.5 (5) 
4 5 (3.5) 
5 3.5 (2) 
6 2 (2) 
7 2 (2) 
 
3.4.2.2 CHO IgG1-9B8 
The contents of the thawed vial were suspended in 5 ml fresh medium containing 3mmol/L 
glutamine and 17.5 mmol/L glucose. The T-Flask was incubated for a day (depending on the 
rate of cell growth) before passaging. After the cell density was appreciably high, the cells 
were passaged to a higher volume of 20 ml. This diluted the DMSO present to an 
insignificant concentration. Thereafter, the T-flasks were incubated for two to three days 
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(depending on the rate of cell growth) before passaging. The glutamine concentration was 
gradually reduced to 2 mmol/L for performing spinner experiments. 
3.5 Experiments 
The first set of experiments that was utilized for model development was performed at the 
Sanofi Pasteur facilities at Sunnybrook Health Sciences Centre with a hybridoma cell line. 
Two different modes of reactor operation were adopted: batch culture (3 to 9 days) and fed 
batch culture (>7 days duration) and were carried out in 250 mL and 1000 mL spinners.  
The second set of batch experiments was performed at the University of Waterloo as part of 
efforts to generate fluorescence images along the course of the run to gain an understanding 
of the incidence of apoptosis. The cell line utilized was a CHO cell line (De Alwis 
Seneviratne, 2004). 
3.5.1 Batch Experiments- Set 1 
Batch experiments (se Set 1, Batch Experiment in Appendix A) were performed in 250 mL 
and 1 L spinners inoculated with 0.1 x 106 cells/mL to start with. The same spinners were re-
inoculated by replacing spent media with fresh media again every 3 days, two times in a row 
before the start of the experiment (i.e., 2 passages prior to start of experiment). Spinners were 
stored at random positions in two incubators at 37.0 ºC and 8.0 % CO2. The starting basal 
medium was MDMEM with 4mmol/L Glutamine, 25 mmol/L Glucose, 2% FBS.  
 
Samples of 1-3 mL volume were taken daily and analyzed for viable cell concentration, 
percent viability, and pH. Thereafter, samples were sent for analysis for total mouse IgG 
assay by ELISA and amino acid analysis by HPLC. Cell concentration and viability were 
determined using a haemocytometer and 0.5% trypan blue in PBS diluted to a ratio of 1:1. 
3.5.2 Fed-batch Experiments- Set 1 
Fed-batch experiments (see Set 1, Fed-batch Experiment in Appendix A) were performed in 
500 mL spinners inoculated with 0.1 x 106 cells/mL in 300 mL medium to start with. The 
experiment duration was 8 days. Initial volume of the culture was 300 mL with 4 mmol/L 
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glutamine and 25 mmol/L glucose. The starting basal medium taken was MDMEM 
containing 2% FBS without glutamine and glucose.  
 
For the fed-batch experiment, the ratio of glutamine to glucose in the feed was kept at 0.32 
while the glutamine concentration was 4mM in one spinner and 2mM in the other. After 
initial sampling, the spinners were left in the incubator undisturbed for about 20 hours. 
Thereafter, samples were taken regularly for analysis of viable cell concentration, percent 
viability, pH, total antibody titre, and amino acid composition. Samples were taken every 3 
hours during the day and every 12 hours overnight. Sample volume of 0.5 mL was taken for 
glucose and glutamine concentration analysis and cell viability analysis; 1.5 mL for pH 
analysis. Sample volumes were replaced with fresh medium containing 4 mmol/L glutamine, 
25 mmol/L glucose, and 2% serum.  The feeding schedule was adjusted over the course of 
the study from 4-hour to 6-hour schedules. Since fed batch experiments ran the duration of at 
least seven days, 8 to 12-hour periods of ‘night-time non-feeding’ occurred. When possible, 
these periods were minimized. 
 
Also, aliquots of a 1 mL sample were taken for cell count and in/out lab sample retention. 
Cell concentration and viability were determined by Trypan Blue dye exclusion test using a 
hemacytometer. Aliquots were frozen at -80°C to be sent out of the lab for total mouse IgG 
assay by ELISA and amino acid analysis by HPLC. 
 
Once fed batch feeding commenced after 60 hours, sample volumes removed from fed batch 
spinners were not replaced. 7.5 % NaHCO3 was added for any necessary pH adjustments 
during the experiment (pH was maintained between 7.1-7.3). The experiment was terminated 
after 194 hrs.  
3.5.3 Batch Experiments- Set 2 
Batch experiments (see Set 2, Batch Experiment in Appendix A) were performed in spinners: 
2x1-100 and 2x1-250 mL spinners inoculated with 0.3 x 106 cells/mL inoculum. Spinners 




The starting basal medium was  HyQ SFX-CHO with 17.5 mmol/L glucose in all spinners 
while the glutamine concentration was 4 mmol/L for 1x100 ml spinner and 3 mmol/L 
glutamine in the rest of the spinners. The cultures were grown in serum free conditions.  
 
Samples of 1 mL and 0.6 ml volume were taken daily and analyzed immediately for viable 
cell concentration, percent viability, glucose and fluorescence imaging. Thereafter, 
eppendorfs were centrifuged at 1000rpm for 5 minutes and the culture supernatant was 
removed and transferred to new eppendorfs and frozen at -30˚C. The samples were kept in a 
frozen state for further analysis- ammonia analysis using an ammonia meter, total mouse IgG 
assay by ELISA, amino acid analysis by HPLC. Cell concentration and viability were 
determined using a haemocytometer and 0.5% trypan blue in PBS diluted to a ratio of 1:1. 
Fluorescence images were generated by adding 10 µL of a fluorescent dye-mix (Acridine 
Orange and Ethidium Bromide, mixed together to a final concentration of 50 µg/ml) and 
added to 250 µL of cell suspension in an eppendorf. The sample was allowed to stand for 1 
minute after which a glass slide was stained with 10 µL of the fluorescent sample and images 
were generated with the use of the imaging software- Image-J.   
3.6 Analytical Methods 
3.6.1 Viable Cell Concentration 
Total cell concentration and viability were determined via the Trypan Blue Exclusion Test 
using a hemacytometer and a 1:1 dilution with 0.5% trypan blue in PBS. Cell count was 
made within one minute of dye addition, and within 30 minutes of sampling. The percent 
viability was determined as a ratio of the number of non-stained i.e., viable cells counted to 
the total number of cells counted i.e., stained+non-stained.  
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3.6.2 Substrate Concentration(s) 
3.6.2.1 Hybridoma 130-8F 
Samples were centrifuged for 4 minutes at 1000 rpm to remove cells. Measurements for 
substrate concentrations were recorded and the sample was further aliquoted and stored at     
-80°C for out of lab analysis. The maximum storage time was approximated 1 month. 
 
Glucose, lactate, glutamine, and glutamate concentration was quantified using two YSI 
Biochemistry Analysers. The detection ranges for each respective substance is summarized in 
Table 3-5. A fresh 5 mmol/L calibration standard for glutamine was prepared daily. Samples 
outside this range were diluted with sterile Milli-Q water. 
 
Table 3-5: Detection Range for YSI Bioanalyser  
(De Alwis Seneviratne, 2004) 
Chemical  Detection Range  
D-Glucose  0-25 g/L  
L-Lactate  0-2.67 g/L  
L-Glutamine  0-8 mmol/L  
L-Glutamate  0-10 mmol/L  
  
3.6.2.2 CHO IgG1-9B8 
Measurements for glucose concentration were recorded using an Ascensia Contour glucose 
meter and the samples were centrifuged for 5 minutes at 1000 rpm to remove cells. The 
sample was further aliquoted and stored at -30°C for further analysis.  
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3.6.3 Ammonia Assay 
For set-1 of experiments, diluted samples (1:10 with Milli-Q water) were stored either at -
80ºC or 4ºC (< 1 week) and tested for ammonia content using a Sigma Ammonia Kit (Sigma 
171-B). 
 
For set-2 of experiments, acidified samples (with phosphoric acid) were stored at -30ºC and 
tested for levels of ammonia using an Orion ammonia meter. Fresh standards for calibration 
of ammonia meter were prepared daily. 
3.6.4 Out-of-lab Analysis for Samples from Set-1 Experiments 
Samples of volume between 0.2-1.0 mL of supernatant were aliquoted and stored at -80ºC 
prior to being sent for analysis for monoclonal antibodies and amino acid assay (De Alwis 
Seneviratne, 2004). 
3.6.4.1 Monoclonal Antibody Assay 
Total IgG titre or monoclonal antibody concentration was determined using the competitive 
Enzyme Linked ImmunoSorbent Assay (ELISA). The assay was carried out by the Research 
Microbiology Group at Aventis Pasteur Ltd. The assay involves standard ELISA techniques. 
3.6.4.2 Amino Acid Assay 
Amino Acids were assayed using High Performance Liquid Chromatography (HPLC, 
Agilent 1100 Series, Hypersil AA-ODS column). Analysis was carried out by the Process 
Development Formulations & Stability Platform of Aventis Pasteur Ltd. Samples were run in 
groups according to each cell culture growth run. The samples were filter centrifuged in 
Millipore Microcon YM-10 and microcentrifuged for 15 minutes at 8000 rpm to deproteinize 
the cell culture media. The filtrate was further diluted as required. Twenty amino acids, listed 
in Table 3-6, in deproteinized cell culture media were quantified using an automated a two 
step precolumn derivatization method for reverse phase HPLC analysis with fluorescence 
detection. The two step pre-column derivatization reaction occured first with OPA (o-
phthaldehyde and 3-mercaptopropionic acid in borate buffer, Agilent 5061-3335), which 
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reacts with primary amino acids; and then with FMOC (9- fluorenylmethylchloroformate in 
acetonitrile, Agilent 5061-3337), which reacts with secondary amino acids. The OPA 
derivatives elute chromatographically before the FMOC derivatives. 
 
Table 3-6: Amino Acids Quantified in Assay 
ASP Aspartic Acid TYR Tyrosine 
GLU Glutamic Acid CYS Cystine 
ASN Asparagine VAL Valine 
SER Serine MET Methionine 
GLN Glutamine TRP Tryptophan 
HIS Histidine PHE Phenylalanine 
GLY Glycine ILE Isoleucine 
THR Threonine LEU Leucine 
ALA Alanine LYS Lysine 
ARG Arginine PRO Proline 
3.6.5 Fluorescence Imaging  
3.6.5.1 Protocol 
Basic Protocol has been adapted from Coligan (1994) and the work of Mercille and Massie 
(1994). According to this assay, a cell suspension is mixed with fluorescent DNA-binding 
dyes and the sample is then observed under a fluorescence microscope to examine chromatin 
organization. 100µg/ml Acridine Orange (AO) and 100 µg/ml Ethidium Bromide (EB) are 
mixed in a ratio of 1:1. 10 µl of this dye mixture is added to 250 µl of cell suspension having 
cell concentration in the range 5x105 to 6x106 cells/ml in an eppendorf that is then allowed to 
stand for a minute. 10 µl of the sample is then placed on a glass slide and covered with a 
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cover-slip. The specimen is examined under a fluorescence microscope (Coligan, 1994; 
Mercille and Massie, 1994; Wyllie, 2004). 
3.6.5.2 Instrument Settings 
Microscope used: Zeiss Axiovert 200 with eppiilumination. 
Objective lens: Nikon 40X Plan Neofluar with numerical aperture 0.75.  
Digital Camera: Sony, Model No.XCD-X700; DC8-30V 
Filter settings: as specified in Table 3-7 below. 
Table 3-7: Filter Specification for Fluorescence Imaging 
Filter set Fluorochrome Excitation Beam Splitter Emission 
Blue Filter Acridine Orange  
(both DNA and RNA)
475-495 nm 510 nm 515-565 nm
Red Filter Ethidium Bromide 515-560 nm 565 nm 580-630 nm
 
3.6.5.3 Image Processing 
The images captured by the available set-up were gray-scale images and needed to be 
processed to colored images by a software called Image-J. Image-J is a public domain, Java-
based image processing program that can open and save all supported data types as TIFF 
(uncompressed) or as raw data. It is capable of opening and saving GIF, JPEG, BMP, PNG, 
PGM, FITS and ASCII, DICOM, TIFFs, GIFs, JPEGs, DICOMs and raw data using a URL 
and many other formats using plugins (http://rsb.info.nih.gov/ij/features.html). 
3.6.5.4 Assays for Identification of Apoptosis and Necrosis 
Before progressing to the classification of cells in regular cell culture, it is imperative to be 
able to independently identify apoptosis and necrosis. In order to do so, assays for apoptosis 
and necrosis were performed whereby apoptosis and necrosis was induced in a cell culture in 




(i) Induction of Apoptosis  
For the induction of apoptosis, the protein synthesis inhibitor cycloheximide was added.  
Cycloheximide was added at a final concentration of 25 µg/ml to a T-75 flask containing 
over 1x106 cells/ml. The flask was then incubated in a CO2 incubator at 37 ˚C. Images were 
taken after addition of the mentioned reagents and incubation overnight. 
 
(ii) Induction of Necrosis 
Although several different methods have been suggested for the induction of necrosis by 
artificial means in a cell culture (Mercille and Massie, 1994), the easiest method was 
considered for application. For induction of necrosis, 25 % v/v HPLC grade ethanol was 
added to a T-75 culture flask with cells at a concentration of over 0.6x106 cells/ml and 
viability equal to 98%. The flask was then incubated in a CO2 incubator at 37 ˚C. After 
overnight incubation, the flask was tested for necrotic morphology every few hours for the 
next day since it was not known for certain what the time span for induction of necrosis was 
using this approach. 24 hours after incubation, all cells were necrotic; the Trypan Blue 














The importance of model development has been highlighted in the literature review section. 
In this section, the exercise of model development and the mathematical concept behind it 
have been explained.  
 
The large-scale production of MAb by mammalian cells in batch and fed-batch culture 
systems is limited by the unwanted decline in cell viability and reduced productivity that may 
result from changes in culture conditions. Therefore, it becomes imperative to gain an in-
depth knowledge of the factors affecting cell viability and subsequently antibody production. 
Although considerable effort has been made to understand the kinetics of hybridoma growth 
and metabolism, it has become evident that a model structure is not a priori obvious. A 
common limitation of the currently available models is that they focus on individual 
characterization of selected aspects of the overall cell metabolism (exponential or post-
exponential).  
 
The aim of the present work is to obtain an overall dynamic model that predicts the behaviour 
of both batch and fed-batch systems as a function of the extra-cellular nutrient/metabolite 
concentration at any time and utilize this model for optimization of MAb production in the 
future. A systematic approach has been adopted for model development based on Metabolic 
Flux Analysis (MFA) for animal cell culture proposed by Provost and Bastin (2004) that has 
been applied by Gao et al. (2006) with some modifications for batch production of MAb. 
However, in the development of the MFA and the resulting dynamic model of metabolites, the 
viable and dead cell concentrations and their corresponding rates of change have not been 
explicitly modeled. Instead, their experimental values have been used as an input for the 





The current work addresses these issues as follows:  
1. MFA has been applied to a fed batch situation in order to obtain a dynamic model for 
this mode of operation. In this context, this study compares the flux values obtained 
in batch and fed batch operations and investigates whether the same structure of the 
dynamic model is applicable to both.  
2. The viable and dead cell concentrations are explicitly modeled. Correlation analysis is 
used to investigate the dependencies of growth and death rates on nutrient and 
product concentrations. Then, the cell concentration model is coupled to the dynamic 
model for metabolites that utilizes experimental starting values to come up with an 
integrated model that predicts for all significant system variables, including viable 
and dead cell concentrations, independent of subsequent experimental values.  
 
The dynamic metabolic model proposed here is based on a combination of stoichiometric and 
dynamic mass balances as is explained in detail in further sections. First, stoichiometric flux 
balances based on a comprehensive metabolic network are constructed. Second, the 
















4.1 Metabolic Flux Analysis (MFA): 
4.1.1 Theory 
A powerful methodology for the determination of significant metabolic pathways is MFA, 
whereby intracellular fluxes are calculated by utilizing a stoichiometric model for the major 
intracellular reactions and applying mass balances around intracellular metabolites 
(Papoutsakis and Lee, 1999). The final outcome of flux calculation is a metabolic flux 
network representing the biochemical reactions included in the calculation along with an 
estimate of the steady state rates, referred to as the fluxes, at which the reactions occur. Thus, 
MFA permits to calculate values of intracellular fluxes from available extracellular fluxes, 
some of which are significant and some are negligible. Based on the set of the most 
significant fluxes, the original metabolic network can be reduced to contain only the 
reactions corresponding to significant fluxes. The reactions in the reduced network are 
further used to formulate a set of elementary macro- reactions linking the substrates to the 
products, thus eliminating involvement of intracellular metabolite concentrations in the 
mathematical model. A set of dynamic mass balances is then devised that involves rate 
expressions for the consumption/ production of substrates/ metabolites.  
 
Furthermore, MFA provides additional information on the following aspects (Papoutsakis 
and Lee, 1999): 
 
(i)  Identification of Alternative Pathways: 
Often the actual biochemical route by which a substrate is converted into products is not 
evident as there are many alternate pathways available for the conversion to take place. MFA 
is important in identifying pathways that can reproduce the macroscopic flux measurements 
of extracellular metabolites equally well and eliminate alternate pathways that are not 






(ii)  Calculation of Non-measured Extracellular Fluxes: 
In case of under-determined systems, where the number of extracellular measurements 
available is less than what is required to calculate intracellular fluxes, we can still compute 
their values by applying the stoichiometric model proposed under MFA approach. 
 
(iii)  Calculation of Maximum Theoretical Yields: 
Although ad hoc theoretical yield determination is possible and is often performed; however, 
in complex metabolite networks MFA provides a more formalized approach.  
4.1.2 Metabolic Network for Hybridoma Cells 
The starting point of MFA is obtaining the reaction network stoichiometries describing the 
conversion of substrates into metabolic products and biomass constituents (or 
macromolecular pools). The overall metabolic network for hybridoma has been taken from 
(Gao et al., 2006) and is shown in Figure 4-1. This figure represents the system under study 
and accounts for all the major energy producing pathways in hybridoma, namely the TCA 
cycle, Embden-Meyerhoff Fermentative pathway, Glutaminolysis and Respiration that 
produce both energy and precursors for biosynthesis (Barford et al., 1992). A key component 
of the metabolic network is the TCA cycle or Citric Acid cycle that is involved in the 
catabolism of all three major food groups: carbohydrates, lipids and proteins. As Figure 4-1 
illustrates, the complete reaction network involves m(=30) metabolites and n(=32) fluxes 























































Figure 4-1 Simplified Metabolic Network of Hybridoma Cells 
adapted from (Gao et al. 2006) 
The reactions corresponding to the metabolic flux network are given in Table 4-1. 









j2.  PYR→ AcCoA + CO2+NADH 
j3. AcCoA + OAA→ aKG + NADH + CO2 
j4.  aKG→ SuCCoA+ NADH + CO2 
j5.  SuCCoA→ FUM + NADH 
j6.  FUM→ OAA + NADH 
j7.  OAA→ PYR + NADPH + CO2 
j8.  PYR + NADH→ LAC 
j9.  THR→ PYR + CO2 + NH3 + 2NADH 
j10.  2GLY→ SER+CO2+NH3 + NADH 
j11.  SER→ PYR+NH3 
j12.  PHE→ TYR + NADH 
j13.  TYR→ FUM + 2AcCoA + NH3 + CO2 + NADPH 
j14.  VAL→ SuCCoA + CO2 + NH3 + NADPH 
j15.  THR→ SuCCoA + NH3 
j16.  ILE→ SuCCoA + AcCoA + NADPH + NH3 
j17.  MET + O2→ SuCCoA + SO2 + NADPH + NH3 
j18.  LEU→ NH3 + 3AcCoA + NADPH 
j19.  LYS→ 2 AcCoA + 2CO2 + 2NADPH + 2NH3 
j20.  HIS→ GLU+2NH3+CO2 
j21.  ARG→ aKG + 2NH3 + UREA + 3 NADH 
j22.  GLU + ATP + 2 NADPH→ PRO 
j23.  ASN→ ASP + ATP + NH3 
j24.  GLN + ASP + 2 ATP→ ASN + GLU 
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j25.  GLN→ GLU + ATP + NH3 
j26.  GLU→ AKG + NADPH + NH3 
j27.  PYR + GLU→ ALA + AKG 
j28.  GLU + OAA→ ASP + AKG 
j29.  CYS + O2→ PYR + SO2 + NADH + NH3 




0.0508GLC +0.0577GLN +0.0133ALA +0.007ARG +0.006ASN 
+0.020lASP +0.0004CYS +0.0016GLU +0.0165GLY +0.0033HIS 





0.0104GLN +0.011ALA +0.005ARG +0.0072ASN +0.0082ASP 
+0.005CYS +0.0107GLU +0.0145GLY +0.0035HIS +0.005ILE 
+0.0142LEU +0.0145LYS +0.0028MET +0.0072PHE +0.0148PRO 
+0.0267SER +0.0160THR +0.0085TYR +0.0189VAL→ MAb 
  
4.1.3 Calculation of Conversion Rates and Fluxes 
Mass balances for the intracellular and extracellular metabolites involved in the system can 
be represented as follows: 
(t)vXdt
(t)d Rψ =   (4.1) 
where ψ is the vector of intracellular and extracellular metabolite concentrations and t is the 
culture time. R is the vector of specific uptake/production rate of substrates/metabolites. 
Xv(t) is the viable cell concentration and is a function of culture time, t. Here, an assumption 
of balanced growth condition has been made. This implies that the system is at a quasi-steady 
state and consequently the net conversion rate of all intracellular metabolites is equal to zero. 
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This is a common assumption made in the literature for this type of flux analysis (Provost 
and Bastin, 2004). 
 







(t)dX(t)d vRψ    (4.2) 
 ψt-ψ0 = R(CHt-CH0)  (4.3) 
CH is referred to as the cumulative volumetric cell hours (Dutton et al., 1998) and can be 




(t)dtXCH v   (4.4) 
The integral expression in equation 4.4 can be approximated by an algebraic expression as 



































∑   (4.5) 
where Xv is the viable cell concentration and t is the culture time. 
 
The use of the cumulative volumetric cell hours allows for an assessment of productivity and 
biological capacity for production on the same cumulative basis (Dutton et al., 1998). 
R is calculated from linear regression between measured concentrations of metabolites and 
volumetric cell hours (CH) based on equation (4.3). The need for concentration measurements 
for intracellular metabolites is eliminated by assuming that the system operates under balanced 
growth conditions and consequently, the reaction rates corresponding to intracellular 
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metabolites(1 to 6 according to the numerical designation given in Figure 4-1) are assumed to 
be equal to zero (Provost and Bastin, 2004; Gambhir et al., 2003). 
 
The growth curve for batch or fed-batch run has been broadly divided into two phases: 
exponential and post-exponential. Essentially, all data points corresponding to the peak viable 
cell density and before are part of the exponential phase. Conversely, the data points from the 
peak viable cell density and beyond constitute the post-exponential phase. This is 



































Figure 4-2 Division into Phases for Calculation of R for (a) Batch Run and (b) Fed-
batch Run, respectively 
 
The division into various growth phases requires special attention for fed-batch culture as 
addition of feed at several instances during the run caused abrupt drop in biomass 
concentration. The separation of data into intervals was done as shown in Figure 4-2(b) by 
classifying all time intervals immediately after a feed addition as exponential and the point in 
time where the viable cell concentration started to fall was considered as the beginning of the 
post-exponential phase. In the experiments under study, there were 10 successive exponential 
phases followed by a post-exponential phase. Thus, an average R value was calculated for the 
exponential phase, one for the post-exponential phase and another for the overall experiment. 
 
Under the assumption of quasi-steady state, the conversion or production rate, R(m) of a 




































α(m) mi,∑=R   (4.6) 
where R is the uptake or production rate of metabolite m (=1,2,…M) in reaction i (=1,2,…N). 
 α
i,m 
is the stoichiometric coefficient for metabolite m in reaction i. α
i,m 
has a negative value for 
substrates that get consumed and is positive for metabolites that are produced. j
i 
is the 
intracellular flux for reaction i. In matrix notation, equation (4.6) may be written as:  
R=Aj    (4.7) 
where R is the vector of average uptake or production rates, j is the vector of all intracellular 
and extracellular species fluxes and A is the matrix of stoichiometric coefficients of the 
corresponding reaction species involved in the system metabolic network as shown in Figure 
4-1.  
A={αi,m}i=1,2,…N;  m=1,2,…M (4.8) 
In the case under study, N=32 and M=28. 
 
Referring back to system of equations in (4.7), experimental data was available to determine 
values of the vector R while the expression for the stoichiometric matrix A was be extracted 
from the reaction scheme in Figure 4-1. Thus, values for the flux vector j were easily 
determined using regression under the Quadratic Programming approach.  
( ) ( )AjRAjR −− TMin   (4.9) 
 
Now, it must be remembered that only 28 extracellular and intracellular measurements were 
known using which 32 flux values needed to be determined. Henceforth, the system of 
equations was underdetermined i.e., less equations than unknowns. Among the unknown 
quantities were concentrations for cystine and ammonia. Fortunately, a unique solution for 
the system was possible by imposing additional constraints on the system. These additional 
constraints were based on the assumption that all reactions should proceed in the direction 
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indicated in the metabolic flux network shown in Figure 4-1. This implies that all fluxes will 
have values at least greater than or equal to zero. Since there were 32 unknowns with 28 
equations, a unique solution is assured as long as the number of active constraints in the 
solution of the QP is greater than or equal to four. All the solutions found in the current work 
satisfied this criterion. Also, since cystine measurements were not available, its consumption 
rate was taken to be equal to zero as opposed to being excluded, because otherwise, a 
physically unrealistic flux distribution was obtained as solution, i.e. the flux corresponding to 
cystine consumption was unusually high. 
 
The metabolic flux analysis presented above is strongly based on averaged measured 
consumption and production rates of extracellular metabolites. Consequently, it is expected 
that the measurement experimental noise will surely affect the calculated flux distribution. In 
order to reduce sensitivity to noise, experimental values of R for a number of batches or for 
measured values of R at different times during the run in case of a fed-batch experiment were 
considered together to conduct the QP regression proposed above. For example, if s sets of 
experimental batches are considered, the augmented system of equations may be expressed 

































  (4.10) 
s: is the number of batches/sections considered in a fedbatch experiment.  
Then, a solution for the resulting over-determined system of equations given by (8) can be 
obtained from the following minimization problem:  
)(T)Min( jmodAmodRjmodAmodR −−  




The problem in (4.11) can be solved by a Quadratic Programming (QP) algorithm (Gao et al., 
2006). The result of flux calculation is a metabolic flux network outlining the various 
biochemical reactions included in the calculations along with an estimate of the steady state 
rate (i.e., the flux) at which each reaction in the diagram occurs. Depending on the 
contribution of each reaction in the network, the smaller flux values that are a negligible 
portion of the net flux through the system can be eliminated to obtain a reduced metabolic 
network. The results of this reduction process are given in Chapter 5.  
4.2 Reaction Kinetics and Development of the Dynamic Model  
A dynamic model was developed for predicting metabolite concentrations over the duration 
of the culture and is specifically referred to as ‘Dynamic Model’ elsewhere in the text to 
differentiate it from other dynamic models developed in this work. 
 
The dynamics involved in a stirred spinner is given by the following macroscopic material 
balance model:  
(t)(t)
dt
(t)d uKrξ +=   (4.12) 








is the vector of concentrations of 









the macro-reaction rate vector. K is the matrix containing stoichiometric coefficients of the 
reaction species involved in the elementary macro reactions. The second term on the right 
hand side of the equation u(t) represents the vector of net exchange rate of species with the 
surroundings. The term is zero for all species except for CO2 which is a gas. However, 
measurements corresponding to CO2 were not available and such measurements are difficult 
to make. As a result, the term u(t) has been effectively dropped from equation 4.12 and it can 
in turn be written in the matrix form as follows: 
(t)
dt















∏=  (4.14) 






are the corresponding substrate 
concentration and half-saturation constant, respectively. a
i 
is the maximum rate at which the 
reaction can proceed, while X
v,e 
is the experimental viable cell concentration.  
 
There are two methods for estimation of the specific growth rate, ai and the associated 
Monod constant, ki in equations elucidating behavior of growing cultures. One is the steady 
state measurement of growth and the limiting substrate concentration in continuous culture at 
different dilution rates. An alternative method is the measurement of the growth rate at 
different substrate concentrations in batch culture (Banerjee, 1993). 
 
The assumption of balanced growth made previously implies that the reactions taking place 
in the system operate at a constant maximum rate during the exponential phase. In the 
absence of experimental data for estimation of ai and ki, the maximal rates, ai’s can be 
obtained by choosing the half saturation constants k
i
’s in equation (4.14) to be significantly 
smaller in comparison to substrate concentration for major part of the experimental run, i.e. 
r(t)≈aX
v,e
(t). However, attention was paid that the values were not too small to avoid any 
numerical stiffness problems (Gao et al., 2006). The dynamic model expressed in (4.13) can 
thus be stated as:  
(t)ev,Xdt
(t)d Kaξ =   (4.15) 
Additionally, following equation (4.1) the mass balances for the extracellular metabolites 










is the conversion rate vector and is a subset of vector R.  
 
Next, utilizing equations (4.13) and (4.14), a system of algebraic equations can be derived as 
follows.  
Ka=Rξ    (4.17) 
As explained before, experimental data is used to compute the values for R and the reduced 
reaction scheme for determining expression for K. Again, the system in (4.17) is generally 
over-determined and correspondingly the a-values can be estimated by applying QP to solve 








s.t. a≥0   (4.18) 
4.3 Development of the Biomass Model 
The second objective of the study was to model the growth and death of the cells. The 
underlying motive was to develop a general model to balance the viable and dead cell 
concentrations as a function of system properties at that instant in time. Thus, the 




























  (4.19) 
where Xv and Xd are the viable and dead cell concentration, respectively and kg and kd are the 
parameters of the system. 
 
Here, Biomass Model refers to the dynamic model that predicts the viable and dead cell 
concentration over the duration of the culture and the metabolite concentrations over time act 
as inputs to the model. The phrase ‘Biomass Model’ has the same implication as mentioned 




The key challenge in this model was to find from experimental data the explicit dependence 
of the growth and death rates with respect to the extracellular metabolites.  Although no 
starting assumptions were made as to whether the model would be multiplicative or not, it 
was expected that the Xv and Xd will show dependence on more than one variable/metabolite. 
To find these dependencies, it was decided to use correlation analysis between the 
experimentally measured terms in the left hand side of equation (4.19) and different 
functional forms of nutrient and product concentrations. Since there was no prior information 
to indicate the nature of mathematical functions that would account for behavior of f(ξ) and 
g(ξ), Monod functions for metabolite concentration were initially used for testing correlation. 
The software- STATISTICA was used to find these explicit functional forms. Results of the 
correlation analysis for the system under study are presented in Chapter 5. Finally, after these 
functions were found, the growth and death rate coefficients, k
g 
and k
d given in (4.19) were 
found from the following minimization problem. 
Min [Sum of squares] = ∑∑ −+− 2)pd,Xed,(X2)pv,Xev,(X   (4.20) 
Where Xv,e, Xv,p, Xd,e, Xd,p are the experimental and predicted values of the viable and dead 
cell concentrations, respectively.  
4.4 Integration of the Dynamic Model and Biomass Model 
Once separate models for predicting metabolite concentrations and biomass concentration 
over time were developed, an integration of these two models is required to come up with an 
overall generalized model. Integration of the two models into one overall model is 
schematically described in Figure 4-3. The advantage of the overall model over the 
individual sub-models is its ability to predict both metabolite and biomass concentration 
solely on the basis of starting concentrations of the metabolite/concentration variables 
involved in the model. The estimated parameters for the two separate models needed to be 
adjusted in order to fine-tune the predictions as combining the two models led to introduction 
of greater noise in the overall data-set. The obtained integrated model is presented in greater 





Figure 4-3 Integration of Dynamic and Biomass Model 
 















As part of the modelling procedure, firstly MFA was applied to a general reaction network 
for hybridoma cells developed on the basis of published information. A reduced metabolic 
network was obtained as a result. The reactions in the reduced network were further utilized 
to develop rate expressions for consumption/ production rates of substrates/products. A 
dynamic model was then constructed that predicted metabolite concentrations over time. 
Next, correlation analysis was applied to obtain the dependence of specific growth and 
specific death rates on metabolite concentration(s). Thus, a multiplicative model was 
developed for biomass prediction. And finally, individual models were integrated to give an 
overall model that utilizes starting values for metabolite concentrations and predicts their 
subsequent concentration values in time.  
 
Two sets each of batch and fed-batch data were available. MFA was applied based on the 
available data sets. One batch and one fed-batch data set were utilized towards model 
calibration and the other set of batch/fed batch data was used for model prediction. This 
enabled us to test the validity of the model(s).  
 
Based on the results obtained from the simulations, hypotheses about the cell metabolism and 
kinetics of the system have been made in Chapter 7. Additionally, the drawbacks of the study 










5.1 Obtainment of the Reduced Metabolic Network 
The first step in the process of model development is the MFA. Initially experimental batch 
data for two separate runs was considered. The complete run was divided into exponential 
and post-exponential phases as described in the previous chapter. The data included 
concentration measurements (mmol/L) for 22 extracellular metabolites that were further 
converted to mmol/(109cell-hours). The formula(s) for such a conversion have been given in 
the previous chapter. Corresponding specific uptake/production rates for these metabolites 
were calculated for the exponential, the post-exponential and the complete run; and have 
been denoted by Rexp, Rpost-exp and Rfull respectively.  The uptake/production rate for 
intracellular metabolites was taken equal to zero under the assumption of balanced growth 
conditions. Equation (4.3) was used to compute these three R-vectors. The calculated values 
have been expressed in Appendix-B. R-values for the intracellular metabolites in the reaction 
scheme were taken to be equal to zero on the basis of the balanced-growth assumption made 
earlier. 
 
Now, it must be mentioned that only 28 measurements- extracellular and intracellular were 
known using which 32 flux values needed to be determined. Henceforth, the system of 
equations was underdetermined i.e., less equations than unknowns. Among the unknown 
quantities were concentrations for cystine and ammonia. However, the system can be made 
over-determined by applying additional constraints to the system; it was stated the solution 
should be such that all flux values are at least greater than or equal to zero. Furthermore, an 
assumption was made to the system; the consumption rate of cystine (missing measurement) 
was taken to be equal to zero rather than being just left out. This is because otherwise a 
physically unrealistic flux distribution was obtained as solution, i.e., flux corresponding to 
cystine consumption had an unusually high value. It was found that any time, more than three 
constraints were satisfied; thus the solution was unique. In order to reduce the sensitivity to 




By substituting values of the calculated uptake/production rate vector Rmod into equation 
(4.10) where the expression for the stoichiometric matrix Amod is obtained by inspection from 
Figure 4-1, the flux vector j was obtained by applying a Quadratic Programming routine as in 
equation (4.11). As explained above, three values for vector R corresponding to the 
exponential, post-exponential and overall average phase were obtained. The corresponding 
values for the flux vector have been denoted by jexp, jpostexp, jfull.  
 
On observation of the overall flux distribution (jfull) in Figure 5-1(a), it is evident that the flux 
values from j9-j22; and then j26, j29 and j30 have values very close to zero. This implies that 
the reactions these fluxes represent do not proceed appreciably and hence do not contribute to 
the overall cellular metabolism. Consequently, they were ignored and henceforth the original 
reaction network was reduced to Figure 5-2. 
 
To obtain the reduced metabolic network for the fed-batch case, the growth phase of each of 
the two fed-batch experimental runs was subdivided into 10 time intervals that has been 
described in detail in Chapter 4. The post-exponential phase of fed-batch experiments has 
been defined as decline phase when feeding was stopped and there was an irreversible drop 
in viable cell concentration. Subsequently, average reaction rate values, as per equation (4.3), 
were calculated for each one of these 10 time intervals (R1,…,R10). Then, the data 
corresponding to the 10 intervals was simultaneously used to define the over-determined 
system of equations given by equation (4.10) and the corresponding fluxes were obtained 
from the QP solution based on (4.11). And finally, an overall average value of R denoted by 
Rfull was computed based on equation (4.3). Again, the calculated values for R have been 
given in Appendix-B while the graphical representation for the average fed-batch flux values 
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(b) 
Figure 5-1 Distribution of Average Fluxes for (a) Batch Run and (b) Fed-batch Run 
 
It is clear from Figures 5-1(a) and 5-1(b) that the distribution trend of fluxes in batch and fed-
batch cultures is strikingly similar. Based, on the flux distribution, the same exercise of 
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eliminating insignificant fluxes from the complete metabolic network was undertaken for the 
fed-batch case. Since the same fluxes were found to be insignificant in both culture modes, a 





































Figure 5-2 Reduced Metabolic Network 
 
The reduced network obtained in the current work is very similar to the one obtained by Gao 
et al. (2006) for hybridoma in batch culture with the only difference being that flux j28 
instead of j26 is eliminated, otherwise the reduced metabolic network is identical.  
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5.2 Obtainment of the Dynamic Model 
5.2.1 Developing Fundamental Macro-Reactions 
Each reaction species in Figure 5-2 represents a ‘flux mode’. Based on the reduced reaction 
network, the elementary flux modes were computed and in turn, translated into a set of 
macro-reactions linking/establishing relationships between the various extracellular 
substrates and products (Provost and Bastin, 2004).  
 
The intracellular metabolites were eliminated by simple algebraic manipulation in light of 
missing measurements for the same. The intracellular fluxes could not be measured in this 
work and therefore even if they could be calculated, their values could not be verified due to 
a lack of experimental data for the same. The process of elimination of the intracellular 
fluxes can be illustrated by the following example: 
 
J1  Glc→2Pyr     … 1 Multiplying equation J1 by 1 and,  
J2  Pyr→Lac     … 2  Multiplying equation J2 by 2 
------------------------------------------------------------Adding up J1 and J2 so as to eliminate Pyr 
E1:  Glc→2Lac  
---------------------------------------------------------------- 
 
After the elimination of intracellular fluxes from the reduced reaction network, 9 elementary 
macro-reactions were derived and have been summarized in Table 5-1.  
 













































Based on the above results for the reduced reaction network, the reduced stoichiometric 


























































  (5.1) 
 
The rows in K represent the various extracellular metabolites being considered in the model, 
and the columns represent the number of macro-reactions obtained as a result of the 
elimination of intracellular measurements that are represented in Table 5-1. It should be 




were eliminated in the equations.  
5.2.2 Development of Rate Expressions 
Since it was assumed that the reactions shown in Table 5-1 proceed by Monod kinetics, the 
reaction rates could be expressed as Monod functions of the nutrient concentrations involved 










=   (5.2) 




Table 5-2: Macro Reactions and Accompanying Reaction Rates 










































=  a9,kQ 
 
5.2.3 Model Calibration and Testing  
The half saturation constants, kij (i= a certain metabolite and j= number of the elementary 
reaction) in Table 5-2 were chosen by inspection such that they were small enough to be 
negligible when the nutrient concentration was reasonably high but would be large enough to 





Table 5-3: Values for the Half-saturation Constants 
Constant Batch Mode  
(in mmol/L) 
Fed-batch Mode  
      (in mmol/L) 
kG 4 0.5 
kQ 0.05 0.5 
kU 0.01 0.01 
kS 0.02 0.12 
kF 0.05 0.05 
 










  (5.3) 
The a-coefficients in the reaction rate expressions in (5.3) were calculated by Christian 
Fischer, a summer co-op student separately for the exponential and post exponential phases 
of batch and then fed-batch operation. It was seen that the a-coefficients determined for batch 
operation differed from similar estimation for fed-batch operation; and even within one 
batch, the values of a-coefficients for exponential phase of growth were different from the 
post-exponential phase because of differences in kinetics. The values for the a-coefficients 
have been given in Appendix-B.  
 
Based on the set of equations derived in (5.3), the model calibration was performed on the 
basis of one batch and one fed-batch experiment, and the estimated a-values were in turn 




Calibrated batch and fed-batch data sets are given in Figure 5-3 (a) and (b). The model has 
been tested by a comparison between experimental data and model predictions given in 
Figure 5-3 (c) and (d). In these figures, experimental cell concentration, also included, was 
used as input to the dynamic model of metabolites. Viable cell concentration acts as input as 
model equations for predicting viable cell concentration had not been developed at this stage. 
Figures are shown on the following page. Figures 5-3(a, b) are the model calibrations and 






























































































































































































































































































































































































































































































































































































































Figure 5-3 Dynamic Model Simulations (-) vs Experimental (●) Metabolite 
Concentrations in Batch Run (a,c) and Fed-batch Run (b,d) 
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5.3 Obtainment of the Biomass Model 
5.3.1 Correlation Analysis 
To obtain a mathematical model that does not require the experimental data for cell 
concentration, it was necessary to predict the trends for growth and death of the cells with 
respect to influencing factors that affect cell growth and viability. To find the exact 
dependence relationship, the software STATISTICA was used to run the correlation analysis 
with respect to the various metabolite measurements available including nutrients, amino 
acids and by-products. 
 
Since Monod expressions are the most common types of mathematical functions used for 
explaining cellular behavior in systems biology, the first few attempts focused on finding 
similar functional dependence (Monod) in the system under study. The functions with which 
the growth and death terms showed correlation were referred to as influencing factors. The 
terms that did not improve correlation were left out from the overall expression for 
influencing factors. The results summarized in Table 5-4 show that the influencing factor is a 
function of glutamine and lactate.  
Table 5-4: Results of Correlation Analysis 




































 0.92 (0.83) 
 








































  (5.4) 
5.3.2 Model Calibration and Testing 
The parameters kgQ and kdQ were determined by simply choosing values that gave the best 
possible fit of the simulations to experimental data. The growth and death coefficients kg and 
kd were estimated by applying a least squares minimization routine in MATLAB using 
fmincon function. The optimized objective function was as follows: 
 
Min [Sum of squares] = ∑∑ −+− 2)pd,Xed,(X2)pv,Xev,(X  (5.5) 
 
Where Xv,e, Xv,p, Xd,e, Xd,p  are the experimental and predicted values of the viable and dead 
cell concentrations, respectively. Values for the estimated coefficients are furnished in Table 
5-5. 
Table 5-5: Values for Parameters in Biomass Model 
Parameter Value for Batch Mode Value for Fed-batch Mode 
kg 0.05 0.05 
kd 0.0004 0.0004 
kgQ 0.05 0.05 
kdQ 0.43 0.43 
 
It is worth commenting that the parameter values in Table 5-5 for batch and fed-batch mode 
are the same and the model built on these values is able to capture the process behaviour. To 
test validity of the model, a separate data set was used for calibration and prediction of the 
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Biomass model for the batch as well as the fed-batch case. Figure 5-4 shows the calibrations 
and predictions based on the calibrations. 
  



































































































Figure 5-4 Experimental Data for Viable and Dead Cell Concentrations (*) vs 
Simulated Data (-) for Biomass Model for Batch Mode (a,c) and Fed-batch Mode (b,d) 
Note: For fed-batch, the various maxima in the graph for X
v 




Graphs in Figure 5-4(a) are calibration results for batch mode and graphs in Figure 5-4(b) are 
calibration results for fed-batch mode. The graphs in Figure 5-4(c) are prediction results for 
batch mode and graphs in Figure 5-4(d) are prediction results for fed-batch mode. 
5.4 The Integrated Model 
The final step in the formulation of a general model for MAb production was the integration 
of the dynamic model for extracellular species and the cell concentration model as per the 
schematic diagram in Figure 4-3. By combining the two sets of equations (5.3 and 5.4) meant 
that instead of using experimental values (as inputs) for model prediction, only starting 
values would be used for successively predicting metabolite concentrations and cell 
concentrations over time. In short, the system of equations for the cell culture system under 











































  (5.6) 
5.4.1 Model Calibration and Testing  
A re-adjustment of growth and death coefficients (kg and kd) was required because upon 
integration of the individual models into one, the predictions were slightly inaccurate. Some 





for batch mode were 0.04 (x106 cells/ml-hr) and 0.001 (x106 cells/ml-
hr) respectively while for fed-batch these values were 0.04 (x106 cells/ml-hr) and 0.0001 
(x106 cells/ml-hr) respectively. The values for the half-saturation constants for the integrated 










kG 4 4 
kQ 0.03 0.05 
kU 0.01 0.01 
kS 0.02 0.12 
kF 0.05 0.05 
 
Based on results obtained from equations in (5.6), a separate set of batch and fed-batch 
experimental runs was taken to test accuracy of estimated parameters in predicting for future 





























































































































































































































































































































Figure 5-5 Comparison of Predicted Data (-) with Experimental Data (●) for (a) Batch 
Culture and (b) Fed-batch Culture.  
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Note: Experimental MAb data is unavailable for batch experiment 
 
In addition to predicting experimentally measured metabolite concentrations, the model also 
predicts for ammonia that was not measured during the course of the experiment. The 
simulated results for ammonia have been given in Figure 5-6. 
 







































Figure 5-6 Simulations for Ammonia Concentration in (a) Batch and (b) Fed-batch 
Systems 
 
At this point, the simulation results for ammonia could not be verified experimentally 







Analysis of the modelling results presented in Chapter 5 suggests that a more detailed 
characterization of the cell population is required. Until now, Trypan blue dye exclusion test 
was used to characterize the overall population of cells as either viable or dead. However, 
this staining technique cannot provide any further details about the state of the cell 
population and hence it is not possible to derive a more detailed characterization of cells 
based on this technique alone. Compared with the usual Trypan blue dye exclusion method 
of establishing culture viability, dual staining demonstrated that under stressful conditions a 
significant proportion of cells that excluded Trypan blue were also moribund through 
apoptosis, i.e. programmed cell death. This chapter presents preliminary results on the 
application of fluorescence imaging for a more detailed classification of cells by identifying 
apoptotic and necrotic cells in-situ. 
6.2 Identification of Apoptosis and Necrosis- Why is it Crucial?  
Even though cell cultures are sometimes treated as a homogeneous mixture of identical cells, 
the fact is that individual cells exhibit heterogeneity as a result of small differences in their 
cellular metabolism and cell-cycle dynamics. Repeated progression through the cell cycle 
yields a heterogeneous population in which individual cells differ according to their size and 
intracellular state (Henson, 2003). 
 
There have been accounts in literature of an increase in the rate of MAb production 
associated with the onset of cell death (Simpson et al., 1997). This negative association 
between productivity and cell growth has been attributed duly in part to the passive release of 
MAb stored in cytoplasmic vesicles (Al-Rubeai et al., 1992). As cells die and membrane 
integrity deteriorates, the cytoplasmic content of the cell is released. Experiments have been 
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conducted with hybridoma cultures where cell growth was slowed by either a DNA synthesis 
inhibitor (thymidine or hydroxyurea) or by a selective inhibitor of initiation of nonantibody 
protein (potassium acetate) and exhibited 50-130 % MAb production rate enhancement for 
growth slowed up to 50 % (Suzuki and Ollis, 1990).  
 
It has been hypothesized in the current research that cells at different stages of the cell cycle 
may exhibit different product formation rates and different death rates in the absence of 
nutrients. Therefore, identifying different patterns of cell death such as apoptosis or necrosis 
may be essential for obtaining an accurate model of the operation. 
6.3 Differentiation between Apoptosis and Necrosis 
As apoptosis marks the onset of cell death, it is important to accurately distinguish between 
the apoptotic and necrotic states from the stand-point of the current work. Table 6-1 and 
Figure 6-1 enlist the differences between the two modes of cell death based on morphology.  
 
Table 6-1: Differential Features and Significance of Necrosis and Apoptosis 
adapted from (Wyllie, 2004) 
Apoptosis Necrosis 
Morphological Features  
• Protrusions on the cell membrane, but no loss 
of membrane integrity 
• Aggregation of chromatin in the nuclear 
membrane 
• Begins with shrinking of cytoplasm and 
condensation of nucleus 
• Ends with fragmentation of cell into smaller 
bodies 
• Formation of membrane bound vesicles 




• Begins with swelling of cytoplasm 
and mitochondria 




• Mitochondria become leaky due to pore 
formation involving proteins of the bcl-2 
family 
 
• No vesicle formation, complete 
lysis 
• Disintegration (swelling) of 
organelles 
Biochemical features  
• Tightly regulated process involving activation 
and enzymatic steps 
• Energy(ATP)-dependent process (active 
process, does not occur at 4˚C)  
• Loss of regulation of ion 
homeostasis 
• No energy requirements (passive 
process, can occur even at 4˚C) 
Physiological significance  
• Affects individual cells  
• Induces physiological stimuli (lack of growth 
factors, changes in hormonal environment) 
• No inflammatory response 
• Affects groups of contiguous cells  
• Evoked by non-physiological 
disturbances (complement attack, 
lytic viruses, hypothermia, hypoxia, 
hyperoxia, ischemica, metabolic 
toxins)  





Figure 6-1 Illustration of the Morphological Features of Necrosis and Apoptosis 
borrowed from (Wyllie, 2004) 
 
6.3.1 Morphology in Apoptosis and Necrosis 
It has been documented that cell morphology may be used to infer the state of a cell. Each 
stage of the cell-life cycle exhibits characteristic morphology. Fluorescence imaging provides 
the means of identifying the different stages of cell growth and death by capturing the 
changes in cell morphology as the cell progresses through the various stages of its life-cycle 
(Mercille and Massie, 1994; Renvoize et al., 1997; Ziegler et al., 2004). 
 
Sources from available literature (Mercille and Massie, 1994: Renvoize et al., 1997; Wyllie, 




Table 6-2: Morphological Characteristics of Various Stages of Cell Growth and Death 
Cell Morphology Identifying Characteristics 
Viable Non-apoptotic (VNA) Cytoplasm intact, nucleus intact 
Viable Apoptotic (VA) Cell-shrinkage, rounding-up, loss of 
contact with adjacent cells  
Non-viable Apoptotic (NVA)- Early Highly condensed chromatin in the shape 
of crescents around the periphery of the 
nucleus or present as groups of spherical 
beads/ Surface protrusions 
Non-viable Apoptotic (NVA)- Late Cell fragmentation into apoptotic bodies 
Non-viable Necrotic (NEC) Swelling of entire cell, ruptured plasma 
membrane, release of intracellular 
constituents and slow dissolution of the 
nucleus 
 
6.3.2 Dual Channel Fluorescence Staining for Apoptosis and Necrosis 
Before proceeding towards the classification of cells in batch and fed-batch cultures, it is 
imperative to be able to independently identify apoptosis and necrosis. In order to do so, 
assays for apoptosis and necrosis were performed whereby cell death was induced in a cell 
culture in the exponential phase of growth. 
 
The determination of cell death by apoptosis is made primarily on the basis of distinct 
structural changes in the cell’s chromatin that occur prior to the lysis of the membrane. These 
changes include the aggregation of chromatin in the nuclear membrane and may be 





Typically, apoptosis begins with the shrinkage of the cytoplasm and condensation of nucleus. 
Fragmentation of cell into smaller membrane bound vesicles (apoptotic bodies) marks the 
end of apoptosis (Coligan, 1994; Wyllie, 2004).  
 
Basic protocol adopted for the purpose of characterization of apoptosis/necrosis utilizes the 
DNA-binding properties of fluorescent dyes- AO and EB. This protocol has been described 
in greater detail in Chapter 3 that discusses the various experimental methods adopted.  
 
AO and EB are both intercalating fluorochromes that bind to the DNA to emit green and 
orange fluorescence respectively. AO can penetrate the plasma membrane and is thus taken 
up by both live and dead cells. It binds to the DNA staining it green and binds to the RNA 
making it fluoresce as red. On the other hand, EB cannot penetrate the cytoplasm and is 
therefore only taken up by non-viable cells that have suffered membrane disintegration. EB 
binds to the DNA making it appear orange and binds somewhat weakly to the RNA present 
that may give weak red fluorescence. Thus, viewed under a fluorescence microscope, a 
viable non-apoptotic cells cell stained with both AO and EB will have bright green nucleus 
with intact structure while early apoptotic cells will display bright green chromatin 
condensed in the form of crescents in the nucleus. As EB dominates AO fluorescence, a non-
viable apoptotic cell will exhibit bright orange nucleus with widespread chromatin 
condensation and the non-viable necrotic cells will appear to be larger than the average cell 
in size and will exhibit an orange nucleus with cytoplasm intact and emitting orange-red to 
bright red fluorescence (Coligan, 1994; Mercille and Massie, 1994). 
6.3.2.1 Induction of Apoptosis 
Method for induction of apoptosis has been discussed in detail in Chapter 3. Briefly stating, 
cycloheximide was added to a cell culture at a final concentration of 25 µg/ml and incubated 
for overnight. Figure 6-2 exhibits the images taken for the cell culture and clearly shows the 
morphology exhibited during apoptosis. The details in Table 6-1 under ‘Morphological 






















Figure 6-2 Images of Apoptotic Cells Exhibiting Characteristic Associated Morphology 
6.3.2.2 Induction of Necrosis 
Method for induction of necrosis has been discussed in detail in Chapter 3. Briefly stating, 
HPLC grade ethanol was added to a cell culture at a final concentration of 25% v/v and 
incubated overnight. Figure 6-3 shows the images taken for the cell culture and clearly 
depicts the morphology exhibited during necrosis. The details in Table 6-1 under 













Figure 6-3 Images of Necrotic Cells Exhibiting Characteristic Associated Morphology 
 
Based on the analysis of images for apoptotic and necrotic cell cultures, a general guideline 
for distinguishing the cell population was developed. Thus, the cells can be categorized as 








   
Viable Apoptotic Non-Viable Apoptotic (early stages) 
Non-Viable Apoptotic (late 
stages) 





6.4 Present Research Efforts 
Efforts in the future focus on carrying out regular batch and fed-batch runs and 
characterization of the overall population into (i) Viable Non-apoptotic, (ii)Viable Apoptotic, 
(iii) Non-viable Apoptotic, (iv) Necrotic. 
6.4.1 Preliminary Image Results for Batch Mode 
Images shown in this section were obtained in experiments conducted with CHO IG1-9B8 
for batch mode in spinners. Two frames for each day have been exhibited for a total duration 
of 12 days for which the experiment was run. 
 
The culture was initiated on March 29 and incubated overnight. This period formed the lag 
period of the culture age. The images taken from the experiment have been illustrated in the 
figures that follow.  
 
Figure 6-5 displays images taken after overnight incubation that revealed some chromatin 
condensation in the cell population indicating a slightly apoptotic cell population on day 1 of 
growth; the culture had not yet entered the exponential phase of growth. Images taken after 
another day of growth on day 2 illustrated an exponentially growing population with viable 















March 30- Day 1  
March 31-Day 2  
 




Figure 6-6 displays images taken on day 3 and 4 of culture. There was marked cell shrinkage 
and the appearance of “blebs” on the surface of the cells at the end of day 3 indicating the 
onset of apoptosis. On day 4, there was visible chromatin condensation in some of the cells 
with no loss of nuclear integrity further confirming apoptotic cell morphology. 
April 1-Day 3  
 
April 2-Day 4  
  




April 3-Day 5  
 
April 4-Day 6  
 





April 5-Day 7  
Figure 6-7 Day 5, 6 and 7 of the Batch Culture Experiment 
 
As Figure 6-7 illustrates, on day 5 the chromatin condensation became more pronounced and 
widespread which is an indicator that the culture was largely apoptotic although apoptosis 
induction was still in its earlier stages. Over the progress of the day, some of the cells 
progressed to the late apoptotic stage where the cellular membrane exhibited permeability 
and stained orange. The trend continued on day 6 and 7 with some cells receding into the 
final stages of apoptotic death or secondary necrosis as indicated by the red stained cells. The 
cells stained green are also apoptotic since they show a large degree of chromatin 
condensation. 
 
Figure 6-8 that follows on the next page confirms that the trend continued for the next two 
days with the progression of culture from early apoptosis to late apoptosis which is marked 
by a greater permeability of the cell membrane to Trypan Blue dye. This is confirmed by the 
results obtained from the Trypan Blue dye exclusion test in Figure 6-11 that displays a 
decline in cell viability. 
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April 6-Day 8  
  
April 7-Day 9  
  
Figure 6-8 Day 8 and 9 of the Batch Culture Experiment 
Figure 6-9 indicates that almost all cells in the culture had turned apoptotic by day 10 and 
this trend carried on to day 11 as evidenced by the formation of apoptotic bodies. By day 11, 
more than 50% of the cells had undergone death via apoptosis. There is sufficient reason to 
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believe that there was not sufficient primary necrosis as the cells did not show incidence of 
necrosis earlier in the run and the cells did not lose membrane integrity which is a salient 
characteristic of necrosis. 
April 8-Day 10  
  
April 9-Day 11  
  




April 10- Day 12  
  
April 12-Day 14  
  




As is evident from Figure 6-10 and Figure 6-11, by the end of day 14, all cells were dead. 
This observation was supported by the results from the Trypan Blue dye exclusion test. The 
reader may see Appendix A for reference. 
 



























Figure 6-11 Viable(*) and Dead(o) Cell Concentration as per the Trypan Blue Exclusion 
Test 
 
In addition, Mercille and Massie (1994) observed similar behavior in D5-hybridoma and 
attributed the induction of apoptosis in batch results to the exhaustion of glutamine. Further 
analysis of the culture supernatant sampled during the course of the experiment will yield 
valuable information about the possible factors leading to cell death by apoptosis and enable 




Conclusions and Recommendations  
Dynamic models for batch and fed-batch operations were derived based on initial metabolic 
flux analysis. The simplified elementary fluxes and consequent model structure were similar 
for batch and fed-batch processes. However, differences in reaction rate constants were noted 
indicating a shift in energy metabolism during fed-batch operation. The results imply that the 
nutrients in fed-batch mode are essentially channeled towards cell-maintenance rather than 
growth.  
 
It was observed from calculated flux values that while glutamine is not exhausted, the viable 
cell count was maintained at about 4.5x10
5 
cells/ml and the dead cell count remained 
relatively low at 1x10
5 
cells/ml until the very end of the experimental run. Also, during this 
period, the death rate k
d 
was significantly lower for fed-batch mode as compared to batch 
mode. Comparing the distribution of fluxes during batch and fed-batch operation, it is 
evident that the ratio of flux 8 (Pyr→Lac) to flux 2 (Pyr→TCA cycle) in batch culture is 2.41 
while in fed-batch culture it equals 1.29, almost twice as high as in batch culture. Moreover, 
there is a slight increase in flux 1(Glc→Pyr) in fedbatch mode because there was no glucose 
limitation during fed-batch experiment. All these facts indicate that the energy-producing 
metabolism becomes more efficient in fed-batch as compared to batch. The reason could be a 
possible metabolic shift with higher emphasis on cellular maintenance rather than growth or 
metabolite accumulation. There is published evidence to support the above statement 
(Follstad, et al., 1999). Thus, although the set of significant fluxes remains the same in batch 







The model is an improvement over pre-existing models of similar nature as: 
1. MFA has been applied to a fed batch situation in order to obtain a dynamic model for 
this mode of operation. The same structure of the dynamic model has been applied to 
both batch and fed-batch systems.  
2. The viable and dead cell concentrations have been explicitly modeled. Correlation 
analysis has been used to investigate the dependencies of growth and death rates on 
nutrient and product concentrations.  
3. The cell concentration model is coupled to the metabolite dynamic model that utilizes 
experimental starting values to generate an integrated model that predicts all 
significant system variables, including viable and dead cell concentrations, 
independent of subsequent experimental values. 
  
However, there are some drawbacks in the model.  
1. In the final predictions for the Integrated Model in fed-batch mode, there was a 
noticeable under-prediction of death and MAb concentration whose accurate 
prediction is the primary objective.  
2. The proposed model does not account for viable apoptotic and non-apoptotic cells 
individually. 
 
The difference between experimental data and corresponding predictions may be explained 
on the basis of the fact that viable cells can be further categorized as apoptotic and non-
apoptotic. Available literature with regards to cell kinetics during fed-batch suggests that 
under nutrient limited conditions, the cells move from a viable, non-apoptotic state to a 
viable apoptotic state. This could lead to variation in antibody production rates and might 
explain inaccurate predictions for cell death and MAb in the current work. It is probable that 
these two different classes of viable cells have different rates of reaction or to be more 
specific, MAb production. Therefore, there is a possibility that the present model predicts an 
average rate of generation based on an averaging of apoptotic and non-apoptotic cells as 
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viable population. Thus, there is a clear motivation to monitor the evolution of apoptotic and 
non-apoptotic cells during operation. 
Fluorescent images taken for batch experiments indicated that death of the CHO cells is 
primarily through apoptosis. This observation is similar to the work of Mercille and Massie 
(1994) who found that death of D5 hybridomas occurred primarily through apoptosis. They 
also found that such a trend coincided with the exhaustion of glutamine. Analysis of the 
culture supernatant is still pending and will yield valuable information in this regard. Such an 
analysis will yield useful information that can then be extended to fed-batch experiments and 
help in the modelling of individual cell populations present in culture more accurately and 
representing the trends of death and MAb production more accurately. 
 
Additionally, it has been hypothesized in this work that under conditions of nutrient 
limitation there is a constant accumulation of apoptotic cells in the system. When the feeding 
is stopped, the apoptotic cells go into death mode almost instantaneously that would explain 
the sudden death scenario in fed-batch cultures. The current model only classifies the cell 
population as viable and dead. As a result, more detailed analysis of this switch from non-
apoptotic to apoptotic state is required.  
 
Based on the above, future work shall focus on the following points: 
1. Use of fluorescence imaging as a tool to capture the changes in cell morphology 
along the course of experimental runs- batch and fed-batch and relate them to 
changes in concentrations of the various metabolites present in the system at any 
time. 
2. Identification of an active death process such as apoptosis and the factors controlling 
it (as opposed to a passive one, i.e., necrosis) may lead to new strategies for the 
minimization of cell death during commercial operation of animal cell cultures. 
Specifically, this will aid in the design of an optimum fed-batch feeding regime with 




3. Modelling of the mechanisms leading to apoptosis at the intracellular level such as 
cell-cell signalling, activation of caspases and the correlation of this activation 





Raw Experimental Data 
SET-1 














1.00 0.0000 0.11 76.27 7.57    
25.10 4.8711 0.33 85.39 7.11    
49.50 20.8364 1.15 88.08 6.81    
73.50 47.1476 1.05 80.44 6.82    
76.00 0.0000 0.12 84.07 7.77    
98.50 2.3730 0.09 75.51 7.40    
123.50 8.0731 0.46 84.26 7.12    
143.00 23.1183 1.21 90.88 6.93    
145.00 0.0000 0.10 84.95 7.68 2.46 3.91 0.18 
164.50 2.3505 0.15 85.29 0.00 2.92 3.62 0.44 
192.00 12.4236 0.74 83.10 6.92 14.08 2.43 1.41 
217.75 38.4855 1.34 94.19 6.90 26.54 1.70 1.68 
239.00 61.4044 0.86 60.64 6.90 44.25 1.63 1.64 
263.50 74.4412 0.30 18.62 7.16 33.08 1.63 1.63 
287.00 77.9675 0.06 3.66 7.20 28.87 1.59 1.66 





Related Amino-acid Data 




ASP GLU ASN SER GLN HIS GLY THR ALA ARG 
1.00 0.26 0.07 0.47 0.36 3.35 0.21 0.38 0.70 0.14 0.33 
25.10 0.21 0.11 0.41 0.33 2.20 0.17 0.34 0.62 0.43 0.26 
49.50 0.08 0.09 0.32 0.28 0.27 0.09 0.30 0.48 1.07 0.12 
73.50 0.01 0.02 0.28 0.33 0.00 0.08 0.36 0.46 1.32 0.13 
76.00 0.25 0.06 0.45 0.36 3.31 0.20 0.37 0.69 0.16 0.33 
98.50 0.23 0.10 0.42 0.34 2.65 0.18 0.35 0.64 0.27 0.29 
123.50 0.18 0.14 0.36 0.32 1.27 0.14 0.34 0.55 0.64 0.20 
143.00 0.09 0.12 0.31 0.33 0.05 0.09 0.30 0.48 1.10 0.12 
145.00 0.27 0.06 0.47 0.39 3.35 0.21 0.41 0.73 0.15 0.35 
164.50 0.26 0.10 0.46 0.41 2.83 0.19 0.47 0.72 0.36 0.33 
192.00 0.15 0.13 0.37 0.34 0.92 0.13 0.37 0.57 0.85 0.19 
217.75 0.03 0.06 0.32 0.33 0.00 0.09 0.38 0.52 1.34 0.14 
239.00 0.01 0.03 0.29 0.33 0.00 0.09 0.52 0.52 1.45 0.15 
263.50 0.02 0.03 0.26 0.33 0.00 0.09 0.62 0.54 1.53 0.16 
287.00 0.04 0.04 0.24 0.33 0.00 0.09 0.64 0.54 1.55 0.17 




TYR VAL MET TRP PHE ILE LEU LYS PRO 
1.00 0.33 0.70 0.18 0.06 0.33 0.63 0.62 0.45 0.23 
25.10 0.30 0.60 0.15 0.05 0.31 0.55 0.53 0.57 0.23 
49.50 0.22 0.41 0.08 0.03 0.22 0.37 0.27 0.34 0.30 
 
 122 
73.50 0.21 0.37 0.07 0.03 0.22 0.31 0.22 0.34 0.43 
76.00 0.33 0.70 0.19 0.06 0.34 0.66 0.66 0.62 0.28 
98.50 0.30 0.63 0.17 0.05 0.32 0.58 0.58 0.57 0.25 
123.50 0.26 0.51 0.12 0.04 0.27 0.46 0.41 0.50 0.24 
143.00 0.23 0.39 0.08 0.03 0.23 0.34 0.24 0.38 0.29 
145.00 0.34 0.70 0.19 0.05 0.33 0.66 0.65 0.62 0.29 
164.50 0.33 0.69 0.19 0.05 0.32 0.60 0.59 0.60 0.29 
192.00 0.26 0.47 0.11 0.03 0.24 0.41 0.33 0.36 0.26 
217.75 0.23 0.41 0.08 0.03 0.22 0.35 0.24 0.36 0.46 
239.00 0.22 0.38 0.08 0.03 0.22 0.29 0.22 0.36 0.51 
263.50 0.23 0.38 0.09 0.03 0.23 0.28 0.22 0.41 0.56 
287.00 0.23 0.38 0.09 0.03 0.23 0.27 0.22 0.39 0.59 

















0 1.00 86.52 4 0.003 4 0.106 
1 1.31 71.43 2.99 0.135 3.92 0.307 
19 1.04 70.76 2.48 0.191 3.66 0.585 
23 1.58 77.78 3.64 0.688 2.21 0.18 
27 1.53 79.22 3.52 0.745 2.21 0.206 
43 3.88 84.24 2.81 1.38 1.62 0.213 
47 4.15 90.71 2.68 1.49 1.3 0.238 
51 5.43 88.93 2.58 1.59 1.08 0.24 
 
 123 
52 5.80 88.93 2.45 1.5 1.04 0.233 
55 6.55 93.24 2.4 1.66 0.824 0.242 
56 6.81 93.24 2.37 1.71 0.767 0.223 
67 8.05 90.06 2.14 1.84 0.125 0.207 
68 8.16 90.06 2.12 1.87 0.103 0.221 
71 8.90 89 2.1 1.84 0.043 0.221 
72 9.14 89 2.09 1.86 0.029 0.212 
75 10.00 80.65 2.08 1.85 0 0.229 
76 10.30 80.65 2.09 1.86 0.003 0.194 
80 9.60 85.33 2.03 1.84 0 0.21 
81 9.41 85.33 1.99 1.83 0.004 0.194 
96 6.95 63.47 1.89 1.8 0 0.212 
97 6.81 63.47 1.86 1.82 0 0.225 
100 7.75 59.16 1.85 1.83 0 0.218 
101 8.08 59.16 1.83 1.81 0 0.223 
104 6.85 56.61 1.88 1.87 0 0.237 
105 6.47 56.61 1.83 1.84 0 0.22 
116 5.00 50.25 1.84 1.84 0 0.24 
120 5.50 52.88 1.9 1.84 0 0.247 
124 4.20 39.81 1.9 1.81 0 0.242 
140 4.15 33.6 1.79 1.73 0 0.28 
144 2.60 22.61 1.86 1.79 0 0.289 
148 3.15 26.25 1.87 1.87 0 0.293 
164 1.60 11.99 1.86 1.83 0 0.289 
 
 124 
168 1.85 15.88 1.82 1.75 0 0.323 
172 0.46 13.96 1.84 1.75 0 0.315 
189 0.80 5.67 1.85 1.84 0 0.329 
194 0.65 5.94 1.84 1.77 0 0.333 
 
Related Amino-Acid Data 
All the concentration measurements for the amino-acids have been expressed in mmol/L. 
 
Time 
(hours) ASP GLU ASN SER GLN HIS GLY THR ALA ARG 
19 0.22 0.17 0.4 0.37 2.28 0.2 0.38 0.64 0.46 0.32 
23 0.21 0.13 0.41 0.37 2.36 0.21 0.39 0.65 0.47 0.32 
27 0.22 0.14 0.41 0.38 2.34 0.21 0.4 0.66 0.51 0.32 
43 0.19 0.19 0.39 0.35 1.52 0.18 0.43 0.62 0.84 0.29 
47 0.19 0.18 0.37 0.34 1.33 0.17 0.62 0.6 0.91 0.27 
51 0.18 0.18 0.37 0.34 1.12 0.17 0.39 0.59 1.01 0.26 
52 0.18 0.18 0.36 0.32 1.06 0.16 0.37 0.58 0.99 0.25 
55 0.17 0.18 0.34 0.31 0.82 0.15 0.4 0.56 1.08 0.24 
56 0.16 0.18 0.34 0.31 0.75 0.15 0.37 0.55 1.1 0.24 
67 0.15 0.19 0.34 0.37 0.19 0.13 0.38 0.56 1.5 0.23 
68 0.14 0.17 0.32 0.35 0.16 0.12 0.35 0.52 1.42 0.2 
71 0.13 0.17 0.31 0.35 0.07 0.12 0.34 0.51 1.42 0.2 
72 0.13 0.16 0.27 0.31 0.04 0.11 0.34 0.46 1.3 0.18 
75 0.12 0.16 0.29 0.33 0.04 0.11 0.39 0.49 1.41 0.19 
76 0.13 0.17 0.32 0.37 0.06 0.12 0.37 0.54 1.53 0.21 
80 0.13 0.18 0.33 0.39 0.03 0.12 0.45 0.57 1.66 0.22 
81 0.12 0.16 0.31 0.36 0.04 0.12 0.46 0.54 1.59 0.21 
96 0.1 0.16 0.28 0.3 0.02 0.12 0.6 0.53 1.68 0.21 
 
 125 
97 0.1 0.17 0.28 0.29 0.03 0.12 0.58 0.52 1.63 0.21 
100 0.1 0.17 0.28 0.28 0.02 0.12 0.64 0.54 1.72 0.21 
101 0.1 0.18 0.28 0.29 0.03 0.12 0.69 0.57 1.82 0.23 
104 0.09 0.17 0.26 0.25 0.02 0.12 0.64 0.51 1.66 0.2 
105 0.1 0.18 0.27 0.26 0.03 0.12 0.68 0.54 1.74 0.21 
116 0.09 0.18 0.24 0.23 0.02 0.11 0.69 0.5 1.65 0.2 
120 0.09 0.18 0.23 0.22 0.02 0.12 0.66 0.49 1.63 0.19 
124 0.09 0.18 0.22 0.21 0.03 0.11 0.68 0.48 1.61 0.19 
140 0.1 0.21 0.23 0.22 0.02 0.12 0.8 0.54 1.88 0.21 
144 0.12 0.21 0.19 0.2 0.03 0.11 0.78 0.51 1.8 0.2 
148 0.12 0.22 0.19 0.21 0.03 0.11 0.8 0.53 1.84 0.2 
164 0.13 0.23 0.18 0.21 0.02 0.1 0.79 0.51 1.82 0.19 
168 0.11 0.21 0.16 0.18 0.02 0.1 0.73 0.46 1.63 0.17 
172 0.12 0.22 0.16 0.19 0.02 0.11 0.75 0.47 1.65 0.18 
189 0.14 0.23 0.15 0.19 0.02 0.11 0.78 0.49 1.72 0.18 
194 0.14 0.24 0.16 0.19 0.02 0.11 0.8 0.5 1.78 0.18 
 
Time 
(hours) TYR VAL MET TRP PHE ILE LEU LYS PRO 
19 0.31 0.59 0.17 0.08 0.33 0.57 0.58 0.66 0.28 
23 0.32 0.61 0.17 0.08 0.34 0.59 0.6 0.7 0.26 
27 0.33 0.61 0.18 0.08 0.34 0.6 0.6 0.71 0.27 
43 0.3 0.54 0.15 0.07 0.31 0.53 0.51 0.63 0.3 
47 0.29 0.53 0.15 0.07 0.3 0.52 0.49 0.61 0.3 
51 0.29 0.52 0.14 0.07 0.3 0.51 0.48 0.61 0.31 
52 0.28 0.5 0.14 0.07 0.29 0.49 0.45 0.57 0.31 
55 0.27 0.48 0.13 0.06 0.28 0.46 0.42 0.53 0.32 
56 0.26 0.47 0.13 0.06 0.27 0.45 0.41 0.53 0.31 
 
 126 
67 0.27 0.47 0.12 0.06 0.28 0.45 0.38 0.54 0.4 
68 0.25 0.44 0.11 0.06 0.26 0.42 0.35 0.5 0.37 
71 0.25 0.42 0.11 0.06 0.25 0.39 0.32 0.42 0.32 
72 0.22 0.37 0.1 0.06 0.22 0.33 0.27 0.37 0.39 
75 0.23 0.39 0.1 0.05 0.24 0.35 0.29 0.43 0.39 
76 0.26 0.44 0.11 0.06 0.26 0.41 0.33 0.48 0.41 
80 0.27 0.45 0.11 0.06 0.27 0.4 0.32 0.53 0.47 
81 0.25 0.42 0.11 0.06 0.25 0.36 0.3 0.46 0.42 
96 0.25 0.39 0.1 0.06 0.26 0.3 0.25 0.5 0.42 
97 0.24 0.37 0.1 0.05 0.24 0.27 0.22 0.29 0.36 
100 0.25 0.38 0.1 0.05 0.25 0.27 0.22 0.37 0.42 
101 0.27 0.4 0.11 0.06 0.27 0.29 0.25 0.52 0.51 
104 0.24 0.36 0.1 0.05 0.24 0.25 0.2 0.4 0.4 
105 0.25 0.37 0.1 0.05 0.26 0.26 0.21 0.46 0.51 
116 0.23 0.32 0.09 0.05 0.24 0.21 0.17 0.46 0.48 
120 0.23 0.32 0.09 0.05 0.24 0.2 0.16 0.44 0.41 
124 0.23 0.3 0.09 0.05 0.23 0.18 0.15 0.45 0.44 
140 0.25 0.31 0.09 0.05 0.26 0.16 0.13 0.52 0.54 
144 0.24 0.29 0.09 0.05 0.25 0.15 0.12 0.49 0.52 
148 0.24 0.3 0.09 0.05 0.26 0.15 0.12 0.49 0.54 
164 0.24 0.27 0.08 0.05 0.25 0.12 0.09 0.47 0.54 
168 0.21 0.24 0.08 0.04 0.22 0.11 0.08 0.39 0.49 
172 0.22 0.24 0.07 0.05 0.23 0.11 0.08 0.43 0.46 
189 0.23 0.25 0.07 0.05 0.23 0.11 0.08 0.29 0.31 









Viable Cell Concentration 










0 1.00 86.52 4 0.003 4 0.106 
1 0.78 76.54 3.01 0.13 3.89 0.303 
19 0.88 84.85 2.54 0.171 3.63 0.576 
23 1.18 82.46 3.68 0.668 2.29 0.187 
27 1.61 76.79 3.57 0.721 2.4 0.2 
43 2.15 86.87 2.98 1.26 1.88 0.23 
47 3.35 87.01 2.8 1.36 1.54 0.254 
51 3.53 87.58 2.75 1.52 1.38 0.263 
52 3.46 87.58 2.79 1.55 1.47 0.266 
55 4.08 90.06 2.57 1.52 1.27 0.243 
56 3.24 90.06 2.45 1.19 1.85 0.214 
67 5.50 90.16 2 1.49 1.1 0.233 
68 4.97 90.16 2 1.33 1.4 0.215 
71 5.05 88 1.91 1.39 0.832 0.252 
72 4.70 88 1.85 1.29 1.37 0.216 
75 4.10 93.71 1.84 1.45 1.17 0.227 
76 3.58 93.71 1.7 1.26 1.34 0.202 
80 4.80 91.43 1.62 1.49 1.15 0.224 
81 3.97 91.43 1.69 1.11 1.62 0.202 
96 5.60 92.56 0.99 1.66 1 0.221 
97 5.32 92.56 1.06 1.63 1.1 0.213 
 
 128 
100 5.05 83.47 0.951 1.67 0.944 0.213 
101 4.59 83.47 1.05 1.69 1.04 0.216 
104 5.50 87.4 0.989 1.69 0.938 0.204 
105 4.69 87.4 1.24 1.27 1.5 0.197 
116 4.65 84.55 0.962 1.6 1 0.211 
120 5.80 87.88 0.893 1.6 0.799 0.222 
124 4.65 85.32 0.802 1.61 0.645 0.223 
125 4.29 85.32 0.826 1.7 0.681 0.201 
140 6.70 79.76 0.598 1.7 0.277 0.235 
144 5.30 70.2 0.507 1.79 0.137 0.235 
148 3.95 62.7 0.485 1.92 0.084 0.235 
164 4.00 55.17 0.342 1.96 0 0.24 
168 3.55 51.08 0.327 1.84 0 0.227 
172 0.60 38.4 0.336 1.88 0 0.243 
189 1.65 20.5 0.333 1.98 0 0.267 
194 1.05 13.82 0.322 1.88 0 0.265 
 
Related Amino-acid Data 






ASP GLU ASN SER GLN HIS GLY THR ALA ARG 
19 5.33 0.22 0.12 0.44 0.39 2.76 0.2 0.4 0.71 0.43 0.34 
23 6.90 0.21 0.11 0.41 0.38 2.66 0.19 0.36 0.7 0.45 0.32 
27 5.97 0.23 0.14 0.43 0.4 2.73 0.2 0.39 0.75 0.52 0.34 
43 8.46 0.2 0.17 0.4 0.36 1.97 0.18 0.37 0.69 0.82 0.31 
 
 129 
47 9.31 0.2 0.19 0.41 0.37 1.84 0.18 0.39 0.71 0.97 0.31 
51 10.30 0.19 0.18 0.37 0.33 1.47 0.17 0.35 0.64 0.99 0.27 
52  0.19 0.18 0.37 0.33 1.54 0.16 0.35 0.66 0.98 0.27 
55 10.87 0.17 0.17 0.36 0.32 1.3 0.15 0.35 0.63 1.06 0.26 
56  0.2 0.15 0.39 0.35 2 0.17 0.36 0.69 0.83 0.29 
67 13.23 0.18 0.18 0.38 0.34 1.29 0.15 0.4 0.67 1.25 0.28 
68  0.19 0.15 0.37 0.33 1.55 0.17 0.36 0.65 1.02 0.28 
71 14.99 0.18 0.15 0.36 0.33 1.37 0.15 0.37 0.65 1.13 0.27 
72  0.19 0.16 0.4 0.35 1.49 0.16 0.4 0.69 1.21 0.3 
75 17.96 0.19 0.16 0.38 0.34 1.56 0.16 0.85 0.69 1.14 0.29 
76  0.2 0.16 0.4 0.35 1.64 0.19 0.39 0.7 1.12 0.29 
80 13.69 0.17 0.15 0.36 0.3 1.28 0.15 0.37 0.63 1.16 0.27 
81  0.18 0.12 0.36 0.31 1.76 0.15 0.39 0.64 0.86 0.28 
96 16.74 0.18 0.17 0.39 0.37 1.17 0.15 0.37 0.68 1.4 0.29 
97  0.18 0.17 0.38 0.37 1.32 0.15 0.37 0.69 1.32 0.29 
100 21.22 0.16 0.16 0.37 0.38 1.03 0.14 0.36 0.65 1.39 0.28 
101  0.17 0.16 0.37 0.37 1.09 0.15 0.39 0.65 1.36 0.28 
104 15.24 0.16 0.15 0.35 0.34 0.98 0.14 0.35 0.62 1.32 0.26 
105  0.17 0.12 0.36 0.34 1.5 0.15 0.36 0.64 1.03 0.28 
116 20.82 0.17 0.15 0.38 0.34 1.12 0.15 0.42 0.67 1.38 0.29 
120 21.12 0.17 0.16 0.38 0.34 0.97 0.18 0.41 0.66 1.45 0.28 
124 23.23 0.15 0.15 0.35 0.34 0.74 0.13 0.37 0.61 1.44 0.26 
125  0.16 0.15 0.34 0.34 0.76 0.13 0.37 0.61 1.43 0.26 
140 31.63 0.16 0.17 0.36 0.35 0.32 0.12 0.47 0.66 1.85 0.28 
144 32.17 0.15 0.17 0.32 0.32 0.16 0.11 0.53 0.64 1.92 0.27 
148 38.65 0.16 0.18 0.34 0.32 0.1 0.12 0.59 0.67 2.06 0.28 
164 44.55 0.13 0.16 0.26 0.21 0 0.09 0.62 0.57 1.87 0.23 
168 44.45 0.13 0.17 0.26 0.2 0 0.09 0.66 0.58 1.91 0.23 
 
 130 
172 50.46 0.14 0.18 0.28 0.2 0 0.1 0.7 0.6 1.99 0.24 
189 53.27 0.15 0.2 0.28 0.19 0 0.1 0.8 0.64 2.14 0.26 




TYR VAL MET TRP PHE ILE LEU LYS PRO 
19 0.33 0.67 0.17 0.1 0.35 0.63 0.64 0.71 0.31 
23 0.31 0.66 0.16 0.05 0.33 0.62 0.62 0.69 0.28 
27 0.34 0.69 0.17 0.05 0.35 0.64 0.63 0.55 0.23 
43 0.32 0.63 0.15 0.05 0.34 0.62 0.61 0.79 0.31 
47 0.33 0.65 0.15 0.05 0.34 0.62 0.6 0.76 0.31 
51 0.29 0.57 0.13 0.04 0.29 0.52 0.49 0.34 0.18 
52 0.29 0.58 0.13 0.03 0.29 0.51 0.47 0.29 0.24 
55 0.29 0.56 0.13 0.04 0.3 0.54 0.51 0.65 0.29 
56 0.31 0.64 0.15 0.04 0.33 0.62 0.6 0.71 0.3 
67 0.3 0.59 0.13 0.04 0.31 0.56 0.52 0.61 0.36 
68 0.3 0.59 0.13 0.04 0.3 0.56 0.53 0.45 0.22 
71 0.29 0.59 0.13 0.04 0.31 0.57 0.53 0.65 0.32 
72 0.31 0.62 0.14 0.04 0.32 0.59 0.55 0.64 0.35 
75 0.31 0.62 0.14 0.04 0.32 0.59 0.55 0.62 0.35 
76 0.31 0.63 0.14 0.04 0.33 0.61 0.57 0.49 0.23 
80 0.28 0.57 0.13 0.04 0.3 0.54 0.5 0.59 0.33 
81 0.28 0.58 0.14 0.04 0.29 0.55 0.52 0.53 0.3 
96 0.31 0.61 0.14 0.05 0.32 0.6 0.55 0.69 0.35 
97 0.31 0.62 0.14 0.04 0.32 0.59 0.54 0.61 0.37 
100 0.29 0.58 0.13 0.04 0.3 0.55 0.5 0.55 0.38 
101 0.29 0.58 0.13 0.04 0.29 0.54 0.49 0.29 0.28 
104 0.28 0.55 0.12 0.04 0.28 0.52 0.47 0.28 0.26 
 
 131 
105 0.28 0.59 0.14 0.04 0.3 0.56 0.54 0.58 0.33 
116 0.3 0.61 0.14 0.04 0.31 0.59 0.54 0.64 0.39 
120 0.3 0.6 0.13 0.04 0.31 0.58 0.53 0.61 0.39 
124 0.27 0.55 0.12 0.04 0.28 0.52 0.47 0.51 0.36 
125 0.27 0.55 0.12 0.03 0.28 0.52 0.47 0.52 0.36 
140 0.29 0.58 0.13 0.04 0.3 0.56 0.49 0.54 0.51 
144 0.28 0.56 0.12 0.03 0.29 0.53 0.47 0.54 0.5 
148 0.3 0.59 0.13 0.04 0.31 0.57 0.5 0.64 0.55 
164 0.25 0.47 0.1 0.03 0.25 0.42 0.35 0.43 0.49 
168 0.25 0.48 0.1 0.02 0.25 0.41 0.35 0.44 0.52 
172 0.26 0.49 0.1 0.03 0.27 0.42 0.36 0.46 0.51 
189 0.28 0.51 0.11 0.03 0.28 0.42 0.36 0.51 0.61 






Viable Cell Concentration 










0 1.00 86.52 4 0.003 4 0.106 
1 0.75 75.95 3.99 0.323 3.95 0.309 
19 1.20 88.89 2.54 0.195 3.66 0.59 
23 1.18 78.33 3.64 0.682 2.33 0.189 
27 1.37 77.7 3.61 0.748 2.32 0.217 
43 3.28 82.91 2.88 1.36 1.81 0.246 
47 2.95 86.13 2.68 1.43 1.56 0.264 
51 4.65 91.18 2.69 1.6 1.41 0.295 
52 5.05 91.18 2.68 1.64 1.42 0.282 
 
 132 
55 3.90 93.41 2.49 1.63 1.22 0.27 
56 2.59 93.41 2.12 1.28 1.33 0.237 
67 3.28 89.12 1.68 1.57 0.801 0.264 
68 3.32 89.12 1.66 1.63 0.761 0.245 
71 4.40 88 1.93 1.46 1.23 0.233 
72 4.16 88 1.45 1.56 0.691 0.246 
75 5.10 86.44 1.45 1.65 0.572 0.243 
76 4.95 86.44 1.33 1.44 0.69 0.229 
80 5.35 90.68 1.21 1.61 0.524 0.233 
81 3.96 90.68 1.13 1.14 0.779 0.2 
96 2.88 86.47 0.513 1.7 0.28 0.246 
97 2.73 86.47 0.328 1.67 0.317 0.235 
100 3.35 88.16 0.416 1.69 0.202 0.234 
101 3.43 88.16 0.425 1.77 0.205 0.231 
104 5.13 86.5 0.375 1.76 0.168 0.221 
105 4.63 86.5 0.508 1.33 0.477 0.186 
116 4.65 85.32 0.217 1.68 0.142 0.222 
120 4.15 82.18 0.146 1.66 0.087 0.212 
121 3.74 82.18 0.208 1.53 0.184 0.212 
124 4.75 84.82 0.14 1.59 0.096 0.214 
125 4.72 84.82 0.211 1.54 0.207 0.209 
140 5.33 81.54 0.025 1.54 0 0.235 
144 4.10 70.09 0.007 1.56 0 0.233 
148 3.80 71.7 0.011 1.7 0 0.244 
164 2.90 50 0 2.02 0 0.24 
 
 133 
168 2.25 37.5 0 1.6 0 0.276 
172 0.46 28.24 0.013 1.53 0 0.278 
189 0.50 9.35 0.013 1.63 0 0.297 
194 1.25 17.99 0.014 1.53 0 0.294 
 
Related Amino-acid Data 





(mg/L) ASP GLU ASN SER GLN HIS GLY THR ALA ARG 
0            
1            
19 5.89 0.22 0.15 0.4 0.38 2.49 0.2 0.38 0.66 0.42 0.31 
23 7.78 0.2 0.13 0.39 0.36 2.53 0.18 0.48 0.67 0.45 0.32 
27 7.35 0.2 0.14 0.38 0.36 2.45 0.17 0.41 0.66 0.48 0.31 
43 9.95 0.18 0.19 0.37 0.34 1.82 0.16 0.41 0.64 0.81 0.29 
47 11.73 0.18 0.2 0.37 0.34 1.65 0.15 0.43 0.64 0.92 0.28 
51 13.88 0.18 0.21 0.37 0.33 1.48 0.15 0.41 0.64 1.01 0.28 
52  0.18 0.21 0.37 0.33 1.48 0.15 0.41 0.64 0.98 0.28 
55 14.07 0.18 0.21 0.36 0.32 1.28 0.15 0.41 0.63 1.06 0.28 
56  0.18 0.17 0.36 0.33 1.36 0.15 0.39 0.64 0.79 0.28 
67 17.38 0.18 0.2 0.37 0.31 0.88 0.14 0.44 0.64 1.12 0.29 
68  0.18 0.2 0.36 0.31 0.86 0.14 0.43 0.64 1.13 0.28 
71 15.57 0.2 0.22 0.41 0.35 0.81 0.16 0.49 0.72 1.35 0.31 
72  0.2 0.21 0.41 0.35 0.73 0.15 0.49 0.71 1.3 0.31 
75 16.34 0.21 0.21 0.43 0.37 0.85 0.16 0.5 0.75 1.23 0.33 
 
 134 
76  0.2 0.21 0.41 0.36 0.85 0.15 0.49 0.72 1.23 0.31 
80 17.04 0.19 0.21 0.4 0.33 0.64 0.15 0.5 0.7 1.24 0.31 
81  0.24 0.19 0.44 0.38 1.04 0.18 0.52 0.79 0.97 0.35 
96 20.39 0.22 0.23 0.43 0.37 0.39 0.15 0.54 0.77 1.33 0.33 
97  0.22 0.24 0.45 0.39 0.44 0.16 0.57 0.81 1.36 0.35 
100 22.37 0.21 0.22 0.42 0.37 0.25 0.14 0.55 0.76 1.39 0.33 
101  0.18 0.2 0.38 0.34 0.24 0.13 0.5 0.69 1.23 0.3 
104 23.11 0.19 0.2 0.37 0.32 0.19 0.13 0.51 0.69 1.23 0.29 
105  0.2 0.16 0.38 0.32 0.5 0.15 0.47 0.68 0.94 0.3 
116 23.23 0.18 0.18 0.41 0.27 0.22 0.12 0.64 0.67 1.11 0.29 
120 24.88 0.19 0.2 0.38 0.29 0.1 0.13 0.54 0.7 1.2 0.3 
121  0.2 0.2 0.4 0.31 0.22 0.14 0.59 0.73 1.16 0.31 
124 26.97 0.19 0.2 0.38 0.3 0.12 0.13 0.54 0.7 1.17 0.3 
125  0.2 0.18 0.37 0.29 0.25 0.14 0.5 0.68 1.01 0.29 
140 32.95 0.18 0.18 0.33 0.23 0.01 0.12 0.55 0.64 1.09 0.26 
144 36.48 0.18 0.19 0.33 0.22 ND 0.12 0.66 0.69 1.26 0.28 
148 37.16 0.19 0.21 0.34 0.21 ND 0.12 0.73 0.72 1.34 0.3 
164 45.27 0.2 0.24 0.33 0.15 ND 0.13 0.85 0.74 1.42 0.3 
168 42.62 0.18 0.23 0.31 0.13 ND 0.11 0.79 0.69 1.33 0.28 
172 44.52 0.19 0.23 0.3 0.12 ND 0.12 0.76 0.67 1.29 0.27 
189 43.20 0.21 0.25 0.3 0.12 ND 0.15 0.78 0.72 1.33 0.29 







(hours) TYR VAL MET TRP PHE ILE LEU LYS PRO 
0          
1          
19 0.32 0.65 0.18 0.05 0.34 0.61 0.62 0.69 0.33 
23 0.31 0.64 0.16 0.04 0.33 0.62 0.62 0.74 0.29 
27 0.31 0.64 0.15 0.03 0.33 0.61 0.62 0.75 0.29 
43 0.3 0.59 0.14 0.03 0.31 0.56 0.55 0.69 0.32 
47 0.29 0.58 0.14 0.03 0.31 0.55 0.53 0.67 0.33 
51 0.29 0.58 0.14 0.03 0.31 0.55 0.53 0.67 0.32 
52 0.29 0.58 0.14 0.03 0.3 0.55 0.53 0.66 0.32 
55 0.29 0.57 0.13 0.03 0.3 0.54 0.51 0.63 0.34 
56 0.29 0.6 0.14 0.03 0.31 0.59 0.58 0.69 0.32 
67 0.3 0.59 0.14 0.03 0.31 0.58 0.56 0.69 0.38 
68 0.29 0.6 0.14 0.02 0.31 0.58 0.55 0.67 0.39 
71 0.33 0.66 0.15 0.03 0.33 0.61 0.56 0.5 0.42 
72 0.33 0.66 0.15 0.04 0.35 0.65 0.61 0.74 0.48 
75 0.35 0.71 0.17 0.04 0.37 0.69 0.66 0.78 0.49 
76 0.33 0.66 0.15 0.03 0.34 0.64 0.61 0.72 0.46 
80 0.33 0.66 0.15 0.03 0.34 0.63 0.59 0.73 0.48 
81 0.36 0.75 0.18 0.04 0.38 0.72 0.7 0.8 0.45 
96 0.36 0.72 0.17 0.04 0.37 0.69 0.65 0.79 0.54 
97 0.37 0.75 0.18 0.04 0.39 0.72 0.68 0.83 0.55 
100 0.35 0.7 0.16 0.03 0.36 0.67 0.63 0.77 0.5 
101 0.31 0.63 0.14 0.03 0.32 0.59 0.55 0.63 0.49 
 
 136 
104 0.31 0.63 0.14 0.03 0.32 0.6 0.55 0.66 0.48 
105 0.3 0.63 0.14 0.02 0.31 0.58 0.54 0.43 0.34 
116 0.31 0.61 0.14 0.02 0.31 0.58 0.55 0.67 0.44 
120 0.32 0.64 0.14 0.03 0.33 0.6 0.56 0.68 0.47 
121 0.33 0.66 0.15 0.03 0.33 0.62 0.58 0.7 0.47 
124 0.32 0.64 0.14 0.03 0.33 0.6 0.56 0.68 0.43 
125 0.31 0.64 0.15 0.03 0.32 0.6 0.56 0.65 0.43 
140 0.29 0.58 0.13 0.02 0.29 0.52 0.47 0.57 0.39 
144 0.31 0.6 0.13 0.02 0.3 0.52 0.47 0.39 0.34 
148 0.33 0.64 0.15 0.02 0.34 0.56 0.52 0.71 0.51 
164 0.33 0.62 0.14 0.02 0.34 0.51 0.48 0.71 0.51 
168 0.3 0.57 0.13 0.02 0.32 0.47 0.44 0.66 0.46 
172 0.29 0.56 0.13 0.02 0.3 0.43 0.39 0.24 0.31 
189 0.33 0.64 0.15 0.02 0.33 0.49 0.45 0.61 0.53 
194 0.31 0.57 0.13 0.02 0.32 0.45 0.42 0.65 0.49 
 
SET-2 (associated with imaging) 






( x 106 cells/mL) 
Dead Cell 
Concentration 
( x 106 cells/mL) 
Total Cell 
Concentration 








0 0.3 0.05 0.35 85.71429    
22 0.55 0.02 0.57 96.49123  0.72 1.122353 
41.4 0.85 0.06 0.91 93.40659 16.2 1.14 1.777059 
48.25 1.08 0.07 1.15 93.91304 13.1 1.46 2.275882 
 
 137 
64 1.89 0.07 1.96 96.42857 10.4 1.88 2.930588 
88 3.3 0.17 3.47 95.10086 8 2.41 3.756765 
94.75 2.78 0.2 2.98 93.28859 6.3 2.5 3.897059 
114 2.28 0.46 2.74 83.21168 4.3 2.65 4.130882 
121.4 3.19 0.17 3.36 94.94048 3.7 2.7 4.208824 
137 2.85 0.33 3.18 89.62264 2.2 2.76 4.302353 
144.7 2.72 0.36 3.08 88.31169 1.3 2.67 4.162059 
163.5 2.36 0.39 2.75 85.81818 0.9 2.8 4.364706 
172 1.95 0.38 2.33 83.69099 1 3.08 4.801176 
186.5 1.78 0.39 2.17 82.02765 LO 3.23 5.035 
206.8 1.25 0.37 1.62 77.16049 LO 3.48 5.424706 
238.75 0.61 0.32 0.93 65.5914 LO 3.71 5.783235 
263.25 0.42 0.35 0.77 54.54545 LO 3.92 6.110588 
289.1 0.22 0.34 0.56 39.28571 LO 4.27 6.656176 
331.7 0 0.45 0.45 0 LO 4.25 6.625 
 






( x 106 cells/mL) 
Dead Cell 
Concentration 
( x 106 cells/mL) 
Total Cell 
Concentration 








0 0.3 0.05 0.35 85.71429    
22 0.43 0.08 0.51 84.31373  0.594 0.925941 
41.4 0.92 0.05 0.97 94.84536 13.6 1.03 1.605588 
48.25 1.37 0.09 1.46 93.83562 12.9 1.38 2.151176 
64 2.47 0.17 2.64 93.56061 10.6 1.5 2.338235 
 
 138 
88 2.84 0.13 2.97 95.6229 9.9 1.15 1.792647 
94.75 2.09 0.23 2.32 90.08621 7.7 1.24 1.932941 
114 2.14 0.25 2.39 89.53975 5.4 1.62 2.525294 
121.4 3.38 0.14 3.52 96.02273 4.4 1.71 2.665588 
137 2.4 0.4 2.8 85.71429 2.8 1.8 2.805882 
144.7 2.36 0.61 2.97 79.46128 2.3 1.91 2.977353 
163.5 2.17 0.62 2.79 77.77778 1.1 2.06 3.211176 
172 1.95 0.57 2.52 77.38095 0.6 2.08 3.242353 
186.5 1.76 0.41 2.17 81.10599 LO 2.16 3.367059 
206.8 1.38 0.6 1.98 69.69697 LO 2.35 3.663235 
238.75 1.07 0.57 1.64 65.2439 LO 2.64 4.115294 
263.25 0.76 0.72 1.48 51.35135 LO 2.9 4.520588 
289.1 0.85 0.77 1.62 52.46914 LO 3.13 4.879118 
331.7 0.42 0.68 1.1 38.18182 LO 3.43 5.346765 
 






( x 106 cells/mL) 
Dead Cell 
Concentration 
( x 106 cells/mL) 
Total Cell 
Concentration 








0 0.3 0.05 0.35 85.71429    
22 0.5 0.03 0.53 94.33962  0.717 1.117676 
41.4 0.81 0.05 0.86 94.18605 16.4 1.2 1.870588 
48.25 1.15 0.16 1.31 87.78626 12.1 1.31 2.042059 
64 1.51 0.11 1.62 93.20988 9.2 1.47 2.291471 
88 1.56 0.05 1.61 96.89441 7.1 1.59 2.478529 
 
 139 
94.75 1.76 0.19 1.95 90.25641 6.6 1.69 2.634412 
114 1.44 0.33 1.77 81.35593 5.8 1.77 2.759118 
121.4 1.21 0.33 1.54 78.57143 5.8 1.87 2.915 
138.5 1.29 0.4 1.69 76.33136 5.5 1.93 3.008529 
146.3 1.3 0.43 1.73 75.14451 5.6 2.1 3.273529 
165.2 1.32 0.56 1.88 70.21277 5.1 2.3 3.585294 
173 1.31 0.66 1.97 66.49746 4.5 2.35 3.663235 
189.75 0.96 0.66 1.62 59.25926 4.2 2.42 3.772353 
209 0.69 0.87 1.56 44.23077 4 2.51 3.912647 
240.75 0.32 0.75 1.07 29.90654 3.1 2.62 4.084118 
265.5 0.3 1.1 1.4 21.42857 2.3 2.7 4.208824 
293.6 0.23 0.85 21 21.2963 2 2.81 4.380294 
333 0.19 0.84 18.4 18.4466 1.6 2.84 4.427059 
        
 






( x 106 cells/mL) 
Dead Cell 
Concentration 
( x 106 cells/mL) 
Total Cell 
Concentration 








0 0.3 0.05 0.35 85.71429    
22 0.46 0.04 0.5 92  0.748 1.166 
41.4 0.8 0.1 0.9 88.88889 14.2 1.29 2.010882 
48.25 1.33 0.09 1.42 93.66197 13.1 1.61 2.509706 
64 1.37 0.19 1.56 87.82051 9.1 1.69 2.634412 
88 1.39 0.16 1.55 89.67742 7.7 1.82 2.837059 
 
 140 
94.75 2.37 0.28 2.65 89.43396 6.2 1.9 2.961765 
114 0.92 0.17 1.09 84.40367 6.2 2 3.117647 
121.4 1.48 0.19 1.67 88.62275 6.1 2.24 3.491765 
138.5 1.46 0.24 1.7 85.88235 5.2 2.3 3.585294 
146.3 1.47 0.5 1.97 74.61929 5 2.34 3.647647 
165.2 1.28 0.41 1.69 75.73964 4.2 2.46 3.834706 
173 1.17 0.39 1.56 75 4 2.5 3.897059 
189.75 1.2 0.42 1.62 74.07407 3.8 2.6 4.052941 
209 1.06 0.43 1.49 71.14094 3.3 2.66 4.146471 
240.75 0.78 0.53 1.31 59.54198 2.3 2.76 4.302353 
265.5 0.75 0.62 1.37 54.74453 1.7 2.86 4.458235 
293.6 0.75 0.56 57 57.25191 1.1 2.96 4.614118 




Calculated Results for Experiment Set-1 
Calculated R-values for Batch Experiment-1 (in mmol/109 cell hours): 
 
Metabolite Rexp Rpost Rfull 
Pyr 0 0 0 
AcCoA 0 0 0 
aKG 0 0 0 
SuCCoA 0 0 0 
FUM 0 0 0 
OAA 0 0 0 
Glc -0.26731323 -0.00918419 -0.11199362 
Lac 0.328126 0.00648532 0.12408664 
Ala 0.02545904 0.00585721 0.0136512 
Arg -0.00459109 0.00084063 -0.00132343 
Asp -0.0060134 0.00043947 -0.00237187 
Asn -0.00348374 -0.00220295 -0.00252385 
Cys 0 0 0 
Gln -0.06972616 0 -0.02718938 
Glu -0.00142231 -0.00040116 -0.00104844 
Gly -0.0019166 0.0067063 0.00311847 
His -0.00252123 0 -0.00100581 
Ile -0.00599654 -0.00193225 -0.00342958 
Leu -0.00844114 -0.00048008 -0.00352847 
Lys -0.00531528 0.00098747 -0.00135043 
Met -0.00266607 0.00039022 -0.00083956 
 
 142 
Phe -0.00236796 0.00028164 -0.00075062 
Pro 0.00529764 0.00334811 0.00428066 
Ser -0.00184839 -7.3089E-19 -0.00067234 
Thr -0.00481256 0.00067186 -0.00151366 
Tyr -0.0024446 4.1605E-05 -0.00096518 
Val -0.00666095 -0.00072011 -0.00296679 
BioMass 0.58469819 0.0843572 0.27580246 
Mab 4.124E-09 6.5733E-10 2.4835E-09 
 
Calculated R-values for a Batch Experiment-2 were unavailable. 
 
Calculated R-values for a Fed-batch Experiment-1 (in mmol/109 cell hours): 
 
Metabolite R1 R2 R3 R4 R5 R6 
Pyr 0 0 0 0 0 0 
AcCoA 0 0 0 0 0 0 
aKG 0 0 0 0 0 0 
SuCCoA 0 0 0 0 0 0 
FUM 0 0 0 0 0 0 
OAA 0 0 0 0 0 0 
Glc -0.91769036 -1.08065625 -0.52007489 -0.332668 -0.26518165 -0.54181663 
Lac 1.63726605 -0.29472443 0.69343319 0.44355733 1.52479448 0.85142614 
Ala 0.09513467 0.07073386 0.08737258 0.07318696 0.02386635 0.07523511 
Arg -0.00823733 -0.00884173 -0.0020803 -0.00665336 -0.01193317 0.00139324 
Asp -0.00485846 -0.01768347 -0.0041606 -0.00665336 -0.01789976 8.5705E-18 
Asn -0.00648865 -0.00884173 -0.0020803 -0.00665336 -0.02386635 0.00417973 
Cys 0 0 0 0 0 0 
 
 143 
Gln -0.16787599 -0.17683466 -0.15602247 -0.37791084 -0.11336516 -0.08638105 
Glu 0.01153475 -0.00884173 0.0062409 7.014E-18 -0.00596659 0.00696621 
Gly -0.0016854 8.4354E-17 0.0083212 0.00665336 -0.01193317 -0.00278649 
His -0.00397651 -0.00884173 -0.0041606 -0.01330672 -0.02386635 4.2852E-18 
Ile -0.0130268 0.0265252 -0.0124818 0.00665336 -0.04176611 0.00696621 
Leu -0.01698807 0.03536693 -0.0166424 0 -0.04176611 0.00417973 
Lys -0.02052016 0.31830239 -0.020803 0.1330672 0.05966587 0.02229188 
Met -0.00510279 1.6871E-17 -0.0041606 8.4168E-18 -0.00596659 1.7141E-18 
Phe -0.0054271 0.00884173 -0.0041606 0.00665336 -0.01789976 0.00417973 
Pro -0.00432718 0.04420866 0.0124818 0.0665336 0.05966587 0.00696621 
Ser -0.0084569 -0.00884173 -0.0020803 0 -0.02983294 0.00835946 
Thr -0.0107647 -0.0265252 -0.0041606 -2.2445E-17 -0.04176611 0.00557297 
Tyr -0.00343409 4.4989E-17 -0.0020803 -0.00665336 -0.01789976 0.00417973 
Val -0.01406359 -0.01768347 -0.0104015 -3.9278E-17 -0.03579952 0.00417973 
BioMass 0.75198001 0.94557514 0.96057049 0.27769063 1.57379337 0.43905398 




Metabolites R7 R8 R9 R10 R11 R-average 
Pyr 0 0 0 0 0 0 
AcCoA 0 0 0 0 0 0 
aKG 0 0 0 0 0 0 
SuCCoA 0 0 0 0 0 0 
FUM 0 0 0 0 0 0 
OAA 0 0 0 0 0 0 
Glc -0.38929962 -0.22391073 -0.26149181 -0.15367506 -0.09637471 -0.4686465 
 
 144 
Lac 0.28572449 -6.7998E-16 0.4238765 -5.037E-16 0.11558634 0.55653537 
Ala 0.04500161 -0.02642881 0.04711841 0.05095541 0.00807957 0.05421762 
Arg -0.0064288 -0.0132144 -0.00168588 0.00242645 -0.0027295 -0.00552553 
Asp -0.0128576 -0.0066072 -0.00162675 -3.4979E-18 -0.00132223 -0.00723472 
Asn -0.0064288 -0.0132144 -0.00017737 0.00242645 -0.00597122 -0.00611448 
Cys 0 0 0 0 0 0 
Gln -0.1002893 -0.06739346 -0.09302404 -0.04901426 -0.01523901 -0.13881112 
Glu -0.0064288 -0.0066072 0.00377126 0.00242645 0.00135471 0.00030953 
Gly -0.0064288 -0.02642881 0.00234427 0.01213224 0.01957028 -0.00198116 
His -0.0064288 -0.0066072 -0.00049537 -0.00121322 -0.00155117 -0.00688965 
Ile -0.0257152 -0.0132144 -0.00267662 0.0048529 -0.01148075 -0.00638833 
Leu -0.0257152 -0.0132144 -0.00607076 0.00242645 -0.01073261 -0.00784238 
Lys -0.03857281 -0.0066072 -0.00491699 0.00242645 -0.00620734 0.04443336 
Met -0.0064288 -0.0066072 -0.00200388 0.00121322 -0.00195994 -0.00290566 
Phe -0.0128576 -0.0066072 -0.00130875 0.00242645 -0.00251277 -0.00261597 
Pro 0.0064288 -0.0132144 0.00434815 0.01819836 0.00255338 0.02012899 
Ser 0.0064288 -0.01982161 2.1352E-17 0.00121322 -0.01183493 -0.0053032 
Thr -0.0257152 -0.01982161 -0.00186325 0.00606612 -0.00407509 -0.01189776 
Tyr -0.0128576 -0.0066072 -0.00017737 0.00242645 -0.00210344 -0.00431035 
Val -0.0257152 -0.01982161 -0.00299462 0.00363967 -0.00706258 -0.01186601 
BioMass 0.35874929 0.96782647 0.09698619 0.75481148 -0.17467905 0.71270371 








Calculated R-values for a Fed-batch Experiment-2 (in mmol/109 cell hours): 
 
Metabolites R1 R2 R3 R4 R5 R6 
Pyr 0 0 0 0 0 0 
AcCoA 0 0 0 0 0 0 
aKG 0 0 0 0 0 0 
SuCCoA 0 0 0 0 0 0 
FUM 0 0 0 0 0 0 
OAA 0 0 0 0 0 0 
Glc -0.78348215 -0.73388552 -1.10577638 -0.3236246 -0.6681828 0.08112545 
Lac 1.45320187 1.05460311 1.05290927 0.91693635 1.21290882 0.41969614 
Ala 0.07718603 0.09823633 -0.06218514 0.00485437 0.07017544 -0.05890319 
Arg -0.00528226 0.00124962 0.01184338 -9.1047E-18 -0.00389864 -0.02426654 
Asp -0.00300282 8.3442E-18 0.00592169 -0.00485437 -0.00389864 -0.01248045 
Asn -0.00230171 0.00124962 0.01184338 -0.00485437 -0.00194932 -0.0321678 
Cys 0 0 0 0 0 0 
Gln -0.13191535 -0.16149418 -0.29397317 -0.08058252 -0.09727096 -0.05479145 
Glu 0.01100109 0.00877817 -0.00414666 -4.5524E-18 0.00779727 -0.01580252 
Gly -0.00507293 0.01295385 0.00592169 0.00485437 0.00389864 -0.02472945 
His -0.00378085 -0.00292606 0.00177503 -9.1047E-18 -0.00584795 -0.01145478 
Ile -0.0097865 -0.00292606 0.04027341 -0.00485437 -0.00584795 -0.04843323 
Leu -0.01346818 -0.00752855 0.05034176 -0.00970874 -0.00974659 -0.05254951 
Lys -0.01182092 -0.00335287 0.12320664 0.00485437 -0.00194932 -0.0698406 
Met -0.00230171 2.7814E-18 0.01184338 -9.1047E-18 -0.00194932 -0.01580252 
Phe -0.00365727 1.1126E-17 0.0201367 0 -0.00194932 -0.02805152 
Pro 0.0047688 0.01923278 0.03080166 0.00970874 0.01754386 -0.02623164 
 
 146 
Ser -0.00421741 -0.00585211 0.01184338 -0.01456311 -0.00194932 -0.02838281 
Thr -0.00380312 6.6754E-17 0.0195401 -0.00970874 -0.00389864 -0.04820177 
Tyr -0.00298056 0.00124962 0.01184338 -9.1047E-18 -3.6635E-18 -0.02449799 
Val -0.00898621 -0.00124962 0.02960846 -1.8209E-17 -0.00584795 -0.04820177 
BioMass 0.92872045 0.50392085 1.07267435 0.15526114 -0.37273327 2.04348336 




Metabolites R7 R8 R9 R10 R Average 
Pyr 0 0 0 0 0 
AcCoA 0 0 0 0 0 
aKG 0 0 0 0 0 
SuCCoA 0 0 0 0 0 
FUM 0 0 0 0 0 
OAA 0 0 0 0 0 
Glc -0.29830956 -0.29664529 -0.13709232 -0.00367211 -0.47398591 
Lac 0.58515701 0.52349169 -1.8797E-16 0.040834 0.80210047 
Ala 0.03685566 0.00785238 0.0106136 0.01502154 0.02052061 
Arg -0.00043848 -0.00785238 -0.0039801 0.00103861 -0.00362504 
Asp -0.00200779 -0.00785238 -0.0026534 0.00130199 -0.00342535 
Asn 0.00131545 -0.01570475 -0.0053068 -0.00326323 -0.00531959 
Cys 0 0 0 0 0 
Gln -0.05879136 -0.0691009 -0.02746269 0 -0.10837584 
Glu 0.00540027 1.9041E-17 -9.7899E-19 0.00554199 0.00144751 
Gly 0.01536999 -0.03926188 0.0066335 0.01847289 -0.00215914 
His -0.0035771 -0.00785238 -0.0026534 0.00074237 -0.00403528 
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Ile 0.00226165 -0.01570475 -0.0106136 -0.00684761 -0.00618127 
Leu 0.00270013 -0.01570475 -0.0119403 -0.00542729 -0.00751164 
Lys 0.03879422 -0.01570475 -0.0106136 0.00240902 0.00595257 
Met 7.1749E-18 -0.00785238 -0.0026534 0.00015848 -0.00207955 
Phe 0.00226165 -1.7921E-17 -0.0039801 0.00170518 -0.00169332 
Pro 0.01908555 -0.0314095 -0.0053068 0.00644461 0.00424372 
Ser -0.00558489 -0.00785238 -0.0079602 -0.0107842 -0.00716876 
Thr 0.00182317 -0.02355713 -0.0053068 0.0028836 -0.00812366 
Tyr 0.00270013 -0.00785238 -0.0026534 0.00061375 -0.00246569 
Val 0.00025386 -0.01570475 -0.0079602 -0.00102881 -0.00645424 
BioMass -0.05527199 1.5199253 0.23791102 -0.16405454 0.67043236 
Mab 1.3585E-09 8.3533E-09 4.9765E-09 8.8458E-09 4.4753E-09 
 
Calculated Average Flux Values for Batch Experiment 1and 2: 
 
Flux Serial Number Exponential Post-exponential Overall Average 
j1 0.32051 2.35E-02 0.172007 
j2 0.1606 0.049514 0.105057 
j3 0.17153 0.053174 0.112352 
j4 0.22796 0.06031 0.144135 
j5 0.23433 0.062859 0.148595 
j6 0.23536 0.062901 0.149131 
j7 0.059652 0.0097467 0.034699 
j8 0.50516 1.71E-04 0.252665 
j9 0.000034119 3.97E-09 1.71E-05 
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j10 0.00047431 5.12E-12 0.000237 
j11 7.1924E-08 3.61E-05 1.81E-05 
j12 0.000092423 3.32E-07 4.64E-05 
j13 0.00099849 1.91E-05 0.000509 
j14 0.0021201 7.28E-04 0.001424 
j15 0.001672 9.16E-08 0.000836 
j16 0.0017275 0.0017975 0.001763 
j17 0.00082258 1.94E-07 0.000411 
j18 0.0015946 0.00058961 0.001092 
j19 0.0012031 2.39E-05 0.000614 
j20 0.00089793 1.95E-03 0.001424 
j21 0.0013824 8.29E-11 0.000691 
j22 0.009163 2.67E-03 0.005919 
j23 0.060203 8.02E-03 0.034112 
j24 0.056414 5.64E-03 0.031027 
j25 0.0077077 1.20E-04 0.003914 
j26 0.0097928 2.43E-10 0.004896 
j27 0.040995 0.0071029 0.024049 
j28 0.0042103 2.75E-08 0.002105 
j29 0.000001654 1.68E-05 9.21E-06 
j30 0.0060156 3.39E-11 0.003008 
j31 0.54561 8.41E-02 0.314867 





Calculated Average Flux Values for Fed-batch Experiment 1and 2: 
 
Flux Serial Number Exponential Post-exponential Overall Average 
j1 0.410662646 0.094383485 0.252523 
j2 0.328097561 0.165048363 0.246573 
j3 0.370968232 0.188169262 0.279569 
j4 0.463434922 0.209142859 0.336289 
j5 0.492940796 0.21703174 0.354986 
j6 0.503836484 0.218014949 0.360926 
j7 0.130015436 0.029872373 0.079944 
j8 0.595659567 0.039084743 0.317372 
j9 0.000118698 3.4262E-06 6.11E-05 
j10 0.000347825 3.53203E-10 0.000174 
j11 0.004400219 0.00576053 0.00508 
j12 0.003965813 0.000496962 0.002231 
j13 0.008532288 0.000951559 0.004742 
j14 0.007477653 0.002089812 0.004784 
j15 0.008935302 0.000467968 0.004702 
j16 0.007083523 0.004711025 0.005897 
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j17 0.003640182 0.000584008 0.002112 
j18 0.004154661 0.00424648 0.004201 
j19 0.00310045 0.001875909 0.002488 
j20 0.006086514 0.003664704 0.004876 
j21 0.003742772 0.00062041 0.002182 
j22 0.014824928 0.003763127 0.009294 
j23 0.083039743 0.017780533 0.05041 
j24 0.07743353 0.014471262 0.045952 
j25 0.012304046 0.005342362 0.008823 
j26 0.022636932 1.01842E-07 0.011319 
j27 0.05566465 0.020315552 0.03799 
j28 0.004822266 1.84138E-08 0.002411 
j29 0.002193692 2.0545E-05 0.001107 
j30 0.019378491 1.13792E-07 0.009689 
j31 0.597395705 0.162979337 0.380188 








Values of a-coefficients: 
 
 Batch Exponential Fed-Batch Exponential 
a1 0.159293 0.275055 
a2 0.01666 0.031789 
a3 0.002791 0.02178 
a4 0.010118 0.025652 
a5 0.038617 0.101629 
a6 0.035737 0.097108 
a7 0.587604 0.718849 
a8 0.004079 9.92E-04 
a9 4.15E-05 4.71E-04 
 
 Batch Post-exponential Fed-Batch Post-exponential 
a1 0.001277 0.062592 
a2 0.0023 0.002917 
a3 2.24E-15 4.01E-12 
a4 0.001655 3.58E-04 
a5 0.001914 0.018823 
a6 2.23E-15 0.016492 
a7 0.084084 3.46E-12 
a8 5.16-04 0.012079 






Predictions for Dynamic Model- Batch and Fed-batch Mode- Main File: 
clear all 
%run data file for DYNAMIC MODEL of METABOLITES for EXPS. 
%xdata1 = Experiment 250-3 
%xdata2 = Experiment 1000-2 
%xdata3 = Experiment 7(3) 
%xdata4 = Experiment 7(4) 





load a8%a8 for batch and a12 for fedbatch 
    a= aExA 
  
load xxxdata 
xdatae = xdata5; 
XvData = xdatae(:,33); 
DataTime = xdatae(:,1); 
start = min(DataTime); 
fin = max(DataTime); 
ttt = (min(DataTime):0.5: max(DataTime)); 
XX = interp1 (DataTime, XvData, ttt); 
  
batch=0;%0 for Batch , 3 for Exp(3), 4 for Exp7(4) 
x10f(:,1) =xdatae(:,9);         %GLC 
x10f(:,2) =xdatae(:,17);        %GLN 
x10f(:,3) =xdatae(:,10);        %LAC 
x10f(:,4) =xdatae(:,11);        %AMM. 
x10f(:,5) =xdatae(:,18)*10;     %GLU 
x10f(:,6) =xdatae(:,15);        %ASN 
x10f(:,7) =xdatae(:,14);        %ASP 
x10f(:,8) =xdatae(:,12);        %ALA 
x10f(:,9) =xdatae(:,26);        %PRO 
x10f(:,10)=xdatae(:,31);        %BIOMASS 
x10f(:,11)=xdatae(:,32)*1E6;    %MAb 
  














Y(1,:)=x10; % x10 is the initial value vector 
  
%number of iterations 
mn = (fin-start)*2 
for i=1:mn 
    i; 
 time = start + (i-1)/2; 
 
%switch to post-exponential phase 
if time>=76 %for both 7(3) and 7(4)=140, 250-3:72, 1000-2:75, 7(1):76 
   a = aPos; 
end 
   
 ooo(i)=i; 
 X = XX(i); 
 [t,x01]=ode23('Testing_a_b_function',[i i+1],x10); 
    
 A1=[t,x01]; 
 [a1,b1]=size(A1); 
     
if batch==3 %Exp7(3), Dilutions are initiated in total 0.5 hrs before 
diluted point 
   batch 
     if time==51 
       for u = 1:11 
           node=2; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilutio 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
          
       end 
   elseif time==55 
       for u = 1:11 
           node=4; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==56 
       for u = 1:11 
           node=5; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==71 
       for u = 1:11 
           node=8; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
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           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==75 
       for u = 1:11 
           node=10; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==80 
       for u = 1:11 
           node=11; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution; 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==96 
       for u = 1:11 
           node=13; dist=DataTime(node+1)-DataTime(node) ;%node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==100 
       for u = 1:11 
           node=16; dist=DataTime(node+1)-DataTime(node) %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)) 
       end 
   elseif time==104 
       for u = 1:11 
           node=17; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==120 
       for u = 1:11 
           node=20; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   else 
       x10=x01(a1,:); 
   end 
  
elseif batch==4 %Exp7(4), Dilutions  are initiated in total 0.5 hrs before 
diluted point 
    if time==43 
        for u = 1:11 
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           node=2; 
           dist=DataTime(node+1)-DataTime(node);%node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
    elseif time==54 
        for u = 1:11 
           node=5; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==71 
        for u = 1:11 
           node=8; 
           dist=DataTime(node+1)-DataTime(node) ;%node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==75 
        for u = 1:11 
           node=12; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==80 
        for u = 1:11 
           node=14; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
        end 
   elseif time==96 
        for u = 1:11 
           node=16; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end     
   elseif time==104 
        for u = 1:11 
           node=20; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
 
 156 
       end 
   elseif time==120 
        for u = 1:11 
           node=23; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
        end 
    elseif time==124 
        for u = 1:11 
           node=25; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
  
  else 
       x10=x01(a1,:); 
       t10=A1(a1,1); 
   end 
 else % for Batch Experiments without Dilution 
 x10=x01(a1,:); 
 end      
   
   %*********************all outputs are positive*************** 
   for j=1:11 
       if x10(j)<0 
           x10(j)=0; 
       end 
   end 
    
      
   Y(i+1,:)=x10; 
   Ydif(i+1,:)=xp; 




save Y1308F Y Ydif 
  














axis([start length min(XX) max(XX)]) 
  
subplot(2,3,2) 
F = Y(:,1); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,3) 
F = Y(:,2); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,4) 
F = Y(:,3); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,5) 
F = Y(:,10); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,6) 
F = Y(:,11)*1E-6; %Mab goes in with 1E6 the value, to get a reasonable a-
coefficient during the QP 












F = Y(:,8); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,2) 
F = Y(:,9); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,3) 
F = Y(:,7); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,4) 
F = Y(:,6); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,5) 
F = Y(:,5)*0.1; 
















axis([start length min(F) max(F)]) 
  
 
Sub-routine for the Dynamic Model: 
  
function xp=DynamicModel(t,x) 



















%G-Glucose; Q-GLutamine; L-Lactate; N-Ammonia; U-GlutamicAcid; 






















Prediction for Integrated Model- Batch and Fedbatch Mode: 
 
clear all 
%run data file for INTEGRATED MODEL of METABOLITES for BATCH & FED-BATCH 
EXPS. 
%xdata1 = Experiment 250-3 
%xdata2 = Experiment 1000-2 
%xdata33 = Experiment 7(3) 
%xdata4 = Experiment 7(4) 





load a8 %for batch and early fed-batch before feeding 
    a= aExA; 
 
% load experimental data 
load xxxdata 
  
%fix xdata and batch no. manually 
xdata = xdata5; 
batch=0;%0 for Batch , 3 for Exp(3), 4 for Exp7(4) 
 
DataTime = xdata(:,1); 
ttt=DataTime'; 
start = min(DataTime); 
fin = max(DataTime); 
  
x10f(:,2) =xdata(:,9);                             %Glucose 
x10f(:,3) =xdata(:,17);                            %Glutamine 
x10f(:,4) =xdata(:,10);                            %Lactate 
x10f(:,5) =xdata(:,11);                            %Ammonia 
x10f(:,6) =xdata(:,18)*10;                         %Glutamic Acid 
x10f(:,7) =xdata(:,15);                            %ASN 
x10f(:,8) =xdata(:,14);                            %ASP 
x10f(:,9) =xdata(:,12);                            %Alanine 
x10f(:,10) =xdata(:,26);                           %Prolin 
x10f(:,11)=xdata(:,31);                            %Biomass 
x10f(:,12)=xdata(:,32)*1E6;                        %MAb 
x10f(:,1)=xdata(:,33);                             %Xv 
x10f(:,13)=xdata(:,34);                            %Xd 
jack=size(x10f); 
  
%load initial values 
 
x10(2) =xdata(1,9);                          %Glc 
x10(3) =xdata(1,17);                         %Gln 
x10(4) =xdata(1,10);                         %Lac 
x10(5) =xdata(1,11);                         %Amm 
x10(6) =xdata(1,18)*10;                      %Glu 
x10(7) =xdata(1,15);                         %ASN 
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x10(8) =xdata(1,14);                         %ASP 
x10(9) =xdata(1,12);                         %Ala 
x10(10) =xdata(1,26);                        %Pro 
x10(11)=xdata(1,31);                         %Biomass 
x10(12)=xdata(1,32)*1E6;                     %MAb 
x10(1)=xdata(1,33) ;                         %Xv 
x10(13)=xdata(1,34);                         %Xd 




%switch to post-exponential phase 
if batch==0 %for batch experiments 
   mn = (fin-start); 
   ttt = (min(DataTime):1: max(DataTime)); 
 for i=1:mn 
    i; 
 time = start + (i-1)/2; 
 if time>=76 %fix switch for 250-3=80, 7(1)=76 
   a = aPos; 
end 
  





   for j=1:12 
       if x10(j)<0 
           x10(j)=0; 
       end 
   end 
    
   Y(i+1,:)=x10; 





 %number of iterations 
 mn = (fin-start)*2; 
 ttt = (min(DataTime):0.5: max(DataTime)); 
 for i=1:mn 
    i; 
 time = start + (i-1)/2; 
 
%switch to fed-batch a-values 
 if time>47 %51 for 7(3) and 47 for 7(4) 
    load a12 
    a= aExA; 
 end 
 
%switch to post-exponential phase 
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 if time>=140 %switch for 7(3)=140, for 7(4)=140 
    load a12 
    a = aPos; 
 end 




 if batch==3 %Exp7(3), Dilutions are initiated in total 0.5 hrs before 
diluted point 
   if time==51 
       for u = 1:12 
           node=2; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
        end 
   elseif time==55 
       for u = 1:12 
           node=4; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==56 
       for u = 1:12 
           node=5; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==71 
       for u = 1:12 
           node=8; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==72 
       for u = 1:12 
           node=9; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
       elseif time==75 
       for u = 1:12 
           node=10; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
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       end 
   elseif time==80 
       for u = 1:12 
           node=11; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==96 
       for u = 1:12 
           node=13; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==100 
       for u = 1:12 
           node=16; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u);+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==104 
       for u = 1:12 
           node=17; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==120 
       for u = 1:12 
           node=20; dist=DataTime(node+1)-DataTime(node); %node=Number of 
Data Node before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   else 
       x10=x01(a1,:); 
       t10=A1(a1,1); 
   end 
  
elseif batch==4 %Exp7(4), Dilutions  are initiated in total 0.5 hrs before 
diluted point 
        if time==43 
        for u = 1:12 
           node=2; 
           dist=DataTime(node+1)-DataTime(node);%node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
    elseif time==54 
        for u = 1:11 
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           node=5; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==71 
        for u = 1:11 
           node=8; 
           dist=DataTime(node+1)-DataTime(node) ;%node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==75 
        for u = 1:11 
           node=12; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==80 
        for u = 1:11 
           node=14; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
        end 
   elseif time==96 
        for u = 1:11 
           node=16; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end     
   elseif time==104 
        for u = 1:11 
           node=20; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
       end 
   elseif time==120 
        for u = 1:11 
           node=23; 
           dist=DataTime(node+1)-DataTime(node); %node=Number of Data Node 
before Dilution 
           v=i+1-2*dist; 
           x10(u)=Y(v,u)+(x10f(node+1,u)-x10f(node,u)); 
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       end 
   else 
       x10=x01(a1,:); 
       t10=A1(a1,1); 
   end 
 else % for Batch Experiments without Dilution 
 x10=x01(a1,:); 
 end   
  %*********************all outputs are positive*************** 
  
   for j=1:12 
       if x10(j)<0 
           x10(j)=0; 
       end 
   end 
    
   Y(i+1,:)=x10; 
   T(i+1,:)=t10; 
end 
end  










F = Y(:,1); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,2) 
F = Y(:,2); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,3) 
F = Y(:,3); 








axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,4) 
F = Y(:,4); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,5) 
F = Y(:,13); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,6) 
F = Y(:,12)*1E-6; %Mab goes in with 1E6 the value, to get a reasonable a-
coeffcient during the QP 












F = Y(:,11); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,2) 
F = Y(:,9); 








axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,3) 
F = Y(:,10); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,4) 
F = Y(:,7); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,5) 
F = Y(:,8); 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
subplot(2,3,6) 
F = Y(:,6)*0.1; 






axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
  
figure(3) 







axis([start length min(min(F),min(E)) max(max(F),max(E))]) 
 
Sub-routine for the Integrated Model: 
 
function xp=Testing_a_function(t,x) 









   kg=0.04;%0.05; 0.04 for fb; 0.04 for batch 
   kd=0.001; 
   kG=4;kQ=0.03; 




    kG=4;kQ=0.05; 
    kU=0.01;kS=0.12;kF=0.05; 
    if t<=47 
    kg=0.04; 
    kd=0.001; 
    else 
    kg=0.04; 
    kd=0.0001; 








%G-Glucose; Q-GLutamine; L-Lactate; N-Ammonia; U-GlutamicAcid; 
%S-Asparagine; F-Aspartic Acid; B-Alanine; P-Proline; M-Biomass; A-MAb;  



















Xv=(kg*X*Q/(Q+0.05))-(kd*X*L/(Q+0.43)); %rate equation for viable cells  




size(K1);%size of K1 is 11X9 





Optimization for Biomass Model 
Main File for Optimizing kg and kd in Biomass Model : 
 
% MAIN PROGRAM FOR FED-BATCH EXPERIMENT: 2EQN 
clear all; 






Sub-routine for Optimizing kg and kd- Fedbatch Mode: 
 
% clear all; 
%Experiment 7(2) 2EQN 2TERM 
function ss = fedb_deathonly(k) 
global tspan  
% k 
k = [0.0004;0.4303]; 
kd = k(1); 
a4 = k(2); 
ZZ0 = 0.237; 
tspan = [27; 43]; 
[t1,X1] = ode23s(@ode_fedb_deathonly,tspan,ZZ0,[],kd,a4); 
YY1 = X1(max(size(X1))); 
ZZ1 = 0.812*X1(max(size(X1)),:);%after 43 
  
tspan = [43; 47; 51]; 
[t2,X2] = ode23s(@ode_fedb_deathonly,tspan,ZZ1,[],kd,a4); 
b2 = max(size(X2)); 
YY2 = X2(2:max(size(X2))); 
ZZ2 = (0.865)*X2(max(size(X2)),:);%after 51 
  
tspan = [51; 52; 55]; 
[t3,X3] = ode23s(@ode_fedb_deathonly,tspan,ZZ2,[],kd,a4); 
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b3 = max(size(X3)); 
YY3 = X3(2:max(size(X2))); 
ZZ3 = X3(b3);%after 55 
  
tspan = [55; 56; 67]; 
[t4,X4] = ode23s(@ode_fedb_deathonly,tspan,ZZ3,[],kd,a4); 
b4 = max(size(X4)); 
YY4 = X4(2:b4); 
ZZ4 = 0.88*X4(b4);%after 67 
  
tspan = [67; 68; 71]; 
[t5,X5] = ode23s(@ode_fedb_deathonly,tspan,ZZ4,[],kd,a4); 
b5 = max(size(X5)); 
YY5 = X5(2:b5); 
ZZ5 = 0.874*X5(b5);%after 71 
  
tspan = [71; 72; 75]; 
[t6,X6] = ode23s(@ode_fedb_deathonly,tspan,ZZ5,[],kd,a4); 
b6 = max(size(X6)); 
YY6 = X6(2:b6); 
ZZ6 = 0.774*X6(b6);%after 75 
  
tspan = [75; 76; 80]; 
[t7,X7] = ode23s(@ode_fedb_deathonly,tspan,ZZ6,[],kd,a4); 
b7 = max(size(X7)); 
YY7 = X7(2:b7); 
ZZ7 = 0.794*X7(b7);%after 80 
  
tspan = [80; 81; 96]; 
[t8,X8] = ode23s(@ode_fedb_deathonly,tspan,ZZ7,[],kd,a4); 
b8 = max(size(X8)); 
YY8 = X8(2:b8); 
ZZ8 = 0.884*X8(b8); 
  
tspan = [96; 97; 100]; 
[t9,X9] = ode23s(@ode_fedb_deathonly,tspan,ZZ8,[],kd,a4); 
b9 = max(size(X9)); 
YY9 = X9(2:b9); 
ZZ9 = 0.88*X9(b9);%after 100 
  
tspan = [100; 101]; 
[t10,X10] = ode23s(@ode_fedb_deathonly,tspan,ZZ9,[],kd,a4); 
b10 = max(size(X10)); 
YY10 = X10(b10); 
ZZ10 = 0.87*X10(b10);%after 101 
  
tspan = [101; 104]; 
[t11,X11] = ode23s(@ode_fedb_deathonly,tspan,ZZ10,[],kd,a4); 
b11 = max(size(X11)); 
YY11 = X11(b11); 




tspan = [104; 105; 116]; 
[t12,X12] = ode23s(@ode_fedb_deathonly,tspan,ZZ11,[],kd,a4); 
b12 = max(size(X12)); 
YY12 = X12(2:b12); 
ZZ12 = 0.925*X12(b12); 
  
tspan = [116; 120; 124]; 
[t13,X13] = ode23s(@ode_fedb_deathonly,tspan,ZZ12,[],kd,a4); 
b13 = max(size(X13)); 
YY13 = X13(2:b13); 
ZZ13 = 0.87*X13(b13);%after 124 
  
tspan = [124; 140; 144]; 
[t14,X14] = ode23s(@ode_fedb_deathonly,tspan,ZZ13,[],kd,a4); 
b14 = max(size(X14)); 
YY14 = X13(2:b14); 
ZZ14 = X14(b14); %after 144 
  
tspan = [144; 148; 164]; 
[t15,X15] = ode23s(@ode_fedb_deathonly,tspan,ZZ14,[],kd,a4); 
b15 = max(size(X15)); 
YY15 = X15(2:b15); 
ZZ15 = X15(b15); %after 164 
  
tspan = [164; 168; 172; 189; 194]; 
[t16,X16] = ode23s(@ode_fedb_deathonly,tspan,ZZ15,[],kd,a4); 
b16 = max(size(X16)); 
YY16 = X16(2:b16); 







t = [ 27; 43; 47; 51; 52; 55; 56; 67; 68; 71; 72; 75;76; 80; 81; 96; 97; 
100; 101; 104; 105; 116; 120; 124; 140; 144; 148; 164; 168; 172; 189; 194 
];%time 
% Xv = [1.41, 2.8, 4.75, 4, 3.7, 4, 6.23 4, 3.65, 7.20, 6.44, 5.05, 4.10, 
5, 3.97, 6.55, 5.96, 5.70, 5.12, 5.1, 4.06, 4.9, 6.45, 6.05, 6.15, 7.10, 
6.25, 4.05, 2.65, 0.85, 1.50, 1.05]';%viable cell concentration 
Xd = [0.237, 0.5238, 0.5248, 0.5998, 0.548, 0.4999, 0.7787, 0.85, 0.7758, 
0.4997, 0.4470, 0.5, 0.406, 0.35 0.2778, 0.7497, 0.6821, 0.8002, 0.7188, 
0.6002, 0.4778, 0.6, 1.05, 0.9996, 2.05, 2.4997, 1.95, 5.5, 5, 1.1748, 
5.9, 8.3 ]';%dead cell concentration 
size(Xd); 
ss = sum((X-Xd).^2) 
  
 
Sub-routine called to the MAT file above- Fed-batch Mode: 
 
%... for experiment 7(2): 2 EQN 2 TERM after correlation 
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function dX = ode_fedb_deathonly(t,X,kd,a4) 
global tspan  
a5 = 1; 
  
%time = 27 to 43 hrs 
if tspan(1) == 27 
Glnp = -0.03375*t+3.21125; 
Lacp = (1000/90)*(0.038125*t-0.29); 
te = [27;43]; 
Xv = [1.41;2.8]; 
Xe = interp1(te,Xv,t); 





%time = 43 to 51 hrs 
if tspan(1) == 43 
Glnp = -0.065*t+4.555; 
Lacp = (1000/90)*(0.025*t+0.275); 
te = [43;51]; 
Xv = [2.8;4]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 51 to 55 
if tspan(1) == 51 
Glnp = -0.065*t+4.555+0.11; 
Lacp = (1000/90)*(0.025*t+0.275-0.05); 
te = [52; 55]; 
Xv = [3.7;4]; 
Xe = interp1(te,Xv,t,'linear','extrap'); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 55 to 67 hrs 
if tspan(1) == 55 
Glnp = -0.065*t+4.555+0.7; 
Lacp = (1000/90)*(0.025*t+0.275-0.4); 
te = [55;75]; 
Xv = [4;5.05]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
t; 
end 
%time = 67 to 71 
if tspan(1) == 67  
Glnp = -0.065*t+4.555+0.8; 
Lacp = (1000/90)*(0.025*t+0.275-0.5); 
te = [67;71]; 
Xv = [4;7.2]; 
Xe = interp1(te,Xv,t); 




%time = 71 to 75 
if tspan(1) == 71  
Glnp = -0.065*t+4.555+1.2; 
Lacp = (1000/90)*(0.025*t+0.275-0.7); 
te = [55;75]; 
Xv = [4;5.05]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 75 to 80 
if tspan(1) == 75 
Glnp = -0.065*t+4.555+1.6; 
Lacp = (1000/90)*(0.025*t+0.275-0.9); 
te = [76; 80]; 
Xv = [4.1;5]; 
Xe = interp1(te,Xv,t,'linear','extrap'); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 80 to 96 
if tspan(1) == 80 
Glnp = -0.065*t+4.555+2.2; 
Lacp = (1000/90)*(0.03933*t-2.086); 
te = [81; 96]; 
Xv = [3.97;6.55]; 
Xe = interp1(te,Xv,t,'linear','extrap'); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 96 to 100 
if tspan(1) == 96 
Glnp = -0.065*t+4.555+2.8; 
Lacp = (1000/90)*(0.03933*t-2.086-0.2); 
te = [96; 97; 100]; 
Xv = [6.55;5.96;5.70]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 100 to 101 
if tspan(1) == 100 
Glnp = -0.065*t+4.555+3; 
Lacp = (1000/90)*(0.03933*t-2.086-0.4); 
te = [100; 101]; 
Xv = [5.70;5.12]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 101 to 104 
if tspan(1) == 101 
Glnp = -0.065*t+4.555+3; 
Lacp = (1000/90)*(0.03933*t-2.086-0.4); 
te = [101; 104]; 
Xv = [5.12;5.10]; 
Xe = interp1(te,Xv,t); 




%time = 104 to 116 
if tspan(1) == 104 
Glnp = -0.05*t+4.555+2.1; 
Lacp = (1000/90)*(0.03933*t-2.086-0.85); 
te = [104; 105; 116]; 
Xv = [5.10;4.06;4.90]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 116 to 124 
if tspan(1) == 116 
Glnp = -0.05*t+4.555+2.1; 
Lacp = (1000/90)*(0.01875*t-0.625); 
te = [116;124]; 
Xv = [4.90;6.05]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 124 to 144 
if tspan(1) == 124 
Glnp = (-0.023*t+3.3658); 
Lacp = (1000/90)*(0.00625*t+0.895); 
te = [124;144]; 
Xv = [6.05;7.10]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
end 
%time = 144 to 164 
if tspan(1) == 144 
Glnp = (-0.003*t+0.5); 
Lacp = (1000/90)*(0.00625*t+0.895); 
te = [144; 148; 164]; 
Xv = [7.1;6.25;4.05]; 
Xe = interp1(te,Xv,t); 
dX = Xe*kd*(Lacp)*a5/(Glnp+a4); 
dX; 
end 
%time = 164 to 194 
if tspan(1) == 164 
Glnp = 0; 
Lacp = (1000/90)*(0.00625*t+0.895); 
te = [164;189; 194]; 
Xv = [4.05;1.5;1.05]; 
Xe = interp1(te,Xv,t); 




Sub-routine for Optimizing kg and kd- Batch Mode : 
 
% clear all; 
%Experiment 250(3) 2EQN 2TERM 
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function ss = b250_3_lin(k) 
global tspan 
k=[0.0004;0.43]; 
% k = [0.05;0.05]; 
kg = 0.05; 
a1 = 0.05; 
ZZ0 = [1.5,0.258]; 
tspan = [22;49;75;96;121;144;166]; 






Xv = [1.6,7.8,10.5,8.8,6.1,2.3,1.6]'; 




ss = sum((X(:,2)-Xd).^2); 
% ss = sum((X(:,1)-Xv).^2) + sum((X(:,2)-Xd).^2); 
xlabel('Time(in hrs)') 
hold on 







Sub-routine called to the MAT file above- Batch Mode: 
 
%... for experiment 250(3): 2 EQN 2 TERM after correlation 
function dX = odeb250_3_lin(t,X,kg,a1,k) 
global tspan 
kd = k(1); 
a2 = k(2); 
dX = zeros(2,1); 
t;   %i= i+1; 
te = [22,49,75,96,121,144,166]; 
Ge = [2.83,0.92,0,0,0,0,0]; 
Le = (1000/90)*[0.44,1.41,1.68,1.64,1.63,1.66,1.77]; 
Glnp = interp1(te,Ge,t); 
Lacp = interp1(te,Le,t); 
dX(1) = kg*X(1)*(Glnp/(Glnp+a1)) -  kd*X(1)*Lacp/(Glnp+a2); 
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